BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425-456. [PMID: 21073339 DOI: 10.1146/annurev-pathol-011110-130246] [Cited by in Crossref: 937] [Cited by in F6Publishing: 920] [Article Influence: 93.7] [Reference Citation Analysis]
Number Citing Articles
1 Sun WY, Song Y, Hu SS, Wang QT, Wu HX, Chen JY, Wei W. Depletion of β-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway. J Cell Biochem. 2013;114:1153-1162. [PMID: 23192415 DOI: 10.1002/jcb.24458] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
2 Westra IM, Oosterhuis D, Groothuis GM, Olinga P. The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices. PLoS One 2014;9:e95462. [PMID: 24755660 DOI: 10.1371/journal.pone.0095462] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
3 Tang J, Yan Z, Feng Q, Yu L, Wang H. The Roles of Neutrophils in the Pathogenesis of Liver Diseases. Front Immunol 2021;12:625472. [PMID: 33763069 DOI: 10.3389/fimmu.2021.625472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chen Q, Zhang H, Cao Y, Li Y, Sun S, Zhang J, Zhang G. Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways. Drug Des Devel Ther 2017;11:2179-91. [PMID: 28794616 DOI: 10.2147/DDDT.S137507] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 9.8] [Reference Citation Analysis]
5 Ma X, Zhou Y, Qiao B, Jiang S, Shen Q, Han Y, Liu A, Chen X, Wei L, Zhou L, Zhao J. Androgen aggravates liver fibrosis by activation of NLRP3 inflammasome in CCl4-induced liver injury mouse model. Am J Physiol Endocrinol Metab 2020;318:E817-29. [PMID: 32182125 DOI: 10.1152/ajpendo.00427.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Fausther M, Lavoie EG, Dranoff JA. Contribution of Myofibroblasts of Different Origins to Liver Fibrosis. Curr Pathobiol Rep 2013;1:225-30. [PMID: 23997993 DOI: 10.1007/s40139-013-0020-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
7 Qiu J, Zhou Q, Zhai X, Jia X, Zhou Y. Curcumin regulates delta-like homolog 1 expression in activated hepatic stellate cell. European Journal of Pharmacology 2014;728:9-15. [DOI: 10.1016/j.ejphar.2014.01.074] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
8 Chen L, Li L, Chen J, Li L, Zheng Z, Ren J, Qiu Y. Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells. Oncotarget 2015;6:42530-40. [PMID: 26729705 DOI: 10.18632/oncotarget.6466] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
9 Adhikari R, Shah R, Reyes-Gordillo K, Arellanes-Robledo J, Cheng Y, Ibrahim J, Tuma PL. Spermidine Prevents Ethanol and Lipopolysaccharide-Induced Hepatic Injury in Mice. Molecules 2021;26:1786. [PMID: 33810101 DOI: 10.3390/molecules26061786] [Reference Citation Analysis]
10 Qin L, Qin J, Zhen X, Yang Q, Huang L. Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12/CXCR4 biological axis in liver fibrosis:A study in vitro and in vivo. Biomed Pharmacother 2018;101:599-607. [PMID: 29518606 DOI: 10.1016/j.biopha.2018.02.091] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
11 Namsen R, Rojanasthien N, Sireeratawong S, Rojsanga P, Nimlamool W, Potikanond S. Thunbergia laurifolia Exhibits Antifibrotic Effects in Human Hepatic Stellate Cells. Evid Based Complement Alternat Med 2017;2017:3508569. [PMID: 29410686 DOI: 10.1155/2017/3508569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Fan QQ, Zhang CL, Qiao JB, Cui PF, Xing L, Oh YK, Jiang HL. Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy. Biomaterials 2020;230:119616. [PMID: 31837823 DOI: 10.1016/j.biomaterials.2019.119616] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
13 Duarte S, Baber J, Fujii T, Coito AJ. Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biol 2015;44-46:147-56. [PMID: 25599939 DOI: 10.1016/j.matbio.2015.01.004] [Cited by in Crossref: 215] [Cited by in F6Publishing: 201] [Article Influence: 35.8] [Reference Citation Analysis]
14 Guan Y, Enejder A, Wang M, Fang Z, Cui L, Chen SY, Wang J, Tan Y, Wu M, Chen X, Johansson PK, Osman I, Kunimoto K, Russo P, Heilshorn SC, Peltz G. A human multi-lineage hepatic organoid model for liver fibrosis. Nat Commun 2021;12:6138. [PMID: 34686668 DOI: 10.1038/s41467-021-26410-9] [Reference Citation Analysis]
15 Caviglia JM, Yan J, Jang MK, Gwak GY, Affo S, Yu L, Olinga P, Friedman RA, Chen X, Schwabe RF. MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis. Hepatology 2018;67:2414-29. [PMID: 29091291 DOI: 10.1002/hep.29627] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
16 Han K, Zhang Y, Yang Z. Cilostazol protects rats against alcohol-induced hepatic fibrosis via suppression of TGF-β1/CTGF activation and the cAMP/Epac1 pathway. Exp Ther Med 2019;17:2381-8. [PMID: 30867723 DOI: 10.3892/etm.2019.7207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Qiao H, Zhou Y, Qin X, Cheng J, He Y, Jiang Y. NADPH Oxidase Signaling Pathway Mediates Mesenchymal Stem Cell-Induced Inhibition of Hepatic Stellate Cell Activation. Stem Cells Int 2018;2018:1239143. [PMID: 29861737 DOI: 10.1155/2018/1239143] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
18 Sepulveda-Crespo D, Resino S, Martinez I. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis. Drugs 2021;81:419-43. [PMID: 33400242 DOI: 10.1007/s40265-020-01458-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Lestari N, Louisa M, Soetikno V, Suwana AG, Ramadhan PA, Akmal T, Arozal W. Alpha Mangostin Inhibits the Proliferation and Activation of Acetaldehyde Induced Hepatic Stellate Cells through TGF-β and ERK 1/2 Pathways. J Toxicol 2018;2018:5360496. [PMID: 30538742 DOI: 10.1155/2018/5360496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Fausther M, Lavoie EG, Goree JR, Dranoff JA. An Elf2-like transcription factor acts as repressor of the mouse ecto-5'-nucleotidase gene expression in hepatic myofibroblasts. Purinergic Signal 2017;13:417-28. [PMID: 28667437 DOI: 10.1007/s11302-017-9570-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Nithyananthan S, Thirunavukkarasu C. Arsenic trioxide, a cancer chemo drug hampers fibrotic liver regeneration by interrupting oxidative stress rekindling and stellate cell rejuvenation. J Cell Physiol 2020;235:1222-34. [PMID: 31270803 DOI: 10.1002/jcp.29037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
22 Lin N, Chen Z, Lu Y, Li Y, Hu K, Xu R. Role of activated hepatic stellate cells in proliferation and metastasis of hepatocellular carcinoma: Role of aHSC in HCC development. Hepatol Res 2015;45:326-36. [DOI: 10.1111/hepr.12356] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
23 Liu X, Wu Y, Yang Y, Li W, Huang C, Meng X, Li J. Role of NLRC5 in progression and reversal of hepatic fibrosis. Toxicology and Applied Pharmacology 2016;294:43-53. [DOI: 10.1016/j.taap.2016.01.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
24 Pesce A, Ciurleo R, Bramanti A, Armeli Iapichino EC, Petralia MC, Magro GG, Fagone P, Bramanti P, Nicoletti F, Mangano K. Effects of Combined Admistration of Imatinib and Sorafenib in a Murine Model of Liver Fibrosis. Molecules 2020;25:E4310. [PMID: 32962198 DOI: 10.3390/molecules25184310] [Reference Citation Analysis]
25 Zou Y, Li S, Li Z, Song D, Zhang S, Yao Q. MiR-146a attenuates liver fibrosis by inhibiting transforming growth factor-β1 mediated epithelial-mesenchymal transition in hepatocytes. Cell Signal 2019;58:1-8. [PMID: 30711634 DOI: 10.1016/j.cellsig.2019.01.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
26 Hall KC, Bernier SG, Jacobson S, Liu G, Zhang PY, Sarno R, Catanzano V, Currie MG, Masferrer JL. sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH. Proc Natl Acad Sci U S A 2019;116:11057-62. [PMID: 31085647 DOI: 10.1073/pnas.1821045116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
27 Mutanen A, Lohi J, Sorsa T, Jalanko H, Pakarinen MP. Features of liver tissue remodeling in intestinal failure during and after weaning off parenteral nutrition. Surgery 2016;160:632-42. [DOI: 10.1016/j.surg.2016.04.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
28 Bae M, Park YK, Lee JY. Food components with antifibrotic activity and implications in prevention of liver disease. J Nutr Biochem 2018;55:1-11. [PMID: 29268106 DOI: 10.1016/j.jnutbio.2017.11.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
29 Wang X, Ai L, Xu Q, Wu C, Chen Z, Su D, Jiang X, Fan Z. A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses. Inflammation 2017;40:840-8. [PMID: 28251449 DOI: 10.1007/s10753-017-0528-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
30 Mazo DF, de Oliveira MG, Pereira IV, Cogliati B, Stefano JT, de Souza GF, Rabelo F, Lima FR, Ferreira Alves VA, Carrilho FJ. S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. Drug Des Devel Ther. 2013;7:553-563. [PMID: 23843692 DOI: 10.2147/dddt.s43930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
31 Wei X, Chen Y, Huang W. Ginsenoside Rg1 ameliorates liver fibrosis via suppressing epithelial to mesenchymal transition and reactive oxygen species production in vitro and in vivo. Biofactors 2018. [PMID: 29761840 DOI: 10.1002/biof.1432] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
32 Deng YL, Xiong XZ, Cheng NS. Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists. Hepatobiliary Pancreat Dis Int 2012;11:467-78. [PMID: 23060391 DOI: 10.1016/s1499-3872(12)60210-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
33 Wan Y, Ceci L, Wu N, Zhou T, Chen L, Venter J, Francis H, Bernuzzi F, Invernizzi P, Kyritsi K, Baker P, Huang Q, Wu C, Sybenga A, Alpini G, Meng F, Glaser S. Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes. Lab Invest 2019;99:764-76. [PMID: 30700848 DOI: 10.1038/s41374-018-0178-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
34 Hu L, Lin X, Lu H, Chen B, Bai Y. An overview of hedgehog signaling in fibrosis. Mol Pharmacol 2015;87:174-82. [PMID: 25395043 DOI: 10.1124/mol.114.095141] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
35 Wong GL. Prediction of fibrosis progression in chronic viral hepatitis. Clin Mol Hepatol 2014;20:228-36. [PMID: 25320725 DOI: 10.3350/cmh.2014.20.3.228] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
36 Furtado KS, Polletini J, Dias MC, Rodrigues MA, Barbisan LF. Prevention of rat liver fibrosis and carcinogenesis by coffee and caffeine. Food Chem Toxicol 2014;64:20-6. [PMID: 24275088 DOI: 10.1016/j.fct.2013.11.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
37 El-Ahwany E, Nagy F, Zoheiry M, Shemis M, Nosseir M, Taleb HA, El Ghannam M, Atta R, Zada S. Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis. Electron Physician. 2016;8:1804-1810. [PMID: 26955452 DOI: 10.19082/1804] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
38 Aher JS, Khan S, Jain S, Tikoo K, Jena G. Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation. Hum Exp Toxicol. 2015;34:44-55. [PMID: 24812151 DOI: 10.1177/0960327114531992] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
39 Chowdhury MR, Sagor MA, Tabassum N, Potol MA, Hossain H, Alam MA. Supplementation of Citrus maxima Peel Powder Prevented Oxidative Stress, Fibrosis, and Hepatic Damage in Carbon Tetrachloride (CCl4) Treated Rats. Evid Based Complement Alternat Med 2015;2015:598179. [PMID: 26106435 DOI: 10.1155/2015/598179] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
40 Yovchev MI, Xue Y, Shafritz DA, Locker J, Oertel M. Repopulation of the fibrotic/cirrhotic rat liver by transplanted hepatic stem/progenitor cells and mature hepatocytes. Hepatology. 2014;59:284-295. [PMID: 23840008 DOI: 10.1002/hep.26615] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 5.5] [Reference Citation Analysis]
41 Ibba-Manneschi L, Rosa I, Manetti M. Telocyte implications in human pathology: An overview. Semin Cell Dev Biol 2016;55:62-9. [PMID: 26805444 DOI: 10.1016/j.semcdb.2016.01.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
42 Chen G, Xia B, Fu Q, Huang X, Wang F, Chen Z, Lv Y. Matrix Mechanics as Regulatory Factors and Therapeutic Targets in Hepatic Fibrosis. Int J Biol Sci 2019;15:2509-21. [PMID: 31754325 DOI: 10.7150/ijbs.37500] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
43 Liu H, Chen Z, Jin W, Barve A, Wan YY, Cheng K. Silencing of α-complex protein-2 reverses alcohol- and cytokine-induced fibrogenesis in hepatic stellate cells. Liver Res 2017;1:70-9. [PMID: 28966795 DOI: 10.1016/j.livres.2017.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
44 Hung W, Yang G, Wang Y, Chiou Y, Tung Y, Yang M, Wang B, Ho C, Wang Y, Pan M. Protective effects of theasinensin A against carbon tetrachloride-induced liver injury in mice. Food Funct 2017;8:3276-87. [DOI: 10.1039/c7fo00700k] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 3.8] [Reference Citation Analysis]
45 Lee DY, Yun SM, Song MY, Ji SD, Son JG, Kim EH. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats. Cells 2020;9:E568. [PMID: 32121064 DOI: 10.3390/cells9030568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Yan Y, Guan C, Du S, Zhu W, Ji Y, Su N, Mei X, He D, Lu Y, Zhang C, Xing XH. Effects of Enzymatically Depolymerized Low Molecular Weight Heparins on CCl4-Induced Liver Fibrosis. Front Pharmacol. 2017;8:514. [PMID: 28871223 DOI: 10.3389/fphar.2017.00514] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
47 He Q, Fu Y, Ding X, Li D, Wang Z, Tian D, Yan W. High-mobility group box 1 induces endoplasmic reticulum stress and activates hepatic stellate cells. Lab Invest 2018;98:1200-10. [PMID: 29959419 DOI: 10.1038/s41374-018-0085-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
48 Pérez-Vargas JE, Zarco N, Vergara P, Shibayama M, Segovia J, Tsutsumi V, Muriel P. l-Theanine prevents carbon tetrachloride-induced liver fibrosis via inhibition of nuclear factor κB and down-regulation of transforming growth factor β and connective tissue growth factor. Hum Exp Toxicol. 2016;35:135-146. [PMID: 25852135 DOI: 10.1177/0960327115578864] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
49 Kim JH, Lee S, Lee MY, Shin HK. Therapeutic effect of Soshiho-tang, a traditional herbal formula, on liver fibrosis or cirrhosis in animal models: a systematic review and meta-analysis. J Ethnopharmacol 2014;154:1-16. [PMID: 24727191 DOI: 10.1016/j.jep.2014.03.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
50 Cui X, Zhang X, Yin Q, Meng A, Su S, Jing X, Li H, Guan X, Li X, Liu S. F actin cytoskeleton reorganization is associated with hepatic stellate cell activation. Mol Med Rep. 2014;9:1641-1647. [PMID: 24626324 DOI: 10.3892/mmr.2014.2036] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
51 Liu Y, Yang X, Jing Y, Zhang S, Zong C, Jiang J, Sun K, Li R, Gao L, Zhao X, Wu D, Shi Y, Han Z, Wei L. Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis. Sci Rep. 2015;5:17762. [PMID: 26643997 DOI: 10.1038/srep17762] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
52 Zhou L, Dong X, Wang L, Shan L, Li T, Xu W, Ding Y, Lai M, Lin X, Dai M, Bai X, Jia C, Zheng H. Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway. Oncotarget 2017;8:56267-80. [PMID: 28915589 DOI: 10.18632/oncotarget.17453] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
53 Yazdani S, Bansal R, Prakash J. Drug targeting to myofibroblasts: Implications for fibrosis and cancer. Advanced Drug Delivery Reviews 2017;121:101-16. [DOI: 10.1016/j.addr.2017.07.010] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 17.3] [Reference Citation Analysis]
54 Gabbia D, Carpi S, Sarcognato S, Cannella L, Colognesi M, Scaffidi M, Polini B, Digiacomo M, Esposito Salsano J, Manera C, Macchia M, Nieri P, Carrara M, Russo FP, Guido M, De Martin S. The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver. Front Nutr 2021;8:715183. [PMID: 34671630 DOI: 10.3389/fnut.2021.715183] [Reference Citation Analysis]
55 de Azevedo LA, Matte U, da Silveira TR, Álvares-da-Silva MR. Genetic variants underlying vitamin D metabolism and VDR-TGFβ-1-SMAD3 interaction may impact on HCV progression: a study based on dbGaP data from the HALT-C study. J Hum Genet 2017;62:969-77. [PMID: 28703134 DOI: 10.1038/jhg.2017.75] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
56 Seubert B, Grünwald B, Kobuch J, Cui H, Schelter F, Schaten S, Siveke JT, Lim NH, Nagase H, Simonavicius N, Heikenwalder M, Reinheckel T, Sleeman JP, Janssen KP, Knolle PA, Krüger A. Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatology 2015;61:238-48. [PMID: 25131778 DOI: 10.1002/hep.27378] [Cited by in Crossref: 97] [Cited by in F6Publishing: 91] [Article Influence: 13.9] [Reference Citation Analysis]
57 Nithyananthan S, Thirunavukkarasu C. Chemotherapeutic doses of arsenic trioxide delays hepatic regeneration by oxidative stress and hepatocyte apoptosis in partial hepatectomy rat. Toxicology and Applied Pharmacology 2019;382:114760. [DOI: 10.1016/j.taap.2019.114760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
58 Coll M, Perea L, Boon R, Leite SB, Vallverdú J, Mannaerts I, Smout A, El Taghdouini A, Blaya D, Rodrigo-Torres D, Graupera I, Aguilar-Bravo B, Chesne C, Najimi M, Sokal E, Lozano JJ, van Grunsven LA, Verfaillie CM, Sancho-Bru P. Generation of Hepatic Stellate Cells from Human Pluripotent Stem Cells Enables In Vitro Modeling of Liver Fibrosis. Cell Stem Cell 2018;23:101-113.e7. [PMID: 30049452 DOI: 10.1016/j.stem.2018.05.027] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 26.7] [Reference Citation Analysis]
59 Li Z, Sun J, Yang X. Recent advances in molecular magnetic resonance imaging of liver fibrosis. Biomed Res Int 2015;2015:595467. [PMID: 25874221 DOI: 10.1155/2015/595467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
60 Yue Z, Jiang Z, Ruan B, Duan J, Song P, Liu J, Han H, Wang L. Disruption of myofibroblastic Notch signaling attenuates liver fibrosis by modulating fibrosis progression and regression. Int J Biol Sci 2021;17:2135-46. [PMID: 34239344 DOI: 10.7150/ijbs.60056] [Reference Citation Analysis]
61 Charchanti A, Kanavaros P, Koniaris E, Kataki A, Glantzounis G, Agnantis NJ, Goussia AC. Expression of Syndecan-1 in Chronic Liver Diseases: Correlation With Hepatic Fibrosis. In Vivo 2021;35:333-9. [PMID: 33402482 DOI: 10.21873/invivo.12264] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Karsdal M, Nielsen S, Leeming D, Langholm L, Nielsen M, Manon-jensen T, Siebuhr A, Gudmann N, Rønnow S, Sand J, Daniels S, Mortensen J, Schuppan D. The good and the bad collagens of fibrosis – Their role in signaling and organ function. Advanced Drug Delivery Reviews 2017;121:43-56. [DOI: 10.1016/j.addr.2017.07.014] [Cited by in Crossref: 167] [Cited by in F6Publishing: 150] [Article Influence: 41.8] [Reference Citation Analysis]
63 Embade N, Mariño Z, Diercks T, Cano A, Lens S, Cabrera D, Navasa M, Falcón-Pérez JM, Caballería J, Castro A, Bosch J, Mato JM, Millet O. Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy. PLoS One 2016;11:e0155094. [PMID: 27158896 DOI: 10.1371/journal.pone.0155094] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
64 Yang G, Zhan J, Yang Y, Yuan L, Wang P, Ho C, Li S. Inhibitory effects of oxyresveratrol on ERK and Smad1/2 phosphorylation and HSC activation in preventing carbon tetrachloride-induced rat liver fibrosis. Food Science and Human Wellness 2021;10:6-12. [DOI: 10.1016/j.fshw.2020.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Chen L, Zhang C, Chen L, Wang X, Xiang B, Wu X, Guo Y, Mou X, Yuan L, Chen B, Wang J, Xiang C. Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators. Stem Cells Transl Med. 2017;6:272-284. [PMID: 28170193 DOI: 10.5966/sctm.2015-0265] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
66 Chen P, Li J, Huo Y, Lu J, Wan L, Yang Q, Huang J, Gan R, Guo C. Adenovirus-mediated expression of orphan nuclear receptor NR4A2 targeting hepatic stellate cell attenuates liver fibrosis in rats. Sci Rep 2016;6:33593. [PMID: 27646469 DOI: 10.1038/srep33593] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
67 He J, Bai K, Hong B, Zhang F, Zheng S. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats. Int Immunopharmacol 2017;53:56-62. [PMID: 29035816 DOI: 10.1016/j.intimp.2017.09.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
68 Huang SC, Wang PW, Kuo PC, Hung HY, Pan TL. Hepatoprotective Principles and Other Chemical Constituents from the Mycelium of Phellinus linteus. Molecules 2018;23:E1705. [PMID: 30002357 DOI: 10.3390/molecules23071705] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
69 Dessein A, Arnaud V, He H, Li J, Dessein H, Hou X, Luo X, Li Y. Genetic analysis of human predisposition to hepatosplenic disease caused by schistosomes reveals the crucial role of connective tissue growth factor in rapid progression to severe hepatic fibrosis. Pathol Biol (Paris) 2013;61:3-10. [PMID: 23414795 DOI: 10.1016/j.patbio.2013.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
70 Zhu X, Ye S, Yu D, Zhang Y, Li J, Zhang M, Leng Y, Yang T, Luo J, Chen X, Zhang H, Kong L. Physalin B attenuates liver fibrosis via suppressing LAP2α-HDAC1-mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation. Br J Pharmacol 2021;178:3428-47. [PMID: 33864382 DOI: 10.1111/bph.15490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
71 Zhao Y, Ma X, Wang J, Zhu Y, Li R, Wang J, He X, Shan L, Wang R, Wang L, Li Y, Xiao X. Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1α through mTOR-dependent pathway. Fitoterapia 2014;99:318-27. [DOI: 10.1016/j.fitote.2014.10.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
72 Park BJ, Lee YJ, Lee HR. Chronic liver inflammation: Clinical implications beyond alcoholic liver disease. World J Gastroenterol 2014; 20(9): 2168-2175 [PMID: 24605015 DOI: 10.3748/wjg.v20.i9.2168] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
73 Wu Y, Liu X, Zhou Q, Huang C, Meng X, Xu F, Li J. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion. Toxicol Appl Pharmacol 2015;289:163-76. [PMID: 26435214 DOI: 10.1016/j.taap.2015.09.028] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 12.0] [Reference Citation Analysis]
74 Altomonte J, Marozin S, De Toni EN, Rizzani A, Esposito I, Steiger K, Feuchtinger A, Hellerbrand C, Schmid RM, Ebert O. Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis. Mol Ther 2013;21:2032-42. [PMID: 23939023 DOI: 10.1038/mt.2013.181] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
75 Lee CY, Suk FM, Twu YC, Liao YJ. Long-Term Exposure to Low-Dose Di-(2-ethylhexyl) Phthalate Impairs Cholesterol Metabolism in Hepatic Stellate Cells and Exacerbates Liver Librosis. Int J Environ Res Public Health 2020;17:E3802. [PMID: 32471116 DOI: 10.3390/ijerph17113802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Yin R, Guo D, Zhang S, Zhang X. miR-706 inhibits the oxidative stress-induced activation of PKCα/TAOK1 in liver fibrogenesis. Sci Rep 2016;6:37509. [PMID: 27876854 DOI: 10.1038/srep37509] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
77 Han M, Liu X, Liu S, Su G, Fan X, Chen J, Yuan Q, Xu G. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces hepatic stellate cell (HSC) activation and liver fibrosis in C57BL6 mouse via activating Akt and NF-κB signaling pathways. Toxicol Lett 2017;273:10-9. [PMID: 28302560 DOI: 10.1016/j.toxlet.2017.03.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
78 Zhou S, Zhu Y, Li Z, Zhu Y, He Z, Zhang C. Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway. J Cell Mol Med 2021;25:2262-73. [PMID: 33345447 DOI: 10.1111/jcmm.16219] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
79 Mallat A, Lotersztajn S. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. Am J Physiol Cell Physiol 2013;305:C789-99. [PMID: 23903700 DOI: 10.1152/ajpcell.00230.2013] [Cited by in Crossref: 144] [Cited by in F6Publishing: 136] [Article Influence: 18.0] [Reference Citation Analysis]
80 Page A, Paoli PP, Hill SJ, Howarth R, Wu R, Kweon SM, French J, White S, Tsukamoto H, Mann DA, Mann J. Alcohol directly stimulates epigenetic modifications in hepatic stellate cells. J Hepatol 2015;62:388-97. [PMID: 25457206 DOI: 10.1016/j.jhep.2014.09.033] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
81 Vallverdú J, Martínez García de la Torre RA, Mannaerts I, Verhulst S, Smout A, Coll M, Ariño S, Rubio-Tomás T, Aguilar-Bravo B, Martínez-Sánchez C, Blaya D, Verfaillie CM, van Grunsven LA, Sancho-Bru P. Directed differentiation of human induced pluripotent stem cells to hepatic stellate cells. Nat Protoc 2021;16:2542-63. [PMID: 33864055 DOI: 10.1038/s41596-021-00509-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Yuan Q, Zhang Z, Hu X, Liao J, Kuang J. miR-374a/Myc axis modulates iron overload-induced production of ROS and the activation of hepatic stellate cells via TGF-β1 and IL-6. Biochem Biophys Res Commun 2019;515:499-504. [PMID: 31171361 DOI: 10.1016/j.bbrc.2019.05.152] [Reference Citation Analysis]
83 Ramachandran S, Ilias Basha H, Sarma NJ, Lin Y, Crippin JS, Chapman WC, Mohanakumar T. Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis. PLoS One. 2013;8:e70744. [PMID: 23950995 DOI: 10.1371/journal.pone.0070744] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
84 Shu Y, Xu Q, Xu Y, Tao Q, Shao M, Cao X, Chen Y, Wu Z, Chen M, Zhou Y, Zhou P, Shi Y, Bu H. Loss of Numb promotes hepatic progenitor expansion and intrahepatic cholangiocarcinoma by enhancing Notch signaling. Cell Death Dis 2021;12:966. [PMID: 34667161 DOI: 10.1038/s41419-021-04263-w] [Reference Citation Analysis]
85 Tang M, Zhou Y, Li Y, Zou J, Yang B, Cai L, Zhang X, Liu Q. Hydrogen donors and acceptors and basic amino acids jointly contribute to carcinogenesis. Med Hypotheses 2017;98:42-4. [PMID: 28012602 DOI: 10.1016/j.mehy.2016.11.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
86 Yu X, Guo R, Ming D, Su M, Lin C, Deng Y, Lin Z, Su Z. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis. J Gastroenterol Hepatol. 2014;29:1065-1072. [PMID: 24236690 DOI: 10.1111/jgh.12459] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
87 Shah R, Reyes-Gordillo K, Arellanes-Robledo J, Lechuga CG, Hernández-Nazara Z, Cotty A, Rojkind M, Lakshman MR. TGF-β1 up-regulates the expression of PDGF-β receptor mRNA and induces a delayed PI3K-, AKT-, and p70(S6K) -dependent proliferative response in activated hepatic stellate cells. Alcohol Clin Exp Res. 2013;37:1838-1848. [PMID: 23895226 DOI: 10.1111/acer.12167] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
88 Li W, Zhang Z, Li K, Jin N, Zhang Y, Zhang T, Miller FH, Larson AC. Respiratory self-gating for free-breathing magnetization transfer MRI of the abdomen. Magn Reson Med 2015;73:2249-54. [PMID: 24962475 DOI: 10.1002/mrm.25341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
89 Ripoche J. Blood platelets and inflammation: their relationship with liver and digestive diseases. Clin Res Hepatol Gastroenterol. 2011;35:353-357. [PMID: 21482218 DOI: 10.1016/j.clinre.2011.02.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
90 Ren L, Qi K, Zhang L, Bai Z, Ren C, Xu X, Zhang Z, Li X. Glutathione Might Attenuate Cadmium-Induced Liver Oxidative Stress and Hepatic Stellate Cell Activation. Biol Trace Elem Res 2019;191:443-52. [PMID: 30715683 DOI: 10.1007/s12011-019-1641-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
91 Tang Y, Hu C, Liu Y. Effect of bioactive peptide of Carapax Trionycis on TGF-β1-induced intracellular events in hepatic stellate cells. Journal of Ethnopharmacology 2013;148:69-73. [DOI: 10.1016/j.jep.2013.03.067] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
92 Marfà S, Morales-Ruiz M, Oró D, Ribera J, Fernández-Varo G, Jiménez W. Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats. Biol Open 2016;5:858-65. [PMID: 27230648 DOI: 10.1242/bio.018887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
93 Fortoul T, Rodriguez-lara V, González-villalva A, Rojas-lemus M, Cano-gutiérrez G, Ustarroz-cano M, Colín-barenque L, Bizarro-nevares P, García-pealez I, Montaño L, Jimenez-martinez R, Lopez-valdez N, Ruiz-guerrero M, Meléndez-garcía N, García-ibarra F, Martínez-baez V, Alfaro DZ, Muñiz-rivera-cambas A, López-zepeda L, Quezada-maldonado E, Cervantes-yépez S. Inhalation of vanadium pentoxide and its toxic effects in a mouse model. Inorganica Chimica Acta 2014;420:8-15. [DOI: 10.1016/j.ica.2014.03.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
94 Yang D, Li D, Li J, Yang Z, Wang Z. Systematic review: The diagnostic efficacy of gadoxetic acid-enhanced MRI for liver fibrosis staging. Eur J Radiol 2020;125:108857. [PMID: 32113153 DOI: 10.1016/j.ejrad.2020.108857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
95 Tseng TH, Lin WL, Chen ZH, Lee YJ, Shie MS, Lee KF, Shen CH, Kuo HC. Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo. J Transl Med 2016;14:263. [PMID: 27612633 DOI: 10.1186/s12967-016-1022-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
96 Nissim O, Melis M, Diaz G, Kleiner DE, Tice A, Fantola G, Zamboni F, Mishra L, Farci P. Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profiling. PLoS One. 2012;7:e49611. [PMID: 23185381 DOI: 10.1371/journal.pone.0049611.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Bukong TN, Maurice SB, Chahal B, Schaeffer DF, Winwood PJ. Versican: a novel modulator of hepatic fibrosis. Lab Invest 2016;96:361-74. [PMID: 26752747 DOI: 10.1038/labinvest.2015.152] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
98 Qian H, Deng X, Huang ZW, Wei J, Ding CH, Feng RX, Zeng X, Chen YX, Ding J, Qiu L, Hu ZL, Zhang X, Wang HY, Zhang JP, Xie WF. An HNF1α-regulated feedback circuit modulates hepatic fibrogenesis via the crosstalk between hepatocytes and hepatic stellate cells. Cell Res 2015;25:930-45. [PMID: 26169608 DOI: 10.1038/cr.2015.84] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
99 Hui ST, Wang F, Stappenbeck F, French SW, Magyar CE, Parhami F, Lusis AJ. Oxy210, a novel inhibitor of hedgehog and TGF-β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in mice. Endocrinol Diabetes Metab 2021;4:e00296. [PMID: 34505423 DOI: 10.1002/edm2.296] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Eissa LA, Kenawy HI, El-Karef A, Elsherbiny NM, El-Mihi KA. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. Chem Biol Interact. 2018;294:91-100. [PMID: 30138605 DOI: 10.1016/j.cbi.2018.08.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
101 Zhai X, Cheng F, Ji L, Zhu X, Cao Q, Zhang Y, Jia X, Zhou Q, Guan W, Zhou Y. Leptin reduces microRNA-122 level in hepatic stellate cells in vitro and in vivo. Mol Immunol 2017;92:68-75. [PMID: 29054053 DOI: 10.1016/j.molimm.2017.10.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
102 Verbeke L, Mannaerts I, Schierwagen R, Govaere O, Klein S, Vander Elst I, Windmolders P, Farre R, Wenes M, Mazzone M, Nevens F, van Grunsven LA, Trebicka J, Laleman W. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Sci Rep. 2016;6:33453. [PMID: 27634375 DOI: 10.1038/srep33453] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 21.0] [Reference Citation Analysis]
103 Huang M, Xu J, Shin CH. Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration. J Vis Exp 2016. [PMID: 27214059 DOI: 10.3791/54002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
104 Wijesundera KK, Izawa T, Tennakoon AH, Golbar HM, Tanaka M, Kuwamura M, Yamate J. M1-/M2-macrophages contribute to the development of GST-P-positive preneoplastic lesions in chemically-induced rat cirrhosis. Experimental and Toxicologic Pathology 2015;67:467-75. [DOI: 10.1016/j.etp.2015.05.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
105 Kong D, Zhang F, Wei D, Zhu X, Zhang X, Chen L, Lu Y, Zheng S. Paeonol inhibits hepatic fibrogenesis via disrupting nuclear factor-κB pathway in activated stellate cells: In vivo and in vitro studies: Paeonol inhibits hepatic fibrogenesis. J Gastroenterol Hepatol 2013;28:1223-33. [DOI: 10.1111/jgh.12147] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
106 Cao H, Li S, Xie R, Xu N, Qian Y, Chen H, Hu Q, Quan Y, Yu Z, Liu J, Xiang M. Exploring the Mechanism of Dangguiliuhuang Decoction Against Hepatic Fibrosis by Network Pharmacology and Experimental Validation. Front Pharmacol 2018;9:187. [PMID: 29556199 DOI: 10.3389/fphar.2018.00187] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
107 Yang MH, Kim NH, Heo JD, Sung SH, Jeong EJ. Hepatoprotective effects of Limonium tetragonum, edible medicinal halophyte growing near seashores. Pharmacogn Mag 2014;10:S563-8. [PMID: 25298675 DOI: 10.4103/0973-1296.139783] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
108 Yu SJ. Regression of liver cirrhosis: orthodoxy or paradigm shift? Clin Mol Hepatol 2015;21:22-3. [PMID: 25834798 DOI: 10.3350/cmh.2015.21.1.22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
109 Horowitz JC, Ajayi IO, Kulasekaran P, Rogers DS, White JB, Townsend SK, White ES, Nho RS, Higgins PD, Huang SK, Sisson TH. Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis. Int J Biochem Cell Biol 2012;44:158-69. [PMID: 22041029 DOI: 10.1016/j.biocel.2011.10.011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
110 da Costa AN, Plymoth A, Santos-Silva D, Ortiz-Cuaran S, Camey S, Guilloreau P, Sangrajrang S, Khuhaprema T, Mendy M, Lesi OA. Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma. Int J Cancer. 2015;136:172-181. [PMID: 24803312 DOI: 10.1002/ijc.28953] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
111 Tang M, Chen Y, Li B, Sugimoto H, Yang S, Yang C, LeBleu VS, McAndrews KM, Kalluri R. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis. FASEB J 2021;35:e21557. [PMID: 33855751 DOI: 10.1096/fj.202002777RR] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Tanikawa AA, Grotto RM, Silva GF, Ferrasi AC, Sarnighausen VC, Pardini MI. Platelet-derived growth factor A mRNA in platelets is associated with the degree of hepatic fibrosis in chronic hepatitis C. Rev Soc Bras Med Trop 2017;50:113-6. [PMID: 28327812 DOI: 10.1590/0037-8682-0302-2016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
113 Chen L, Guo YZ, Li AD, Ma JJ, Hao HY, Zhang D, Wang Y, Ji CG, Qi W, Wang J, Jiang HQ. Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells. Dig Dis Sci 2016;61:1961-71. [PMID: 26879903 DOI: 10.1007/s10620-016-4075-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
114 Yang JA, Kong WH, Sung DK, Kim H, Kim TH, Lee KC, Hahn SK. Hyaluronic acid-tumor necrosis factor-related apoptosis-inducing ligand conjugate for targeted treatment of liver fibrosis. Acta Biomater 2015;12:174-82. [PMID: 25305513 DOI: 10.1016/j.actbio.2014.10.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
115 Ni MM, Xu T, Wang YR, He YH, Zhou Q, Huang C, Meng XM, Li J. Inhibition of IRF3 expression reduces TGF-β1-induced proliferation of hepatic stellate cells. J Physiol Biochem 2016;72:9-23. [PMID: 26611114 DOI: 10.1007/s13105-015-0452-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
116 Liedtke C, Luedde T, Sauerbruch T, Scholten D, Streetz K, Tacke F, Tolba R, Trautwein C, Trebicka J, Weiskirchen R. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenesis Tissue Repair. 2013;6:19. [PMID: 24274743 DOI: 10.1186/1755-1536-6-19] [Cited by in Crossref: 199] [Cited by in F6Publishing: 192] [Article Influence: 24.9] [Reference Citation Analysis]
117 Greuter T, Shah VH. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights. J Gastroenterol. 2016;51:511-519. [PMID: 26939970 DOI: 10.1007/s00535-016-1190-4] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 13.8] [Reference Citation Analysis]
118 Breuer DA, Pacheco MC, Washington MK, Montgomery SA, Hasty AH, Kennedy AJ. CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 2020;318:G211-24. [PMID: 31709830 DOI: 10.1152/ajpgi.00040.2019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
119 Doyle MA, Singer J, Lee T, Muir M, Cooper C. Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial. Trials 2016;17:331. [PMID: 27439433 DOI: 10.1186/s13063-016-1454-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
120 Armandi A, Rosso C, Caviglia GP, Bugianesi E. Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease. Metabolites 2021;11:155. [PMID: 33800465 DOI: 10.3390/metabo11030155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
121 Shaaban AA, Shaker ME, Zalata KR, El-kashef HA, Ibrahim TM. Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3. Chemico-Biological Interactions 2014;207:81-91. [DOI: 10.1016/j.cbi.2013.10.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
122 Yang YR, Bu FT, Yang Y, Li H, Huang C, Meng XM, Zhang L, Lv XW, Li J. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway. Mol Immunol 2020;126:31-9. [PMID: 32745796 DOI: 10.1016/j.molimm.2020.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Zong Z, Liu J, Wang N, Yang C, Wang Q, Zhang W, Chen Y, Liu X, Deng H. Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE2 degradation. Free Radic Biol Med 2021;162:571-81. [PMID: 33220424 DOI: 10.1016/j.freeradbiomed.2020.11.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
124 Zhang H, Chen Q, Dahan A, Xue J, Wei L, Tan W, Zhang G. Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl4-induced liver fibrosis in rats by RNA-sequencing. Chem Biol Interact 2019;309:108675. [PMID: 31150632 DOI: 10.1016/j.cbi.2019.05.041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
125 Tariq S, Koloko BL, Malik A, Rehman S, Ijaz B, Shahid AA. Tectona grandis leaf extract ameliorates hepatic fibrosis: Modulation of TGF- β /Smad signaling pathway and upregulating MMP3/TIMP1 ratio. J Ethnopharmacol 2021;272:113938. [PMID: 33610708 DOI: 10.1016/j.jep.2021.113938] [Reference Citation Analysis]
126 Wang W, Li A, Yan B, Niu S, Tang J, Li X, Du X, Challis GL, Che Y, Sun H, Pu J. LC-MS-Guided Isolation of Penicilfuranone A: A New Antifibrotic Furancarboxylic Acid from the Plant Endophytic Fungus Penicillium sp. sh18. J Nat Prod 2016;79:149-55. [DOI: 10.1021/acs.jnatprod.5b00814] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
127 Zeybel M, Hardy T, Robinson SM, Fox C, Anstee QM, Ness T, Masson S, Mathers JC, French J, White S, Mann J. Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease. Clin Epigenetics 2015;7:25. [PMID: 25859289 DOI: 10.1186/s13148-015-0056-6] [Cited by in Crossref: 86] [Cited by in F6Publishing: 82] [Article Influence: 14.3] [Reference Citation Analysis]
128 Yan Y, Zeng J, Xing L, Li C. Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation. Biomedicines 2021;9:1014. [PMID: 34440218 DOI: 10.3390/biomedicines9081014] [Reference Citation Analysis]
129 Niu F, Chong S, Qin M, Li S, Wei R, Zhao Y. Mechanism of Fibrosis Induced by Echinococcus spp. Diseases 2019;7:E51. [PMID: 31409055 DOI: 10.3390/diseases7030051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
130 Schneier AT, Citti CC, Dieterich DT. Management and diagnosis of fatty liver disease. Expert Rev Gastroenterol Hepatol. 2015;9:671-683. [PMID: 25716275 DOI: 10.1586/17474124.2015.1003209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
131 Bae M, Lee Y, Park YK, Shin DG, Joshi P, Hong SH, Alder N, Koo SI, Lee JY. Astaxanthin attenuates the increase in mitochondrial respiration during the activation of hepatic stellate cells. J Nutr Biochem 2019;71:82-9. [PMID: 31302374 DOI: 10.1016/j.jnutbio.2019.06.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
132 Lan T, Zhuang L, Li S, Yang G, Xuan Y, Guo J. Polydatin attenuates hepatic stellate cell proliferation and liver fibrosis by suppressing sphingosine kinase 1. Biomed Pharmacother 2020;130:110586. [PMID: 34321171 DOI: 10.1016/j.biopha.2020.110586] [Reference Citation Analysis]
133 Huang SC, Kuo PC, Hung HY, Pan TL, Chen FA, Wu TS. Ionone Derivatives from the Mycelium of Phellinus linteus and the Inhibitory Effect on Activated Rat Hepatic Stellate Cells. Int J Mol Sci 2016;17:E681. [PMID: 27164091 DOI: 10.3390/ijms17050681] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
134 Zhang H, Yan X, Yang C, Zhan Q, Fu Y, Luo H, Luo H. Intrahepatic T helper 17 cells recruited by hepatitis B virus X antigen-activated hepatic stellate cells exacerbate the progression of chronic hepatitis B virus infection. J Viral Hepat 2020;27:1138-49. [PMID: 32559002 DOI: 10.1111/jvh.13352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
135 Xuanfei L, Hao C, Zhujun Y, Yanming L, Jianping G. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway. Oncotarget 2017;8:21015-30. [PMID: 28423499 DOI: 10.18632/oncotarget.15472] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
136 Zhu X, Zhang F, Zhou L, Kong D, Chen L, Lu Y, Zheng S. Diallyl trisulfide attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic oxidative stress in rats. Naunyn Schmiedebergs Arch Pharmacol 2014;387:445-55. [PMID: 24557053 DOI: 10.1007/s00210-014-0959-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
137 Chang Y, Xia L, Song M, Tang M, Patpur BK, Li J, Yang W, Yang C. The in vitro effects of phospholipase D1-mTOR axis in liver fibrogenesis. Life Sci 2020;251:117595. [PMID: 32240681 DOI: 10.1016/j.lfs.2020.117595] [Reference Citation Analysis]
138 Gadd VL, Melino M, Roy S, Horsfall L, O’Rourke P, Williams MR, Irvine KM, Sweet MJ, Jonsson JR, Clouston AD. Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C. Liver Int. 2013;33:569-579. [PMID: 23240894 DOI: 10.1111/liv.12050] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
139 Wang M, Gong Q, Zhang J, Chen L, Zhang Z, Lu L, Yu D, Han Y, Zhang D, Chen P, Zhang X, Yuan Z, Huang J, Zhang X. Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis. Sci Rep 2017;7:43446. [PMID: 28262670 DOI: 10.1038/srep43446] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
140 He YH, Li Z, Ni MM, Zhang XY, Li MF, Meng XM, Huang C, Li J. Cryptolepine derivative-6h inhibits liver fibrosis in TGF-β1-induced HSC-T6 cells by targeting the Shh pathway. Can J Physiol Pharmacol 2016;94:987-95. [PMID: 27295431 DOI: 10.1139/cjpp-2016-0157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
141 He L, Gubbins J, Peng Z, Medina V, Fei F, Asahina K, Wang J, Kahn M, Rountree CB, Stiles BL. Activation of hepatic stellate cell in Pten null liver injury model. Fibrogenesis Tissue Repair. 2016;9:8. [PMID: 27307790 DOI: 10.1186/s13069-016-0045-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
142 Peters MG, Bacchetti P, Boylan R, French AL, Tien PC, Plankey MW, Glesby MJ, Augenbraun M, Golub ET, Karim R, Parkes J, Rosenberg W. Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV. AIDS 2016;30:723-9. [PMID: 26595542 DOI: 10.1097/QAD.0000000000000975] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
143 Lu CH, Hou QR, Deng LF, Fei C, Xu WP, Zhang Q, Wu KM, Ning BF, Xie WF, Zhang X. MicroRNA-370 Attenuates Hepatic Fibrogenesis by Targeting Smoothened. Dig Dis Sci. 2015;60:2038-2048. [PMID: 25686745 DOI: 10.1007/s10620-015-3585-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
144 Wu X, Liu G, Mu M, Peng Y, Li X, Deng L, Zhang Z, Chen M, You S, Kong X. Augmenter of Liver Regeneration Gene Therapy Using a Novel Minicircle DNA Vector Alleviates Liver Fibrosis in Rats. Human Gene Therapy 2016;27:880-91. [DOI: 10.1089/hum.2016.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
145 Zimmer V, Lammert F. Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases. Best Pract Res Clin Gastroenterol. 2011;25:269-280. [PMID: 21497744 DOI: 10.1016/j.bpg.2011.02.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
146 Yang Y, Yang F, Wu X, Lv X, Li J. EPAC activation inhibits acetaldehyde-induced activation and proliferation of hepatic stellate cell via Rap1. Can J Physiol Pharmacol. 2016;94:498-507. [PMID: 26854595 DOI: 10.1139/cjpp-2015-0437] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
147 Wijesundera KK, Izawa T, Tennakoon AH, Murakami H, Golbar HM, Katou-ichikawa C, Tanaka M, Kuwamura M, Yamate J. M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3. Experimental and Molecular Pathology 2014;96:382-92. [DOI: 10.1016/j.yexmp.2014.04.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
148 Cobbold JFL, Patel D, Taylor-robinson SD. Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques: Imaging in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2012;27:1281-92. [DOI: 10.1111/j.1440-1746.2012.07127.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
149 Nithyananthan S, Keerthana P, Umadevi S, Guha S, Mir IH, Behera J, Thirunavukkarasu C. Nutrient mixture from germinated legumes: Enhanced medicinal value with herbs-attenuated liver cirrhosis. J Food Biochem 2020;44:e13085. [PMID: 31646659 DOI: 10.1111/jfbc.13085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Yovchev MI, Locker J, Oertel M. Biliary fibrosis drives liver repopulation and phenotype transition of transplanted hepatocytes. J Hepatol 2016;64:1348-57. [PMID: 26855174 DOI: 10.1016/j.jhep.2016.01.036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
151 Tabernilla A, Dos Santos Rodrigues B, Pieters A, Caufriez A, Leroy K, Van Campenhout R, Cooreman A, Gomes AR, Arnesdotter E, Gijbels E, Vinken M. In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach. Int J Mol Sci 2021;22:5038. [PMID: 34068678 DOI: 10.3390/ijms22095038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
152 Xie SR, An JY, Zheng LB, Huo XX, Guo J, Shih D, Zhang XL. Effects and mechanism of adenovirus-mediated phosphatase and tension homologue deleted on chromosome ten gene on collagen deposition in rat liver fibrosis. World J Gastroenterol 2017; 23(32): 5904-5912 [PMID: 28932082 DOI: 10.3748/wjg.v23.i32.5904] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
153 Kim SM, Choi JE, Hur W, Kim JH, Hong SW, Lee EB, Lee JH, Li TZ, Sung PS, Yoon SK. RAR-Related Orphan Receptor Gamma (ROR-γ) Mediates Epithelial-Mesenchymal Transition Of Hepatocytes During Hepatic Fibrosis. J Cell Biochem 2017;118:2026-36. [PMID: 27791279 DOI: 10.1002/jcb.25776] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
154 Hasegawa D, Wallace MC, Friedman SL. Stellate Cells and Hepatic Fibrosis. Stellate Cells in Health and Disease. Elsevier; 2015. pp. 41-62. [DOI: 10.1016/b978-0-12-800134-9.00004-x] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
155 Ocker M. Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma. World J Gastroenterol 2020; 26(3): 279-290 [PMID: 31988589 DOI: 10.3748/wjg.v26.i3.279] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
156 Xiang D, Zou J, Zhu X, Chen X, Luo J, Kong L, Zhang H. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling. Phytomedicine 2020;78:153294. [PMID: 32771890 DOI: 10.1016/j.phymed.2020.153294] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
157 Akdoğan Ö, Atak Yücel A, Gök Sargin Z, Sönmez C, Esendağli Yilmaz G, Özenirler S. Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker. J Clin Exp Hepatol 2019;9:29-33. [PMID: 30765936 DOI: 10.1016/j.jceh.2018.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
158 Wang Y, Shen RW, Han B, Li Z, Xiong L, Zhang FY, Cong BB, Zhang B. Notch signaling mediated by TGF-β/Smad pathway in concanavalin A-induced liver fibrosis in rats. World J Gastroenterol 2017; 23(13): 2330-2336 [PMID: 28428712 DOI: 10.3748/wjg.v23.i13.2330] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
159 Yin M, Glaser KJ, Talwalkar JA, Chen J, Manduca A, Ehman RL. Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations. Radiology. 2016;278:114-124. [PMID: 26162026 DOI: 10.1148/radiol.2015142141] [Cited by in Crossref: 156] [Cited by in F6Publishing: 136] [Article Influence: 26.0] [Reference Citation Analysis]
160 Challa AA, Vukmirovic M, Blackmon J, Stefanovic B. Withaferin-A reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivo. PLoS One 2012;7:e42989. [PMID: 22900077 DOI: 10.1371/journal.pone.0042989] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
161 Ceni E, Mello T, Polvani S, Vasseur-Cognet M, Tarocchi M, Tempesti S, Cavalieri D, Beltrame L, Marroncini G, Pinzani M, Milani S, Galli A. The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells. J Hepatol 2017;66:754-64. [PMID: 27866920 DOI: 10.1016/j.jhep.2016.11.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
162 Zhang K, Zhang YQ, Ai WB, Hu QT, Zhang QJ, Wan LY, Wang XL, Liu CB, Wu JF. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling. World J Gastroenterol 2015; 21(3): 878-887 [PMID: 25624721 DOI: 10.3748/wjg.v21.i3.878] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
163 Königshofer P, Brusilovskaya K, Petrenko O, Hofer BS, Schwabl P, Trauner M, Reiberger T. Nuclear Receptors in Liver Fibrosis. Biochim Biophys Acta Mol Basis Dis 2021;:166235. [PMID: 34339839 DOI: 10.1016/j.bbadis.2021.166235] [Reference Citation Analysis]
164 Lu C, Xu W, Shao J, Zhang F, Chen A, Zheng S. Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2/STAT3 signaling in hepatic stellate cells. International Immunopharmacology 2017;49:203-11. [DOI: 10.1016/j.intimp.2017.06.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
165 He C, Yang Y, Zheng K, Chen Y, Liu S, Li Y, Han Q, Zhao RC, Wang L, Zhang F. Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges. Ther Adv Chronic Dis 2021;12:2040622321993442. [PMID: 33633826 DOI: 10.1177/2040622321993442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
166 Sun HQ, Zhang JY, Zhang H, Zou ZS, Wang FS, Jia JH. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat. 2012;19:396-403. [PMID: 22571901 DOI: 10.1111/j.1365-2893.2011.01561.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 8.6] [Reference Citation Analysis]
167 Stokkeland K, Lageborn CT, Ekbom A, Höijer J, Bottai M, Stål P, Söderberg-löfdal K. Statins and Angiotensin-Converting Enzyme Inhibitors are Associated with Reduced Mortality and Morbidity in Chronic Liver Disease. Basic Clin Pharmacol Toxicol 2018;122:104-10. [DOI: 10.1111/bcpt.12844] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
168 Liang Z, Li J, Zhao L, Deng Y. miR‑375 affects the hedgehog signaling pathway by downregulating RAC1 to inhibit hepatic stellate cell viability and epithelial‑mesenchymal transition. Mol Med Rep 2021;23:182. [PMID: 33398380 DOI: 10.3892/mmr.2020.11821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
169 Wu K, Ye C, Lin L, Chu Y, Ji M, Dai W, Zeng X, Lin Y. Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT. Clin Sci (Lond) 2016;130:1469-80. [PMID: 27226339 DOI: 10.1042/CS20160334] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
170 Yang Y, Wu XQ, Li WX, Huang HM, Li HD, Pan XY, Li XF, Huang C, Meng XM, Zhang L, Lv XW, Wang H, Li J. PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis. Oncogene. 2018;37:6119-6135. [PMID: 29993036 DOI: 10.1038/s41388-018-0383-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
171 Ye Q, Zhou Y, Zhao C, Xu L, Ping J. Salidroside Inhibits CCl4-Induced Liver Fibrosis in Mice by Reducing Activation and Migration of HSC Induced by Liver Sinusoidal Endothelial Cell-Derived Exosomal SphK1. Front Pharmacol 2021;12:677810. [PMID: 34054552 DOI: 10.3389/fphar.2021.677810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Zeng J, Zhu B, Su M. Autophagy is involved in acetylshikonin ameliorating non-alcoholic steatohepatitis through AMPK/mTOR pathway. Biochem Biophys Res Commun 2018;503:1645-50. [PMID: 30055803 DOI: 10.1016/j.bbrc.2018.07.094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
173 Hsu DC, Sereti I, Ananworanich J. Serious Non-AIDS events: Immunopathogenesis and interventional strategies. AIDS Res Ther 2013;10:29. [PMID: 24330529 DOI: 10.1186/1742-6405-10-29] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
174 Fang H, Judd RL. Adiponectin Regulation and Function. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1031-63. [DOI: 10.1002/cphy.c170046] [Cited by in Crossref: 137] [Cited by in F6Publishing: 137] [Article Influence: 45.7] [Reference Citation Analysis]
175 Fuchs BC, Wang H, Yang Y, Wei L, Polasek M, Schühle DT, Lauwers GY, Parkar A, Sinskey AJ, Tanabe KK, Caravan P. Molecular MRI of collagen to diagnose and stage liver fibrosis. J Hepatol 2013;59:992-8. [PMID: 23838178 DOI: 10.1016/j.jhep.2013.06.026] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 11.8] [Reference Citation Analysis]
176 Febres-Aldana CA, Alghamdi S, Krishnamurthy K, Poppiti RJ. Liver Fibrosis Helps to Distinguish Autoimmune Hepatitis from DILI with Autoimmune Features: A Review of Twenty Cases. J Clin Transl Hepatol 2019;7:21-6. [PMID: 30944815 DOI: 10.14218/JCTH.2018.00053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
177 Bian F, Jiang H, Man M, Mai K, Zhou H, Xu W, He G. Dietary gossypol suppressed postprandial TOR signaling and elevated ER stress pathways in turbot (Scophthalmus maximus L.). Am J Physiol Endocrinol Metab 2017;312:E37-47. [PMID: 27894064 DOI: 10.1152/ajpendo.00285.2016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
178 Traber PG, Zomer E. Therapy of experimental NASH and fibrosis with galectin inhibitors. PLoS One. 2013;8:e83481. [PMID: 24367597 DOI: 10.1371/journal.pone.0083481] [Cited by in Crossref: 111] [Cited by in F6Publishing: 104] [Article Influence: 13.9] [Reference Citation Analysis]
179 Zhao ZM, Liu HL, Sun X, Guo T, Shen L, Tao YY, Liu CH. Levistilide A inhibits angiogenesis in liver fibrosis via vascular endothelial growth factor signaling pathway. Exp Biol Med (Maywood) 2017;242:974-85. [PMID: 28440736 DOI: 10.1177/1535370217701005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
180 Rancoule C, Pradère J, Gonzalez J, Klein J, Valet P, Bascands J, Schanstra JP, Saulnier-blache J. Lysophosphatidic acid-1-receptor targeting agents for fibrosis. Expert Opinion on Investigational Drugs 2011;20:657-67. [DOI: 10.1517/13543784.2011.566864] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
181 Phaosri M, Jantrapirom S, Takuathung MN, Soonthornchareonnon N, Sireeratawong S, Buacheen P, Pitchakarn P, Nimlamool W, Potikanond S. Salacia chinensis L. Stem Extract Exerts Antifibrotic Effects on Human Hepatic Stellate Cells Through the Inhibition of the TGF-β1-Induced SMAD2/3 Signaling Pathway. Int J Mol Sci 2019;20:E6314. [PMID: 31847284 DOI: 10.3390/ijms20246314] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
182 Wang S, Li M, Zhao X, Wang H, Zhu J, Wang C, Zhou M, Dong H, Zhou R. Upregulation of KSRP by miR-27b attenuates schistosomiasis-induced hepatic fibrosis by targeting TGF-β1. FASEB J 2020;34:4120-33. [PMID: 31953889 DOI: 10.1096/fj.201902438R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
183 Sheng R, Zhang Y, Sun W, Ji Y, Zeng M, Yao X, Dai Y. Staging Chronic Hepatitis B Related Liver Fibrosis with a Fractional Order Calculus Diffusion Model. Acad Radiol 2021:S1076-6332(21)00313-5. [PMID: 34429260 DOI: 10.1016/j.acra.2021.07.005] [Reference Citation Analysis]
184 Liu Y, Lv W. Research Progress in Astragalus Membranaceus and Its Active Components on Immune Responses in Liver Fibrosis. Chin J Integr Med 2020;26:794-800. [DOI: 10.1007/s11655-019-3039-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
185 Xu LM, Liu P; Hepatology Committee of Chinese Association of Integrative Medicine, China. Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition). J Integr Med 2020;18:203-13. [PMID: 32331978 DOI: 10.1016/j.joim.2020.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
186 [DOI: 10.1101/733931] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
187 Li JZ, Huang Y, Karaman R, Ivanova PT, Brown HA, Roddy T, Castro-Perez J, Cohen JC, Hobbs HH. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J Clin Invest. 2012;122:4130-4144. [PMID: 23023705 DOI: 10.1172/jci65179] [Cited by in Crossref: 166] [Cited by in F6Publishing: 99] [Article Influence: 20.8] [Reference Citation Analysis]
188 Wu C, Cheng D, Peng Y, Li Y, Fu C, Wang Y, Fu L, Peng S, Ni X. Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity. Front Med (Lausanne) 2021;8:683506. [PMID: 34336890 DOI: 10.3389/fmed.2021.683506] [Reference Citation Analysis]
189 Gastaldelli A, Marchesini G. Time for Glucagon like peptide-1 receptor agonists treatment for patients with NAFLD? J Hepatol 2016;64:262-4. [PMID: 26643784 DOI: 10.1016/j.jhep.2015.11.031] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
190 Zhang X, Zhang F, Kong D, Wu X, Lian N, Chen L, Lu Y, Zheng S. Tetramethylpyrazine inhibits angiotensin II-induced activation of hepatic stellate cells associated with interference of platelet-derived growth factor β receptor pathways. FEBS J 2014;281:2754-68. [PMID: 24725506 DOI: 10.1111/febs.12818] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
191 Hu JP, Zhang R, Tang M, Li YL, Xun LT, Shi ZZ, An Y, Li T, Song ZJ. Loureirin B inhibits the proliferation of hepatic stellate cells and the Wnt/β-catenin signaling pathway by regulating miR-148-3p. Cell Mol Biol Lett 2018;23:35. [PMID: 30123297 DOI: 10.1186/s11658-018-0098-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
192 Khurana A, Sayed N, Allawadhi P, Weiskirchen R. It's all about the spaces between cells: role of extracellular matrix in liver fibrosis. Ann Transl Med 2021;9:728. [PMID: 33987426 DOI: 10.21037/atm-20-2948] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
193 Xu T, Ni MM, Xing-Li, Li XF, Meng XM, Huang C, Li J. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis. Int J Biochem Cell Biol 2016;70:92-104. [PMID: 26592197 DOI: 10.1016/j.biocel.2015.11.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
194 Jantararussamee C, Rodniem S, Taweechotipatr M, Showpittapornchai U, Pradidarcheep W. Hepatoprotective Effect of Probiotic Lactic Acid Bacteria on Thioacetamide-Induced Liver Fibrosis in Rats. Probiotics Antimicrob Proteins 2021;13:40-50. [PMID: 32468435 DOI: 10.1007/s12602-020-09663-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
195 Thirupathi A, Silveira P, Nesi R, Pinho R. β-Amyrin, a pentacyclic triterpene, exhibits anti-fibrotic, anti-inflammatory, and anti-apoptotic effects on dimethyl nitrosamine–induced hepatic fibrosis in male rats. Hum Exp Toxicol 2017;36:113-22. [DOI: 10.1177/0960327116638727] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
196 Al-Nimer MS. Is COVID-19-induced liver injury different from other RNA viruses?‎ World J Meta-Anal 2021; 9(2): 108-127 [DOI: 10.13105/wjma.v9.i2.108] [Reference Citation Analysis]
197 Han L, Bittner S, Dong D, Cortez Y, Dulay H, Arshad S, Shen WJ, Kraemer FB, Azhar S. Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH). Mol Cell Endocrinol 2019;498:110538. [PMID: 31415794 DOI: 10.1016/j.mce.2019.110538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
198 Elizalde M, Urtasun R, Azkona M, Latasa MU, Goñi S, García-Irigoyen O, Uriarte I, Segura V, Collantes M, Di Scala M, Lujambio A, Prieto J, Ávila MA, Berasain C. Splicing regulator SLU7 is essential for maintaining liver homeostasis. J Clin Invest 2014;124:2909-20. [PMID: 24865429 DOI: 10.1172/JCI74382] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
199 Kalaz EB, Aydın AF, Doğan-ekici I, Çoban J, Doğru-abbasoğlu S, Uysal M. Protective effects of carnosine alone and together with alpha-tocopherol on lipopolysaccharide (LPS) plus ethanol-induced liver injury. Environmental Toxicology and Pharmacology 2016;42:23-9. [DOI: 10.1016/j.etap.2015.12.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
200 Ohara M, Ohnishi S, Hosono H, Yamamoto K, Fu Q, Maehara O, Suda G, Sakamoto N. Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats. Front Pharmacol 2018;9:709. [PMID: 30057547 DOI: 10.3389/fphar.2018.00709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
201 Jiao J, Watt GP, Lee M, Rahbar MH, Vatcheva KP, Pan JJ, McCormick JB, Fisher-Hoch SP, Fallon MB, Beretta L. Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity. PLoS One 2016;11:e0150978. [PMID: 26950933 DOI: 10.1371/journal.pone.0150978] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
202 Zhang Z, Zha Y, Hu W, Huang Z, Gao Z, Zang Y, Chen J, Dong L, Zhang J. The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development. J Biol Chem. 2013;288:37082-37093. [PMID: 24196965 DOI: 10.1074/jbc.M113.517953] [Cited by in Crossref: 76] [Cited by in F6Publishing: 47] [Article Influence: 9.5] [Reference Citation Analysis]
203 Chen YP, Peng J, Hou JL. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatol Int 2013;7:356-68. [PMID: 26201770 DOI: 10.1007/s12072-013-9439-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
204 Wang S, Tang C, Zhao H, Shen P, Lin C, Zhu Y, Han D. Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis. Front Pharmacol 2021;12:656115. [PMID: 34276360 DOI: 10.3389/fphar.2021.656115] [Reference Citation Analysis]
205 Park JH, Yoon J, Lee KY, Park B. Effects of geniposide on hepatocytes undergoing epithelial-mesenchymal transition in hepatic fibrosis by targeting TGFβ/Smad and ERK-MAPK signaling pathways. Biochimie 2015;113:26-34. [PMID: 25818617 DOI: 10.1016/j.biochi.2015.03.015] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 7.8] [Reference Citation Analysis]
206 Huang H, Wang K, Liu Q, Ji F, Zhou H, Fang S, Zhu J. The Active Constituent From Gynostemma Pentaphyllum Prevents Liver Fibrosis Through Regulation of the TGF-β1/NDRG2/MAPK Axis. Front Genet 2020;11:594824. [PMID: 33329740 DOI: 10.3389/fgene.2020.594824] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Ni HM, Chao X, Yang H, Deng F, Wang S, Bai Q, Qian H, Cui Y, Cui W, Shi Y, Zong WX, Wang Z, Yang L, Ding WX. Dual Roles of Mammalian Target of Rapamycin in Regulating Liver Injury and Tumorigenesis in Autophagy-Defective Mouse Liver. Hepatology. 2019;70:2142-2155. [PMID: 31095752 DOI: 10.1002/hep.30770] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
208 Liao X, Zhan W, Tian T, Yu L, Li R, Yang Q. MicroRNA-326 attenuates hepatic stellate cell activation and liver fibrosis by inhibiting TLR4 signaling. J Cell Biochem 2019. [PMID: 31692098 DOI: 10.1002/jcb.29520] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
209 Kuo LM, Kuo CY, Lin CY, Hung MF, Shen JJ, Hwang TL. Intracellular glutathione depletion by oridonin leads to apoptosis in hepatic stellate cells. Molecules 2014;19:3327-44. [PMID: 24647034 DOI: 10.3390/molecules19033327] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 9.7] [Reference Citation Analysis]
210 Kim KM, Han CY, Kim JY, Cho SS, Kim YS, Koo JH, Lee JM, Lim SC, Kang KW, Kim JS, Hwang SJ, Ki SH, Kim SG. Gα12 overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells. J Hepatol 2018;68:493-504. [PMID: 29080810 DOI: 10.1016/j.jhep.2017.10.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
211 Li JP, Gao Y, Chu SF, Zhang Z, Xia CY, Mou Z, Song XY, He WB, Guo XF, Chen NH. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis. Acta Pharmacol Sin 2014;35:1031-44. [PMID: 24976156 DOI: 10.1038/aps.2014.41] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 8.7] [Reference Citation Analysis]
212 Ünver Saraydin S, Saraydin D, Şahin İnan ZD. A digital image analysis study on the disintegration kinetics of reticular fibers in the ethylene glycol-induced rat liver tissue. Microsc Res Tech 2020;83:1585-93. [PMID: 33220018 DOI: 10.1002/jemt.23554] [Reference Citation Analysis]
213 Auguet T, Aragonès G, Berlanga A, Martínez S, Sabench F, Binetti J, Aguilar C, Porras JA, Molina A, Del Castillo D, Richart C. Hepcidin in morbidly obese women with non-alcoholic fatty liver disease. PLoS One 2017;12:e0187065. [PMID: 29065180 DOI: 10.1371/journal.pone.0187065] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
214 Quillin RC, Wilson GC, Nojima H, Freeman CM, Wang J, Schuster RM, Blanchard JA, Edwards MJ, Gandhi CR, Gulbins E. Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice. Hepatol Res. 2014; May 4. [Epub ahead of print]. [PMID: 24796378 DOI: 10.1111/hepr.12352] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
215 Tan W, Li Y, Lim SG, Tan TM. miR-106b-25/miR-17-92 clusters: Polycistrons with oncogenic roles in hepatocellular carcinoma. World J Gastroenterol 2014; 20(20): 5962-5972 [PMID: 24876719 DOI: 10.3748/wjg.v20.i20.5962] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 65] [Article Influence: 8.9] [Reference Citation Analysis]
216 Attallah AM, El-far M, Malak CAA, Omran MM, Shiha GE, Farid K, Barakat LA, Albannan MS, Attallah AA, Abdelrazek MA, Elbendary MS, Sabry R, Hamoda GA, Elshemy MM, Ragab AA, Foda BM, Abdallah SO. HCC-DETECT: a combination of nuclear, cytoplasmic, and oncofetal proteins as biomarkers for hepatocellular carcinoma. Tumor Biol 2015;36:7667-74. [DOI: 10.1007/s13277-015-3501-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
217 Song J, Ge Z, Yang X, Luo Q, Wang C, You H, Ge T, Deng Y, Lin H, Cui Y. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin. Cancer Lett. 2015;356:713-720. [PMID: 25449435 DOI: 10.1016/j.canlet.2014.10.021] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
218 Lafoz E, Ruart M, Anton A, Oncins A, Hernández-Gea V. The Endothelium as a Driver of Liver Fibrosis and Regeneration. Cells 2020;9:E929. [PMID: 32290100 DOI: 10.3390/cells9040929] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
219 Lacoste B, Raymond VA, Lapierre P, Bilodeau M. Protection against Acute Hepatocellular Injury Afforded by Liver Fibrosis Is Independent of T Lymphocytes. PLoS One. 2016;11:e0165360. [PMID: 27792745 DOI: 10.1371/journal.pone.0165360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
220 Zhao Y, Wang Z, Feng D, Zhao H, Lin M, Hu Y, Zhang N, Lv L, Gao Z, Zhai X, Tian X, Yao J. p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species. Theranostics 2019;9:1510-22. [PMID: 30867846 DOI: 10.7150/thno.29620] [Cited by in Crossref: 24] [Cited by in F6Publishing: 32] [Article Influence: 12.0] [Reference Citation Analysis]
221 Nie Y, Liu Q, Zhang W, Wan Y, Huang C, Zhu X. Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis. Gut Microbes 2021;13:1972746. [PMID: 34530693 DOI: 10.1080/19490976.2021.1972746] [Reference Citation Analysis]
222 Saber S, Goda R, El-tanbouly GS, Ezzat D. Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis. International Immunopharmacology 2018;64:340-9. [DOI: 10.1016/j.intimp.2018.09.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
223 Xu X, Zhu H, Li R, Lin H, Grimm R, Fu C, Yan F. Whole-liver histogram and texture analysis on T1 maps improves the risk stratification of advanced fibrosis in NAFLD. Eur Radiol 2021;31:1748-59. [PMID: 32897416 DOI: 10.1007/s00330-020-07235-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
224 Salloum S, Holmes JA, Jindal R, Bale SS, Brisac C, Alatrakchi N, Lidofsky A, Kruger AJ, Fusco DN, Luther J, Schaefer EA, Lin W, Yarmush ML, Chung RT. Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types. Hepatology 2016;64:1951-68. [PMID: 27531241 DOI: 10.1002/hep.28766] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
225 An J, Zheng L, Xie S, Yin F, Huo X, Guo J, Zhang X. Regulatory Effects and Mechanism of Adenovirus-Mediated PTEN Gene on Hepatic Stellate Cells. Dig Dis Sci 2016;61:1107-20. [DOI: 10.1007/s10620-015-3976-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
226 Liao J, Zhang Z, Yuan Q, Liu Q, Kuang J, Fang Y, Hu X. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation. Toxicol Lett 2021;336:21-31. [PMID: 33069761 DOI: 10.1016/j.toxlet.2020.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
227 Tao YY, Wang QL, Shen L, Fu WW, Liu CH. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro. Exp Biol Med (Maywood). 2013;238:1284-1296. [PMID: 24006304 DOI: 10.1177/1535370213498979] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
228 Lv PY, Feng H, Huang WH, Tian YY, Wang YQ, Qin YH, Li XH, Hu K, Zhou HH, Ouyang DS. Aucubin and its hydrolytic derivative attenuate activation of hepatic stellate cells via modulation of TGF-β stimulation. Environ Toxicol Pharmacol 2017;50:234-9. [PMID: 28199906 DOI: 10.1016/j.etap.2017.02.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
229 Ju H, Han K, Lee JD, Ro SW. Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy: Transgenic mouse models generated by hydrodynamic transfection. Int J Cancer 2016;138:1601-8. [DOI: 10.1002/ijc.29703] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
230 Zhao J, Tang N, Wu K, Dai W, Ye C, Shi J, Zhang J, Ning B, Zeng X, Lin Y. MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis. PLoS One. 2014;9:e108005. [PMID: 25303175 DOI: 10.1371/journal.pone.0108005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 9.9] [Reference Citation Analysis]
231 Li W, Chen X, Yang Y, Huang H, Li H, Huang C, Meng X, Li J. Hesperitin derivative-11 suppress hepatic stellate cell activation and proliferation by targeting PTEN/AKT pathway. Toxicology 2017;381:75-86. [DOI: 10.1016/j.tox.2016.11.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
232 Coulouarn C, Corlu A, Glaise D, Guénon I, Thorgeirsson SS, Clément B. Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma. Cancer Res. 2012;72:2533-2542. [PMID: 22419664 DOI: 10.1158/0008-5472.can-11-3317] [Cited by in Crossref: 133] [Cited by in F6Publishing: 67] [Article Influence: 14.8] [Reference Citation Analysis]
233 Ni HM, Woolbright BL, Williams J, Copple B, Cui W, Luyendyk JP, Jaeschke H, Ding WX. Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy. J Hepatol. 2014;61:617-625. [PMID: 24815875 DOI: 10.1016/j.jhep.2014.04.043] [Cited by in Crossref: 140] [Cited by in F6Publishing: 147] [Article Influence: 20.0] [Reference Citation Analysis]
234 Saidu NEB, Bonini C, Dickinson A, Grce M, Inngjerdingen M, Koehl U, Toubert A, Zeiser R, Galimberti S. New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions. Front Immunol 2020;11:578314. [PMID: 33162993 DOI: 10.3389/fimmu.2020.578314] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
235 Zhou R, Fan X, Schnabl B. Role of the intestinal microbiome in liver fibrosis development and new treatment strategies. Transl Res 2019;209:22-38. [PMID: 30853445 DOI: 10.1016/j.trsl.2019.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
236 Ding N, Hah N, Yu RT, Sherman MH, Benner C, Leblanc M, He M, Liddle C, Downes M, Evans RM. BRD4 is a novel therapeutic target for liver fibrosis. Proc Natl Acad Sci U S A 2015;112:15713-8. [PMID: 26644586 DOI: 10.1073/pnas.1522163112] [Cited by in Crossref: 105] [Cited by in F6Publishing: 101] [Article Influence: 17.5] [Reference Citation Analysis]
237 Johnson A, DiPietro LA. Apoptosis and angiogenesis: an evolving mechanism for fibrosis. FASEB J. 2013;27:3893-3901. [PMID: 23783074 DOI: 10.1096/fj.12-214189] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 10.1] [Reference Citation Analysis]
238 Attallah AM, El-far M, Ghaly MF, Omran MM, Albannan MS, Attallah AA, Shoghey TM, Atrees MM, Elbendary MS, Farid K. Circulating levels of collagen III and MMP-1 in patients with chronic hepatitis C co-infected with hepatitis B virus. British Journal of Biomedical Science 2017;74:95-100. [DOI: 10.1080/09674845.2017.1278888] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
239 Chen JY, Feeney ER, Chung RT. HCV and HIV co-infection: mechanisms and management. Nat Rev Gastroenterol Hepatol. 2014;11:362-371. [PMID: 24535328 DOI: 10.1038/nrgastro.2014.17] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 15.1] [Reference Citation Analysis]
240 Martin IV, Borkham-Kamphorst E, Zok S, van Roeyen CR, Eriksson U, Boor P, Hittatiya K, Fischer HP, Wasmuth HE, Weiskirchen R. Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis. Am J Pathol. 2013;182:107-117. [PMID: 23141925 DOI: 10.1016/j.ajpath.2012.09.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
241 Xu H, Hong S, Yan Z, Zhao Q, Shi Y, Song N, Xie J, Jiang X. RAP-8 ameliorates liver fibrosis by modulating cell cycle and oxidative stress. Life Sciences 2019;229:200-9. [DOI: 10.1016/j.lfs.2019.04.037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
242 Damba T, Zhang M, Buist-Homan M, van Goor H, Faber KN, Moshage H. Hydrogen sulfide stimulates activation of hepatic stellate cells through increased cellular bio-energetics. Nitric Oxide 2019;92:26-33. [PMID: 31401106 DOI: 10.1016/j.niox.2019.08.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
243 Bae JS, Park JM, Lee J, Oh BC, Jang SH, Lee YB, Han YM, Ock CY, Cha JY, Hahm KB. Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice. Metabolism 2017;66:32-44. [PMID: 27923447 DOI: 10.1016/j.metabol.2016.10.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
244 Elias MB, Oliveira FL, Guma FCR, Martucci RB, Borojevic R, Teodoro AJ. Lycopene inhibits hepatic stellate cell activation and modulates cellular lipid storage and signaling. Food Funct 2019;10:1974-84. [PMID: 30889234 DOI: 10.1039/c8fo02369g] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
245 Wang Z, Zhao Y, Zhao H, Zhou J, Feng D, Tang F, Li Y, Lv L, Chen Z, Ma X, Tian X, Yao J. Inhibition of p66Shc Oxidative Signaling via CA-Induced Upregulation of miR-203a-3p Alleviates Liver Fibrosis Progression. Mol Ther Nucleic Acids 2020;21:751-63. [PMID: 32781430 DOI: 10.1016/j.omtn.2020.07.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
246 Mederacke I, Dapito DH, Affò S, Uchinami H, Schwabe RF. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat Protoc 2015;10:305-15. [PMID: 25612230 DOI: 10.1038/nprot.2015.017] [Cited by in Crossref: 217] [Cited by in F6Publishing: 215] [Article Influence: 36.2] [Reference Citation Analysis]
247 Ganai AA, Husain M. Genistein attenuates D-GalN induced liver fibrosis/chronic liver damage in rats by blocking the TGF-β/Smad signaling pathways. Chemico-Biological Interactions 2017;261:80-5. [DOI: 10.1016/j.cbi.2016.11.022] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
248 Tang XH, Melis M, Lu C, Rappa A, Zhang T, Jessurun J, Gross SS, Gudas LJ. A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease. J Biol Chem 2021;297:101331. [PMID: 34688661 DOI: 10.1016/j.jbc.2021.101331] [Reference Citation Analysis]
249 Liu Z, Chalasani N, Lin J, Gawrieh S, He Y, Tseng YJ, Liu W. Integrative omics analysis identifies macrophage migration inhibitory factor signaling pathways underlying human hepatic fibrogenesis and fibrosis. J BioX Res 2019;2:16-24. [PMID: 32953199 DOI: 10.1097/jbr.0000000000000026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
250 Qiu R, Murata S, Oshiro K, Hatada Y, Taniguchi H. Transplantation of fetal liver tissue coated by ultra-purified alginate gel over liver improves hepatic function in the cirrhosis rat model. Sci Rep 2020;10:8231. [PMID: 32427847 DOI: 10.1038/s41598-020-65069-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
251 Cheng Q, Li C, Yang CF, Zhong YJ, Wu D, Shi L, Chen L, Li YW, Li L. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways. Chem Biol Interact 2019;299:131-9. [PMID: 30543783 DOI: 10.1016/j.cbi.2018.12.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
252 Choi B, Choi IY, Cha SH, Yeom SK, Chung HH, Lee SH, Cha J, Lee JH. Feasibility of computed tomography texture analysis of hepatic fibrosis using dual-energy spectral detector computed tomography. Jpn J Radiol 2020;38:1179-89. [PMID: 32666182 DOI: 10.1007/s11604-020-01020-5] [Reference Citation Analysis]
253 Raffaele M, Carota G, Sferrazzo G, Licari M, Barbagallo I, Sorrenti V, Signorelli SS, Vanella L. Inhibition of Heme Oxygenase Antioxidant Activity Exacerbates Hepatic Steatosis and Fibrosis In Vitro. Antioxidants (Basel) 2019;8:E277. [PMID: 31387260 DOI: 10.3390/antiox8080277] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
254 Zhang X, Lou J, Bai L, Chen Y, Zheng S, Duan Z. Immune Regulation of Intrahepatic Regulatory T Cells in Fibrotic Livers of Mice. Med Sci Monit 2017;23:1009-16. [PMID: 28235976 DOI: 10.12659/msm.899725] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
255 Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World J Gastroenterol 2020; 26(40): 6111-6140 [PMID: 33177789 DOI: 10.3748/wjg.v26.i40.6111] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
256 Abu El Makarem MA, El-Sagheer GM, Abu El-Ella MA. The Role of Signal Transducer and Activator of Transcription 5 and Transforming Growth Factor-β1 in Hepatic Fibrosis Induced by Chronic Hepatitis C Virus Infection in Egyptian Patients. Med Princ Pract 2018;27:115-21. [PMID: 29402841 DOI: 10.1159/000487308] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
257 Shao T, Josephson L, Liang SH. PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease. Mol Imaging 2019;18:1536012119871455. [PMID: 31478458 DOI: 10.1177/1536012119871455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
258 Zhou J, Lan Q, Li W, Yang L, You J, Zhang YM, Ni W. Tripartite motif protein 52 (TRIM52) promoted fibrosis in LX-2 cells through PPM1A-mediated Smad2/3 pathway. Cell Biol Int 2019. [PMID: 31329338 DOI: 10.1002/cbin.11206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
259 Cao F, Zhang Y, Li W, Shimizu K, Xie H, Zhang C. Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways. International Immunopharmacology 2018;55:183-92. [DOI: 10.1016/j.intimp.2017.12.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
260 Yu L, Li Y, Grisé A, Wang H. CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis. Adv Exp Med Biol 2020;1276:197-222. [PMID: 32705602 DOI: 10.1007/978-981-15-6082-8_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Bae M, Kim MB, Kang H, Park YK, Lee JY. Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells. Lipids 2019;54:401-10. [PMID: 31140624 DOI: 10.1002/lipd.12157] [Reference Citation Analysis]
262 Takahashi Y. The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. Int J Mol Sci. 2017;18. [PMID: 28678199 DOI: 10.3390/ijms18071447] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 18.5] [Reference Citation Analysis]
263 Fan Y, Du Z, Steib CJ, Ding Q, Lu P, Tian D, Liu M. Effect of SEPT6 on the biological behavior of hepatic stellate cells and liver fibrosis in rats and its mechanism. Lab Invest 2019;99:17-36. [PMID: 30315255 DOI: 10.1038/s41374-018-0133-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
264 Crawford JM, Bioulac-sage P, Hytiroglou P. Structure, Function, and Responses to Injury. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 1-87. [DOI: 10.1016/b978-0-7020-6697-9.00001-7] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
265 Pines M. Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract. World J Gastroenterol 2014; 20(40): 14778-14786 [PMID: 25356039 DOI: 10.3748/wjg.v20.i40.14778] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
266 Polanec SH, Bickel H, Baltzer PA, Thurner P, Gittler F, Hodge JC, Bashir MR, Ba-ssalamah A. Respiratory motion artifacts during arterial phase imaging with gadoxetic acid: Can the injection protocol minimize this drawback?: How to Minimize Gadoxetic Acid Artifacts. J Magn Reson Imaging 2017;46:1107-14. [DOI: 10.1002/jmri.25657] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
267 Xu T, Wu BM, Yao HW, Meng XM, Huang C, Ni MM, Li J. Novel insights into TRPM7 function in fibrotic diseases: a potential therapeutic target. J Cell Physiol 2015;230:1163-9. [PMID: 25204892 DOI: 10.1002/jcp.24801] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
268 Soydemir S, Comella O, Abdelmottaleb D, Pritchett J. Does Mechanocrine Signaling by Liver Sinusoidal Endothelial Cells Offer New Opportunities for the Development of Anti-fibrotics? Front Med (Lausanne) 2019;6:312. [PMID: 31998732 DOI: 10.3389/fmed.2019.00312] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
269 Yoshida K, Murata M, Yamaguchi T, Matsuzaki K, Okazaki K. Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions. J Clin Med 2016;5:E7. [PMID: 26771649 DOI: 10.3390/jcm5010007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
270 Chen A, Xu C, Luo Y, Liu L, Song K, Deng G, Yang M, Cao J, Yuan L, Li X. Disruption of crosstalk between LX-2 and liver cancer stem-like cells from MHCC97H cells by DFOG via inhibiting FOXM1. Acta Biochim Biophys Sin (Shanghai) 2019;51:1267-75. [PMID: 31750892 DOI: 10.1093/abbs/gmz129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
271 Xiong Y, Huang J. Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment. Chin Med 2021;16:80. [PMID: 34407830 DOI: 10.1186/s13020-021-00489-0] [Reference Citation Analysis]
272 Han CY, Koo JH, Kim SH, Gardenghi S, Rivella S, Strnad P, Hwang SJ, Kim SG. Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt. Nat Commun. 2016;7:13817. [PMID: 28004654 DOI: 10.1038/ncomms13817] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
273 Lin W, Weinberg EM, Chung RT. Pathogenesis of accelerated fibrosis in HIV/HCV co-infection. J Infect Dis. 2013;207 Suppl 1:S13-S18. [PMID: 23390300 DOI: 10.1093/infdis/jis926] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
274 Sarma MS, Seetharaman J. Pediatric non-cirrhotic portal hypertension: Endoscopic outcome and perspectives from developing nations. World J Hepatol 2021; 13(10): 1269-1288 [DOI: 10.4254/wjh.v13.i10.1269] [Reference Citation Analysis]
275 Demetris AJ, Bellamy CO, Gandhi CR, Prost S, Nakanuma Y, Stolz DB. Functional Immune Anatomy of the Liver-As an Allograft. Am J Transplant. 2016;16:1653-1680. [PMID: 26848550 DOI: 10.1111/ajt.13749] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 10.0] [Reference Citation Analysis]
276 Buonaguro L, Tagliamonte M, Petrizzo A, Damiano E, Tornesello ML, Buonaguro FM. Cellular prognostic markers in hepatocellular carcinoma. Future Oncol 2015;11:1591-8. [PMID: 26043213 DOI: 10.2217/fon.15.39] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
277 Chen X, Li HD, Bu FT, Li XF, Chen Y, Zhu S, Wang JN, Chen SY, Sun YY, Pan XY, Yin NN, Xu JJ, Huang C, Li J. Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis. Theranostics 2020;10:4851-70. [PMID: 32308754 DOI: 10.7150/thno.42423] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
278 Feng R, Morine Y, Ikemoto T, Imura S, Iwahashi S, Saito Y, Shimada M. Photobiomodulation with red light-emitting diodes accelerates hepatocyte proliferation through reactive oxygen species/extracellular signal-regulated kinase pathway. Hepatol Res 2018;48:926-36. [PMID: 29710411 DOI: 10.1111/hepr.13182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
279 Jin K, Liu Y, Shi Y, Zhang H, Sun Y, Zhangyuan G, Wang F, Yu W, Wang J, Tao X, Chen X, Zhang W, Sun B. PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis. Theranostics 2020;10:5290-304. [PMID: 32373213 DOI: 10.7150/thno.42658] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
280 Karsdal MA, Detlefsen S, Daniels SJ, Nielsen MJ, Krag A, Schuppan D. Is the Total Amount as Important as Localization and Type of Collagen in Liver Fibrosis Attributable to Steatohepatitis? Hepatology 2020;71:346-51. [PMID: 31553813 DOI: 10.1002/hep.30969] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
281 Huang R, Jiang N, Yang R, Geng X, Lin J, Xu G, Liu D, Chen J, Zhou G, Wang S, Luo T, Wu J, Liu X, Xu K, Yang X. Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B. Exp Ther Med. 2016;11:1673-1677. [PMID: 27168788 DOI: 10.3892/etm.2016.3135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
282 Tanaka H, Leung PSC, Kenny TP, Gershwin ME, Bowlus CL. Immunological Orchestration of Liver Fibrosis. Clinic Rev Allerg Immunol 2012;43:220-9. [DOI: 10.1007/s12016-012-8323-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
283 McKee C, Sigala B, Soeda J, Mouralidarane A, Morgan M, Mazzoccoli G, Rappa F, Cappello F, Cabibi D, Pazienza V, Selden C, Roskams T, Vinciguerra M, Oben JA. Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis. Sci Rep 2015;5:8812. [PMID: 25744849 DOI: 10.1038/srep08812] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
284 Traber PG, Chou H, Zomer E, Hong F, Klyosov A, Fiel MI, Friedman SL. Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease. PLoS One 2013;8:e75361. [PMID: 24130706 DOI: 10.1371/journal.pone.0075361] [Cited by in Crossref: 127] [Cited by in F6Publishing: 119] [Article Influence: 15.9] [Reference Citation Analysis]
285 Ansari AW, Schmidt RE, Shankar EM, Kamarulzaman A. Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus. J Transl Med 2014;12:341. [PMID: 25528160 DOI: 10.1186/s12967-014-0341-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
286 Cheng CF, Pan TM. Ankaflavin and Monascin Induce Apoptosis in Activated Hepatic Stellate Cells through Suppression of the Akt/NF-κB/p38 Signaling Pathway. J Agric Food Chem 2016;64:9326-34. [PMID: 27960292 DOI: 10.1021/acs.jafc.6b03700] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
287 Gowifel AMH, Khalil MG, Nada SA, Kenawy SA, Ahmed KA, Salama MM, Safar MM. Combination of pomegranate extract and curcumin ameliorates thioacetamide-induced liver fibrosis in rats: impact on TGF-β/Smad3 and NF-κB signaling pathways. Toxicol Mech Methods 2020;30:620-33. [PMID: 32718261 DOI: 10.1080/15376516.2020.1801926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
288 Luo H, Li L, Tang J, Zhang F, Zhao F, Sun D, Zheng F, Wang X. Amygdalin inhibits HSC-T6 cell proliferation and fibrosis through the regulation of TGF-β/CTGF. Mol Cell Toxicol 2016;12:265-71. [DOI: 10.1007/s13273-016-0031-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
289 Wu P, Huang R, Xiong Y, Wu C. Protective effects of curcumin against liver fibrosis through modulating DNA methylation. Chinese Journal of Natural Medicines 2016;14:255-64. [DOI: 10.1016/s1875-5364(16)30025-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
290 Demiroren K, Dogan Y, Kocamaz H, Ozercan IH, Ilhan S, Ustundag B, Bahcecioglu IH. Protective effects of L-carnitine, N-acetylcysteine and genistein in an experimental model of liver fibrosis. Clinics and Research in Hepatology and Gastroenterology 2014;38:63-72. [DOI: 10.1016/j.clinre.2013.08.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
291 Mak M. Impact of crosslink heterogeneity on extracellular matrix mechanics and remodeling. Comput Struct Biotechnol J 2020;18:3969-76. [PMID: 33335693 DOI: 10.1016/j.csbj.2020.11.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
292 Choi S, Jung HJ, Kim MW, Kang JH, Shin D, Jang YS, Yoon YS, Oh SH. A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice. Biochem Biophys Res Commun. 2019;513:49-55. [PMID: 30935693 DOI: 10.1016/j.bbrc.2019.03.156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
293 Aoudjehane L, Bisch G, Scatton O, Granier C, Gaston J, Housset C, Roingeard P, Cosset FL, Perdigao F, Balladur P, Wakita T, Calmus Y, Conti F. Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C. PLoS One 2015;10:e0134141. [PMID: 26214688 DOI: 10.1371/journal.pone.0134141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
294 Feng G, Zhang JY, Zeng QL, Yu X, Zhang Z, Lv S, Xu X, Wang FS. Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells. Hepatol Res. 2014;44:E198-E205. [PMID: 23905760 DOI: 10.1111/hepr.12215] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
295 Bae M, Lee Y, Pham TX, Hu S, Park YK, Lee JY. Astaxanthin inhibits the reduction of glycolysis during the activation of hepatic stellate cells. Life Sci 2020;256:117926. [PMID: 32535081 DOI: 10.1016/j.lfs.2020.117926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
296 Negash AA, Gale M Jr. Hepatitis regulation by the inflammasome signaling pathway. Immunol Rev. 2015;265:143-155. [PMID: 25879290 DOI: 10.1111/imr.12279] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
297 Cui Q, He F, Hu J, Li S, Guo D, Bie X, Liu W, Zhao Y. Evaluation of Rabbits Liver Fibrosis Using Gd-DTPA-BMA of Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Evid Based Complement Alternat Med 2021;2021:2791142. [PMID: 34567208 DOI: 10.1155/2021/2791142] [Reference Citation Analysis]
298 Kikuchi A, Monga SP. PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer. Gene Expr 2015;16:109-27. [PMID: 25700367 DOI: 10.3727/105221615X14181438356210] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
299 Sayed N, Khurana A, Saifi MA, Singh M, Godugu C. Withaferin A reverses bile duct ligation‐induced liver fibrosis by modulating extracellular matrix deposition: Role of LOXL2/Snail1, vimentin, and NFκB signaling. BioFactors 2019;45:959-74. [DOI: 10.1002/biof.1546] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
300 Nguyen-Lefebvre AT, Ajith A, Portik-Dobos V, Horuzsko DD, Arbab AS, Dzutsev A, Sadek R, Trinchieri G, Horuzsko A. The innate immune receptor TREM-1 promotes liver injury and fibrosis. J Clin Invest 2018;128:4870-83. [PMID: 30137027 DOI: 10.1172/JCI98156] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
301 Sun Q, Miao J, Luo J, Yuan Q, Cao H, Su W, Zhou Y, Jiang L, Fang L, Dai C, Zen K, Yang J. The feedback loop between miR-21, PDCD4 and AP-1 functions as a driving force for renal fibrogenesis. J Cell Sci 2018;131:jcs202317. [PMID: 29361523 DOI: 10.1242/jcs.202317] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
302 Zhang Z, Zhang F, Lu Y, Zheng S. Update on implications and mechanisms of angiogenesis in liver fibrosis. Hepatol Res 2015;45:162-78. [PMID: 25196587 DOI: 10.1111/hepr.12415] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
303 Yang JJ, Tao H, Li J. Hedgehog signaling pathway as key player in liver fibrosis: new insights and perspectives. Expert Opin Ther Targets. 2014;18:1011-1021. [PMID: 24935558 DOI: 10.1517/14728222.2014.927443] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
304 Kuehl T, Lagares D. BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts. Matrix Biol 2018;68-69:94-105. [PMID: 29408011 DOI: 10.1016/j.matbio.2018.01.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
305 Wang J, Chen X, Zhang C, Tao L, Zhang Z, Liu X, Xu Y, Wang H, Li J, Xu D. Phenylbutyric acid protects against carbon tetrachloride-induced hepatic fibrogenesis in mice. Toxicology and Applied Pharmacology 2013;266:307-16. [DOI: 10.1016/j.taap.2012.11.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
306 Nygård IE, Mortensen KE, Hedegaard J, Conley LN, Bendixen C, Sveinbjørnsson B, Revhaug A. Tissue Remodelling following Resection of Porcine Liver. Biomed Res Int 2015;2015:248920. [PMID: 26240819 DOI: 10.1155/2015/248920] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
307 Guo Y, Ding Q, Chen L, Ji C, Hao H, Wang J, Qi W, Xie X, Ma J, Li A, Jiang X, Li X, Jiang H. Overexpression of Heparin-Binding Epidermal Growth Factor-Like Growth Factor Mediates Liver Fibrosis in Transgenic Mice. The American Journal of the Medical Sciences 2017;354:199-210. [DOI: 10.1016/j.amjms.2017.04.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
308 Omar R, Yang J, Liu H, Davies NM, Gong Y. Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy. Rev Physiol Biochem Pharmacol 2016;172:1-37. [PMID: 27534415 DOI: 10.1007/112_2016_6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
309 Wu CF, Lin YL, Huang YT. Hepatitis C virus core protein stimulates fibrogenesis in hepatic stellate cells involving the obese receptor. J Cell Biochem. 2013;114:541-550. [PMID: 22961938 DOI: 10.1002/jcb.24392] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
310 Hayes BJ, Riehle KJ, Shimizu-Albergine M, Bauer RL, Hudkins KL, Johansson F, Yeh MM, Mahoney WM Jr, Yeung RS, Campbell JS. Activation of platelet-derived growth factor receptor alpha contributes to liver fibrosis. PLoS One 2014;9:e92925. [PMID: 24667490 DOI: 10.1371/journal.pone.0092925] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
311 Dhar D, Baglieri J, Kisseleva T, Brenner DA. Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med (Maywood) 2020;245:96-108. [PMID: 31924111 DOI: 10.1177/1535370219898141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
312 Kassel KM, Sullivan BP, Cui W, Copple BL, Luyendyk JP. Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease. Am J Pathol. 2012;181:1287-1295. [PMID: 22841818 DOI: 10.1016/j.ajpath.2012.06.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
313 刘梅, 李树杰, 李阳, 解瑞金, 汲书生. Fe-NTA诱导的氧应激通过调节Bcl-2家族蛋白及线粒体膜电位影响人肝星状细胞和肝细胞的凋亡. 世界华人消化杂志 2016; 24(25): 3705-3711 [DOI: 10.11569/wcjd.v24.i25.3705] [Reference Citation Analysis]
314 Kim G, Kim KJ, Rhee Y, Lim SK. Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease. PLoS One 2017;12:e0182202. [PMID: 28759632 DOI: 10.1371/journal.pone.0182202] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
315 Zhang X, Feng M, Liu X, Bai L, Kong M, Chen Y, Zheng S, Liu S, Wan YJ, Duan Z. Persistence of cirrhosis is maintained by intrahepatic regulatory T cells that inhibit fibrosis resolution by regulating the balance of tissue inhibitors of metalloproteinases and matrix metalloproteinases. Transl Res. 2016;169:67-79.e2. [PMID: 26613891 DOI: 10.1016/j.trsl.2015.10.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
316 Qiu C, Sha T, Yin T, Zhang W, Chen X, Miao X, Zheng R, Shuai X, Ren J. VEGFR2-targeted ultrasound molecular imaging of angiogenesis to evaluate liver allograft fibrosis. Biomater Sci 2021;9:5802-11. [PMID: 34008615 DOI: 10.1039/d1bm00100k] [Reference Citation Analysis]
317 Kim LB, Shkurupy VA, Putyatina AN. Altered Liver Proteoglycan/Glycosaminoglycan Structure as a Manifestation of Extracellular Matrix Remodeling upon BCG-induced Granulomatosis in Mice. Bull Exp Biol Med 2017;162:331-5. [PMID: 28091914 DOI: 10.1007/s10517-017-3608-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
318 Kiziltas S. Toll-like receptors in pathophysiology of liver diseases. World J Hepatol 2016; 8(32): 1354-1369 [PMID: 27917262 DOI: 10.4254/wjh.v8.i32.1354] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 11.4] [Reference Citation Analysis]
319 Wu J, Huang J, Kuang S, Chen J, Li X, Chen B, Wang J, Cheng D, Shuai X. Synergistic MicroRNA Therapy in Liver Fibrotic Rat Using MRI-Visible Nanocarrier Targeting Hepatic Stellate Cells. Adv Sci (Weinh) 2019;6:1801809. [PMID: 30886803 DOI: 10.1002/advs.201801809] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
320 Bao YL, Wang L, Pan HT, Zhang TR, Chen YH, Xu SJ, Mao XL, Li SW. Animal and Organoid Models of Liver Fibrosis. Front Physiol 2021;12:666138. [PMID: 34122138 DOI: 10.3389/fphys.2021.666138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
321 Wang R, Ding Q, De Assuncao TM, Mounajjed T, Maiers JL, Dou C, Cao S, Yaqoob U, Huebert RC, Shah VH. Hepatic Stellate Cell Selective Disruption of Dynamin-2 GTPase Increases Murine Fibrogenesis through Up-Regulation of Sphingosine-1 Phosphate-Induced Cell Migration. Am J Pathol 2017;187:134-45. [PMID: 27840081 DOI: 10.1016/j.ajpath.2016.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
322 Jia B, Guo M, Li G, Yu D, Zhang X, Lan K, Deng Q. Hepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase kinase 7. J Virol. 2015;89:2041-2051. [PMID: 25428880 DOI: 10.1128/jvi.03106-14] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
323 Li X, Chen R, Kemper S, Brigstock DR. Dynamic Changes in Function and Proteomic Composition of Extracellular Vesicles from Hepatic Stellate Cells during Cellular Activation. Cells 2020;9:E290. [PMID: 31991791 DOI: 10.3390/cells9020290] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
324 Parvaresh Anbar A, Piran T, Farhadi M, Karimi P. Iranian crack induces hepatic injury through mitogen-activated protein kinase pathway in the liver of Wistar rat. Iran J Basic Med Sci 2018;21:1179-85. [PMID: 30483393 DOI: 10.22038/IJBMS.2018.23543.5930] [Reference Citation Analysis]
325 Zhang F, Ni C, Kong D, Zhang X, Zhu X, Chen L, Lu Y, Zheng S. Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways. Toxicol Appl Pharmacol. 2012;265:51-60. [PMID: 23022513 DOI: 10.1016/j.taap.2012.09.016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
326 Xu H, Fan Z, Tian W, Xu Y. Protein inhibitor of activated STAT 4 (PIAS4) regulates liver fibrosis through modulating SMAD3 activity. J Biomed Res 2016;30:496-501. [PMID: 27924068 DOI: 10.7555/JBR.30.20160049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
327 Rombouts K, Carloni V, Mello T, Omenetti S, Galastri S, Madiai S, Galli A, Pinzani M. Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo. Cancer Letters 2013;333:244-52. [DOI: 10.1016/j.canlet.2013.01.040] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
328 Wang N, Xu Q, Tan HY, Hong M, Li S, Yuen MF, Feng Y. Berberine Inhibition of Fibrogenesis in a Rat Model of Liver Fibrosis and in Hepatic Stellate Cells. Evid Based Complement Alternat Med 2016;2016:8762345. [PMID: 27239214 DOI: 10.1155/2016/8762345] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
329 Ferreira AG, da Cunha AA, Machado FR, Pederzolli CD, Dalazen GR, de Assis AM, Lamers ML, dos Santos MF, Dutra-Filho CS, Wyse AT. Experimental hyperprolinemia induces mild oxidative stress, metabolic changes, and tissue adaptation in rat liver. J Cell Biochem 2012;113:174-83. [PMID: 21882227 DOI: 10.1002/jcb.23342] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
330 Li H, Lan J, Han C, Guo K, Wang G, Hu J, Gong J, Luo X, Cao Z. Brg1 promotes liver fibrosis via activation of hepatic stellate cells. Experimental Cell Research 2018;364:191-7. [DOI: 10.1016/j.yexcr.2018.02.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
331 Chen Z, Jain A, Liu H, Zhao Z, Cheng K. Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis. J Pharmacol Exp Ther 2019;370:695-702. [PMID: 30886124 DOI: 10.1124/jpet.118.256156] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
332 Li Z, Chen B, Dong W, Kong M, Shao Y, Fan Z, Yu L, Wu D, Lu J, Guo J, Xu Y. The Chromatin Remodeler Brg1 Integrates ROS Production and Endothelial-Mesenchymal Transition to Promote Liver Fibrosis in Mice. Front Cell Dev Biol 2019;7:245. [PMID: 31750301 DOI: 10.3389/fcell.2019.00245] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
333 Yoshioka H, Nonogaki T, Fukaya S, Ichimaru Y, Nagatsu A, Yoshikawa M, Fujii H, Nakao M. Sasa veitchii extract protects against carbon tetrachloride-induced hepatic fibrosis in mice. Environ Health Prev Med 2018;23:49. [PMID: 30322375 DOI: 10.1186/s12199-018-0739-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
334 Schattenberg JM, Nagel M, Kim YO, Kohl T, Wörns MA, Zimmermann T, Schad A, Longerich T, Schuppan D, He YW. Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP. Am J Physiol Gastrointest Liver Physiol. 2012;303:G498-G506. [PMID: 22700824 DOI: 10.1152/ajpgi.00525.2011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
335 Rodríguez‐aguilera JR, Guerrero‐hernández C, Pérez‐molina R, Cadena‐del‐castillo CE, Pérez‐cabeza de Vaca R, Guerrero‐celis N, Domínguez‐lópez M, Murillo‐de‐ozores AR, Arzate‐mejía R, Recillas‐targa F, Chagoya de Sánchez V. Epigenetic Effects of an Adenosine Derivative in a Wistar Rat Model of Liver Cirrhosis. J Cell Biochem 2018;119:401-13. [DOI: 10.1002/jcb.26192] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
336 Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, Chen L, Lv S, Li Y, Yu S, Geng H, Jin L, Lau GK, Wang FS. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol. 2012;27 Suppl 2:112-120. [PMID: 22320928 DOI: 10.1111/j.1440-1746.2011.07024.x] [Cited by in Crossref: 197] [Cited by in F6Publishing: 179] [Article Influence: 21.9] [Reference Citation Analysis]
337 Habibie H, Adhyatmika A, Schaafsma D, Melgert BN. The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and/or biological target for the treatment of fibrotic diseases. Pharmacol Ther 2021;228:107941. [PMID: 34171336 DOI: 10.1016/j.pharmthera.2021.107941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
338 Qu K, Liu T, Lin T, Zhang X, Cui R, Liu S, Meng F, Zhang J, Tai M, Wan Y, Liu C. Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis? Oncotarget 2016;7:67650-60. [PMID: 27588502 DOI: 10.18632/oncotarget.11767] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
339 Sharma A, Verma AK, Kofron M, Kudira R, Miethke A, Wu T, Wang J, Gandhi CR. Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription Factors. Hepatology 2020;72:1800-18. [PMID: 32064648 DOI: 10.1002/hep.31188] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
340 Bu FT, Chen Y, Yu HX, Chen X, Yang Y, Pan XY, Wang Q, Wu YT, Huang C, Meng XM, Li J. SENP2 alleviates CCl4-induced liver fibrosis by promoting activated hepatic stellate cell apoptosis and reversion. Toxicol Lett 2018;289:86-98. [PMID: 29535048 DOI: 10.1016/j.toxlet.2018.03.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
341 Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN. TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells 2019;8:E1419. [PMID: 31718044 DOI: 10.3390/cells8111419] [Cited by in Crossref: 96] [Cited by in F6Publishing: 107] [Article Influence: 48.0] [Reference Citation Analysis]
342 Wong JSL, Kwok GGW, Tang V, Li BCW, Leung R, Chiu J, Ma KW, She WH, Tsang J, Lo CM, Cheung TT, Yau T. Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors. J Immunother Cancer 2021;9:e001945. [PMID: 33563773 DOI: 10.1136/jitc-2020-001945] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
343 Bao S, Zheng J, Shi G. The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis (Review). Mol Med Rep 2017;16:3713-9. [PMID: 28731149 DOI: 10.3892/mmr.2017.7044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
344 Debes JD, Bohjanen PR, Boonstra A. Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection. J Clin Transl Hepatol. 2016;4:328-335. [PMID: 28097102 DOI: 10.14218/jcth.2016.00034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
345 Liang Z, Li T, Jiang S, Xu J, Di W, Yang Z, Hu W, Yang Y. AMPK: a novel target for treating hepatic fibrosis. Oncotarget 2017;8:62780-92. [PMID: 28977988 DOI: 10.18632/oncotarget.19376] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
346 Stefanovic L, Stefanovic B. Role of cytokine receptor-like factor 1 in hepatic stellate cells and fibrosis. World J Hepatol 2012; 4(12): 356-364 [PMID: 23355913 DOI: 10.4254/wjh.v4.i12.356] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
347 Zuo L, Tan T, Wei C, Wang H, Tan L, Hao Y, Qian J, Chen Y, Wu C. HOXB13 expression is correlated with hepatic inflammatory activity of patients with hepatic fibrosis. J Mol Histol 2020;51:183-9. [PMID: 32200464 DOI: 10.1007/s10735-020-09868-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
348 de Souza Basso B, Haute GV, Ortega-Ribera M, Luft C, Antunes GL, Bastos MS, Carlessi LP, Levorse VG, Cassel E, Donadio MVF, Santarém ER, Gracia-Sancho J, Rodrigues de Oliveira J. Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-ɣ and NF-kB mechanism. J Ethnopharmacol 2021;280:114433. [PMID: 34280502 DOI: 10.1016/j.jep.2021.114433] [Reference Citation Analysis]
349 Chen D. Fighting against viral hepatitis: Lessons from Taiwan. Hepatology 2011;54:381-92. [DOI: 10.1002/hep.24500] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
350 Gong J, Tu W, Han J, He J, Liu J, Han P, Wang Y, Li M, Liu M, Liao J, Tian D. Hepatic SATB1 induces paracrine activation of hepatic stellate cells and is upregulated by HBx. Sci Rep 2016;6:37717. [PMID: 27883059 DOI: 10.1038/srep37717] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
351 Li X, Ge J, Zheng Q, Zhang J, Sun R, Liu R. Evodiamine and rutaecarpine from Tetradium ruticarpum in the treatment of liver diseases. Phytomedicine 2020;68:153180. [DOI: 10.1016/j.phymed.2020.153180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
352 Ke B, Lee C. Cordyceps cicadae NTTU 868 mycelium prevents CCl 4 -induced hepatic fibrosis in BALB/c mice via inhibiting the expression of pro-inflammatory and pro-fibrotic cytokines. Journal of Functional Foods 2018;43:214-23. [DOI: 10.1016/j.jff.2018.02.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
353 Zhai X, Yan K, Fan J, Niu M, Zhou Q, Zhou Y, Chen H, Zhou Y. The β-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosis. Br J Pharmacol 2013;169:197-212. [PMID: 23347184 DOI: 10.1111/bph.12114] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
354 Furtado KS, Prado MG, Aguiar E Silva MA, Dias MC, Rivelli DP, Rodrigues MA, Barbisan LF. Coffee and caffeine protect against liver injury induced by thioacetamide in male Wistar rats. Basic Clin Pharmacol Toxicol 2012;111:339-47. [PMID: 22646289 DOI: 10.1111/j.1742-7843.2012.00903.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
355 Bosch J, Groszmann RJ, Shah VH. Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments. J Hepatol. 2015;62:S121-S130. [PMID: 25920081 DOI: 10.1016/j.jhep.2015.01.003] [Cited by in Crossref: 112] [Cited by in F6Publishing: 92] [Article Influence: 22.4] [Reference Citation Analysis]
356 Wu LY, Liu S, Liu Y, Guo C, Li H, Li W, Jin X, Zhang K, Zhao P, Wei L, Zhao J. Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C. Clin Immunol. 2015;158:77-87. [PMID: 25771172 DOI: 10.1016/j.clim.2015.03.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
357 Mormone E, George J, Nieto N. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact. 2011;193:225-231. [PMID: 21803030 DOI: 10.1016/j.cbi.2011.07.001] [Cited by in Crossref: 171] [Cited by in F6Publishing: 163] [Article Influence: 17.1] [Reference Citation Analysis]
358 Zhu J, Wang R, Xu T, Zhang S, Zhao Y, Li Z, Wang C, Zhou J, Gao D, Hu Y, Tian X, Yao J. Salvianolic Acid A Attenuates Endoplasmic Reticulum Stress and Protects Against Cholestasis-Induced Liver Fibrosis via the SIRT1/HSF1 Pathway. Front Pharmacol 2018;9:1277. [PMID: 30455644 DOI: 10.3389/fphar.2018.01277] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
359 Li Y, Shang W, Liang X, Zeng C, Liu M, Wang S, Li H, Tian J. The diagnosis of hepatic fibrosis by magnetic resonance and near-infrared imaging using dual-modality nanoparticles. RSC Adv 2018;8:6699-708. [DOI: 10.1039/c7ra10847h] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
360 Zhang F, Dang S, Shu R, Xiang Y, Kuang Y, Fei J, Wang Z. Deficiency of BPOZ2 Decreases Liver Fibrosis After Chronic Carbon Tetrachloride Administration in Mice. Int J Toxicol 2015;34:204-10. [PMID: 25568138 DOI: 10.1177/1091581814566472] [Reference Citation Analysis]
361 Atallah MAA, Elaidy SM, Tawfik MK. Assessment of the possible roles of SB-269970 versus ketanserin on carbon tetrachloride-induced liver fibrosis in rats: Oxidative stress/TGF-β1-induced HSCs activation pathway. Pharmacol Rep 2018;70:509-18. [PMID: 29660654 DOI: 10.1016/j.pharep.2017.11.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
362 Berasain C, Avila MA. Regulation of hepatocyte identity and quiescence. Cell Mol Life Sci 2015;72:3831-51. [DOI: 10.1007/s00018-015-1970-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
363 Yang F, Luo L, Zhu ZD, Zhou X, Wang Y, Xue J, Zhang J, Cai X, Chen ZL, Ma Q, Chen YF, Wang YJ, Luo YY, Liu P, Zhao L. Chlorogenic Acid Inhibits Liver Fibrosis by Blocking the miR-21-Regulated TGF-β1/Smad7 Signaling Pathway in Vitro and in Vivo. Front Pharmacol 2017;8:929. [PMID: 29311932 DOI: 10.3389/fphar.2017.00929] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
364 Aldaba-Muruato LR, Moreno MG, Hernández-Mercado E, Shibayama M, Muriel P. Secondary biliary cirrhosis in the rat is prevented by decreasing NF-κB nuclear translocation and TGF-β expression using allopurinol, an inhibitor of xanthine oxidase. Can J Physiol Pharmacol. 2012;90:1469-1478. [PMID: 23181275 DOI: 10.1139/y2012-125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
365 Lee H, Jeong H, Park S, Yoo W, Choi S, Choi K, Lee MG, Lee M, Cha D, Kim YS, Han J, Kim W, Park SH, Oh J. Fusion protein of retinol-binding protein and albumin domain III reduces liver fibrosis. EMBO Mol Med 2015;7:819-30. [PMID: 25864124 DOI: 10.15252/emmm.201404527] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
366 Long T, Wang L, Yang Y, Yuan L, Zhao H, Chang C, Yang G, Ho C, Li S. Protective effects of trans -2,3,5,4′-tetrahydroxystilbene 2- O -β- d -glucopyranoside on liver fibrosis and renal injury induced by CCl 4via down-regulating p-ERK1/2 and p-Smad1/2. Food Funct 2019;10:5115-23. [DOI: 10.1039/c9fo01010f] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
367 Ibba-Manneschi L, Rosa I, Manetti M. Telocytes in Chronic Inflammatory and Fibrotic Diseases. Adv Exp Med Biol 2016;913:51-76. [PMID: 27796880 DOI: 10.1007/978-981-10-1061-3_4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
368 Zhang S, Wang Z, Zhu J, Xu T, Zhao Y, Zhao H, Tang F, Li Z, Zhou J, Gao D, Tian X, Yao J. Carnosic Acid Alleviates BDL-Induced Liver Fibrosis through miR-29b-3p-Mediated Inhibition of the High-Mobility Group Box 1/Toll-Like Receptor 4 Signaling Pathway in Rats. Front Pharmacol 2017;8:976. [PMID: 29403377 DOI: 10.3389/fphar.2017.00976] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
369 Adel N, Mantawy EM, El-Sherbiny DA, El-Demerdash E. Iron chelation by deferasirox confers protection against concanavalin A-induced liver fibrosis: A mechanistic approach. Toxicol Appl Pharmacol 2019;382:114748. [PMID: 31499193 DOI: 10.1016/j.taap.2019.114748] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
370 Qu K, Huang Z, Lin T, Liu S, Chang H, Yan Z, Zhang H, Liu C. New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials. Front Pharmacol. 2016;6:300. [PMID: 26834633 DOI: 10.3389/fphar.2015.00300] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
371 Hübbers A, Hennings J, Lambertz D, Haas U, Trautwein C, Nevzorova YA, Sonntag R, Liedtke C. Pharmacological Inhibition of Cyclin-Dependent Kinases Triggers Anti-Fibrotic Effects in Hepatic Stellate Cells In Vitro. Int J Mol Sci 2020;21:E3267. [PMID: 32380742 DOI: 10.3390/ijms21093267] [Reference Citation Analysis]
372 Hah N, Sherman MH, Yu RT, Downes M, Evans RM. Targeting Transcriptional and Epigenetic Reprogramming in Stromal Cells in Fibrosis and Cancer. Cold Spring Harb Symp Quant Biol. 2015;80:249-255. [PMID: 26801159 DOI: 10.1101/sqb.2015.80.027185] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
373 Wang R, Ding Q, Yaqoob U, de Assuncao TM, Verma VK, Hirsova P, Cao S, Mukhopadhyay D, Huebert RC, Shah VH. Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration. J Biol Chem. 2015;290:30684-30696. [PMID: 26534962 DOI: 10.1074/jbc.m115.671735] [Cited by in Crossref: 107] [Cited by in F6Publishing: 69] [Article Influence: 17.8] [Reference Citation Analysis]
374 Manojlovic Z, Blackmon J, Stefanovic B. Tacrolimus (FK506) prevents early stages of ethanol induced hepatic fibrosis by targeting LARP6 dependent mechanism of collagen synthesis. PLoS One 2013;8:e65897. [PMID: 23755290 DOI: 10.1371/journal.pone.0065897] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
375 Choi JH, Park S, Kim GD, Kim JY, Jun JH, Bae SH, Baik SK, Hwang SG, Kim GJ. Increased Phosphatase of Regenerating Liver-1 by Placental Stem Cells Promotes Hepatic Regeneration in a Bile-Duct-Ligated Rat Model. Cells 2021;10:2530. [PMID: 34685509 DOI: 10.3390/cells10102530] [Reference Citation Analysis]
376 Ghallab A, Myllys M, Holland CH, Zaza A, Murad W, Hassan R, Ahmed YA, Abbas T, Abdelrahim EA, Schneider KM, Matz-Soja M, Reinders J, Gebhardt R, Berres ML, Hatting M, Drasdo D, Saez-Rodriguez J, Trautwein C, Hengstler JG. Influence of Liver Fibrosis on Lobular Zonation. Cells 2019;8:E1556. [PMID: 31810365 DOI: 10.3390/cells8121556] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
377 Hu X, Zhou Y. Curcumin reduces methionine adenosyltransferase 2B expression by interrupting phosphorylation of p38 MAPK in hepatic stellate cells. Eur J Pharmacol 2020;886:173424. [PMID: 32738342 DOI: 10.1016/j.ejphar.2020.173424] [Reference Citation Analysis]
378 Suh YG, Kim JK, Byun JS, Yi HS, Lee YS, Eun HS, Kim SY, Han KH, Lee KS, Duester G. CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice. Hepatology. 2012;56:1902-1912. [PMID: 22544759 DOI: 10.1002/hep.25817] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
379 Rothlin CV, Hille TD, Ghosh S. Determining the effector response to cell death. Nat Rev Immunol 2021;21:292-304. [PMID: 33188303 DOI: 10.1038/s41577-020-00456-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
380 Zhao J, Jiang Y, Sun X, Liu X, Liu F, Song M, Zhang L. The mechanism and role of intracellular α-ketoglutarate reduction in hepatic stellate cell activation. Biosci Rep 2020;40:BSR20193385. [PMID: 32124915 DOI: 10.1042/BSR20193385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
381 Liu Y, She W, Wang F, Li J, Wang J, Jiang W. 3, 3'-Diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance. Int Immunopharmacol. 2014;23:489-498. [PMID: 25281898 DOI: 10.1016/j.intimp.2014.09.024] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
382 Attallah AM, Omran D, Omran MM, Albannan MS, Zayed RA, Saif S, Farid A, Hassany M, Yosry A. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients. Br J Biomed Sci 2018;75:19-23. [PMID: 28945150 DOI: 10.1080/09674845.2017.1362950] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
383 Zhang L, Yao W, Xia J, Wang T, Huang F. Glucagon-Induced Acetylation of Energy-Sensing Factors in Control of Hepatic Metabolism. Int J Mol Sci 2019;20:E1885. [PMID: 30995792 DOI: 10.3390/ijms20081885] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
384 Ju B, Nie Y, Yang X, Wang X, Li F, Wang M, Wang C, Zhang H. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells. J Cell Mol Med. 2019;23:3824-3832. [PMID: 30945448 DOI: 10.1111/jcmm.14210] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
385 Kornek M, Lynch M, Mehta SH, Lai M, Exley M, Afdhal NH, Schuppan D. Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology 2012;143:448-58. [PMID: 22537612 DOI: 10.1053/j.gastro.2012.04.031] [Cited by in Crossref: 117] [Cited by in F6Publishing: 112] [Article Influence: 13.0] [Reference Citation Analysis]
386 Kabra H, Walimbe T, Stuart K, Indey C, Jalgaonkar S, Ikwa E, Skurnac T, Chen J, Woolley A, Snead NM, Bachtell N, Leeming DJ, Karsdal M, Prestwich G, Panitch A, Paderi J. Localized inhibition of platelets and platelet derived growth factor by a matrix targeted glycan mimetic significantly attenuates liver fibrosis. Biomaterials 2021;269:120538. [PMID: 33246740 DOI: 10.1016/j.biomaterials.2020.120538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
387 Chen L, Yao X, Yao H, Ji Q, Ding G, Liu X. Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells. FASEB J. 2020;34:5178-5192. [PMID: 32061112 DOI: 10.1096/fj.201902307rrr] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 22.0] [Reference Citation Analysis]
388 Kong XY, Kase ET, Herskedal A, Schjalm C, Damme M, Nesset CK, Thoresen GH, Rustan AC, Eskild W. Lack of the Lysosomal Membrane Protein, GLMP, in Mice Results in Metabolic Dysregulation in Liver. PLoS One 2015;10:e0129402. [PMID: 26047317 DOI: 10.1371/journal.pone.0129402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
389 Gong J, Han J, He J, Liu J, Han P, Wang Y, Li M, Li D, Ding X, Du Z, Liao J, Tian D. Paired related homeobox protein 1 regulates PDGF-induced chemotaxis of hepatic stellate cells in liver fibrosis. Lab Invest 2017;97:1020-32. [DOI: 10.1038/labinvest.2017.65] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
390 Pan TL, Wang PW, Huang CH, Leu YL, Wu TH, Wu YR, You JS. Herbal formula, Scutellariae radix and Rhei rhizoma attenuate dimethylnitrosamine-induced liver fibrosis in a rat model. Sci Rep 2015;5:11734. [PMID: 26133262 DOI: 10.1038/srep11734] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
391 Mastroianni CM, Lichtner M, Mascia C, Zuccalà P, Vullo V. Molecular mechanisms of liver fibrosis in HIV/HCV coinfection. Int J Mol Sci 2014;15:9184-208. [PMID: 24865485 DOI: 10.3390/ijms15069184] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
392 Cheng Y, Tian Y, Xia J, Wu X, Yang Y, Li X, Huang C, Meng X, Ma T, Li J. The role of PTEN in regulation of hepatic macrophages activation and function in progression and reversal of liver fibrosis. Toxicol Appl Pharmacol. 2017;317:51-62. [PMID: 28095306 DOI: 10.1016/j.taap.2017.01.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
393 Huang M, Chang A, Choi M, Zhou D, Anania FA, Shin CH. Antagonistic interaction between Wnt and Notch activity modulates the regenerative capacity of a zebrafish fibrotic liver model. Hepatology. 2014; Jul 4. [Epub ahead of print]. [PMID: 24995814 DOI: 10.1002/hep.27285] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
394 Wu Z, Huang S, Zheng X, Gu S, Xu Q, Gong Y, Zhang J, Fu B, Tang L. Regulatory long non-coding RNAs of hepatic stellate cells in liver fibrosis (Review). Exp Ther Med 2021;21:351. [PMID: 33732324 DOI: 10.3892/etm.2021.9782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Rao C, Ni YR, Zhao YM, Zhang YQ, Zhou RT, Liu CB, Han L, Wu JF. Class C1 decoy oligodeoxynucleotide inhibits profibrotic genes expression in rat hepatic stellate cells. Mol Med Rep 2020;21:667-74. [PMID: 31974596 DOI: 10.3892/mmr.2019.10881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
396 Gao W, Sun J, Wang F, Lu Y, Wen C, Bian Q, Wu H. Deoxyelephantopin suppresses hepatic stellate cells activation associated with inhibition of aerobic glycolysis via hedgehog pathway. Biochem Biophys Res Commun 2019;516:1222-8. [PMID: 31296386 DOI: 10.1016/j.bbrc.2019.07.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
397 Li X, Xing Y, Mao D, Ying L, Luan Y, Xu M, Wang H, Li C, Li Y, Zheng S, Li Z, Hu J, Li Z, Wang H, Luan Y. Codonopis bulleynana Forest ex Diels (cbFeD) effectively attenuates hepatic fibrosis in CCl4-induced fibrotic mice model. Biomed Pharmacother 2021;133:110960. [PMID: 33197763 DOI: 10.1016/j.biopha.2020.110960] [Reference Citation Analysis]
398 Lam HYP, Liang TR, Lan YC, Chang KC, Cheng PC, Peng SY. Antifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice. J Microbiol Immunol Infect 2021:S1684-1182(21)00086-4. [PMID: 34167886 DOI: 10.1016/j.jmii.2021.03.017] [Reference Citation Analysis]
399 Gajendiran P, Vega LI, Itoh K, Sesaki H, Vakili MR, Lavasanifar A, Hong K, Mezey E, Ganapathy-Kanniappan S. Elevated mitochondrial activity distinguishes fibrogenic hepatic stellate cells and sensitizes for selective inhibition by mitotropic doxorubicin. J Cell Mol Med 2018;22:2210-9. [PMID: 29397578 DOI: 10.1111/jcmm.13501] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
400 Allen J, Zhang J, Quickel MD, Kennett M, Patterson AD, Hankey-Giblin PA. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model. J Proteome Res 2018;17:3268-80. [PMID: 30091925 DOI: 10.1021/acs.jproteome.8b00379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
401 Chen PJ, Huang C, Meng XM, Li J. Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis. Biochimie 2015;116:61-9. [PMID: 26116886 DOI: 10.1016/j.biochi.2015.06.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
402 Kennedy P, Taouli B. Collagen-targeted MRI contrast agent for liver fibrosis detection. Nat Rev Gastroenterol Hepatol 2020;17:201-2. [PMID: 31980755 DOI: 10.1038/s41575-020-0266-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
403 Cardoso AC, A Villela-Nogueira C, de Figueiredo-Mendes C, Leão Filho H, Pinto Silva RA, Valle Tovo C, Perazzo H, Matteoni AC, de Carvalho-Filho RJ, Lisboa Bittencourt P. Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases. Ann Hepatol 2021;22:100341. [PMID: 33737252 DOI: 10.1016/j.aohep.2021.100341] [Reference Citation Analysis]
404 Zehra M, Curry JC, Pillai SS, Lakhani HV, Edwards CE, Sodhi K. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis. Int J Mol Sci 2020;21:E4737. [PMID: 32635162 DOI: 10.3390/ijms21134737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
405 Wang X, Copmans D, de Witte PAM. Using Zebrafish as a Disease Model to Study Fibrotic Disease. Int J Mol Sci 2021;22:6404. [PMID: 34203824 DOI: 10.3390/ijms22126404] [Reference Citation Analysis]
406 Yu F, Lu Z, Huang K, Wang X, Xu Z, Chen B, Dong P, Zheng J. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis. Oncotarget. 2016;7:81-93. [PMID: 26637809 DOI: 10.18632/oncotarget.6447] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 7.6] [Reference Citation Analysis]
407 Zhang F, Kong DS, Zhang ZL, Lei N, Zhu XJ, Zhang XP, Chen L, Lu Y, Zheng SZ. Tetramethylpyrazine induces G0/G1 cell cycle arrest and stimulates mitochondrial-mediated and caspase-dependent apoptosis through modulating ERK/p53 signaling in hepatic stellate cells in vitro. Apoptosis. 2013;18:135-149. [PMID: 23247439 DOI: 10.1007/s10495-012-0791-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
408 Huebener P, Schwabe RF. Regulation of wound healing and organ fibrosis by toll-like receptors. Biochim Biophys Acta. 2013;1832:1005-1017. [PMID: 23220258 DOI: 10.1016/j.bbadis.2012.11.017] [Cited by in Crossref: 86] [Cited by in F6Publishing: 85] [Article Influence: 9.6] [Reference Citation Analysis]
409 Juliano RL, Carver K, Cao C, Ming X. Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides. J Drug Target 2013;21:27-43. [PMID: 23163768 DOI: 10.3109/1061186X.2012.740674] [Cited by in Crossref: 58] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
410 Yuan T, Chen J, Shie R, Yeh Y, Chen Y, Chan C. Liver fibrosis associated with potential vinyl chloride and ethylene dichloride exposure from the petrochemical industry. Science of The Total Environment 2020;739:139920. [DOI: 10.1016/j.scitotenv.2020.139920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
411 Stamataki Z, Swadling L. The liver as an immunological barrier redefined by single-cell analysis. Immunology 2020;160:157-70. [PMID: 32176810 DOI: 10.1111/imm.13193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
412 Giambartolomei GH, Delpino MV. Immunopathogenesis of Hepatic Brucellosis. Front Cell Infect Microbiol 2019;9:423. [PMID: 31956605 DOI: 10.3389/fcimb.2019.00423] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
413 Lesurtel M, Clavien PA. Serotonin: a key molecule in acute and chronic liver injury! Clin Res Hepatol Gastroenterol 2012;36:319-22. [PMID: 22749697 DOI: 10.1016/j.clinre.2012.05.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
414 Carotti S, Perrone G, Amato M, Vespasiani Gentilucci U, Righi D, Francesconi M, Pellegrini C, Zalfa F, Zingariello M, Picardi A, Onetti Muda A, Morini S. Reelin expression in human liver of patients with chronic hepatitis C infection. Eur J Histochem 2017;61:2745. [PMID: 28348420 DOI: 10.4081/ejh.2017.2745] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
415 Nevzorova YA, Bangen JM, Hu W, Haas U, Weiskirchen R, Gassler N, Huss S, Tacke F, Sicinski P, Trautwein C. Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice. Hepatology. 2012;56:1140-1149. [PMID: 22454377 DOI: 10.1002/hep.25736] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
416 Kim LB, Shkurupy VA, Putyatina AN. Serum, Liver, and Lung Levels of the Major Extracellular Matrix Components at the Early Stage of BCG-Induced Granulomatosis Depending on the Infection Route. Bull Exp Biol Med 2015;158:322-5. [DOI: 10.1007/s10517-015-2752-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
417 Feng J, Chen K, Xia Y, Wu L, Li J, Li S, Wang W, Lu X, Liu T, Guo C. Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways. Drug Des Devel Ther 2018;12:1837-53. [PMID: 29970958 DOI: 10.2147/DDDT.S162950] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 9.7] [Reference Citation Analysis]
418 Lejnine S, Marton MJ, Wang IM, Howell BJ, Webber AL, Maxwell JW, Shire N, Malkov V, Lunceford J, Zeremski M, Sun A, Ruddy M, Talal AH. Gene expression analysis in serial liver fine needle aspirates. J Viral Hepat 2015;22:64-76. [PMID: 24475909 DOI: 10.1111/jvh.12213] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
419 Paredes BD, Faccioli LAP, Quintanilha LF, Asensi KD, Valle CZD, Canary PC, Takiya CM, Carvalho ACC, Goldenberg RCDS. Bone marrow progenitor cells do not contribute to liver fibrogenic cells. World J Hepatol 2012; 4(10): 274-283 [PMID: 23293712 DOI: 10.4254/wjh.v4.i10.274] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
420 Paquissi FC. Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis. Front Immunol. 2017;8:1195. [PMID: 29033929 DOI: 10.3389/fimmu.2017.01195] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
421 Doyle MA, Singer J, Lee T, Muir M, Cooper C. Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial. Trials. 2016;17:331. [PMID: 27439433 DOI: 10.1186/s13063] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
422 Petrescu AD, Grant S, Frampton G, McMillin M, Kain J, Kodali M, Shetty AK, DeMorrow S. Gulf war illness-related chemicals increase CD11b/c+ monocyte infiltration into the liver and aggravate hepatic cholestasis in a rodent model. Sci Rep 2018;8:13147. [PMID: 30177688 DOI: 10.1038/s41598-018-31599-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
423 Böttcher K, Pinzani M. Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents. Adv Drug Deliv Rev 2017;121:3-8. [PMID: 28600202 DOI: 10.1016/j.addr.2017.05.016] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 13.0] [Reference Citation Analysis]
424 Nevzorova YA, Hu W, Cubero FJ, Haas U, Freimuth J, Tacke F, Trautwein C, Liedtke C. Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis. Biochim Biophys Acta. 2013;1832:1765-1775. [PMID: 23770341 DOI: 10.1016/j.bbadis.2013.06.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
425 Chen X, Li WX, Chen Y, Li XF, Li HD, Huang HM, Bu FT, Pan XY, Yang Y, Huang C, Meng XM, Li J. Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis. Cell Death Dis 2018;9:1021. [PMID: 30282980 DOI: 10.1038/s41419-018-1032-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
426 Zhang F, Lu Y, Zheng S. Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis. Cell Signal. 2012;24:596-605. [PMID: 22108088 DOI: 10.1016/j.cellsig.2011.11.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
427 阮四军, 邬林泉, 周凡. VEGF与肝脏疾病的关系. 世界华人消化杂志 2013; 21(13): 1191-1196 [DOI: 10.11569/wcjd.v21.i13.1191] [Reference Citation Analysis]
428 Li G, Peng Y, Zhao T, Lin J, Duan X, Wei Y, Ma J. Plumbagin Alleviates Capillarization of Hepatic Sinusoids In Vitro by Downregulating ET-1, VEGF, LN, and Type IV Collagen. Biomed Res Int 2017;2017:5603216. [PMID: 28770223 DOI: 10.1155/2017/5603216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
429 Puente A, Fortea JI, Cabezas J, Arias Loste MT, Iruzubieta P, Llerena S, Huelin P, Fábrega E, Crespo J. LOXL2-A New Target in Antifibrogenic Therapy? Int J Mol Sci 2019;20:E1634. [PMID: 30986934 DOI: 10.3390/ijms20071634] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
430 Kerola A, Lampela H, Lohi J, Heikkilä P, Mutanen A, Jalanko H, Pakarinen MP. Molecular signature of active fibrogenesis prevails in biliary atresia after successful portoenterostomy. Surgery 2017;162:548-56. [PMID: 28655415 DOI: 10.1016/j.surg.2017.04.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
431 Fang X, Liu L, Dong J, Zhang J, Song H, Song Y, Huang Y, Cui X, Lin J, Chen C, Liu B, Chen Z, Pan J, Chen X. A study about immunomodulatory effect and efficacy and prognosis of human umbilical cord mesenchymal stem cells in patients with chronic hepatitis B-induced decompensated liver cirrhosis. J Gastroenterol Hepatol. 2018;33:774-780. [PMID: 29293276 DOI: 10.1111/jgh.14081] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
432 Debes JD, de Knegt RJ, Boonstra A. The Path to Cancer and Back: Immune Modulation During Hepatitis C Virus Infection, Progression to Fibrosis and Cancer, and Unexpected Roles of New Antivirals. Transplantation. 2017;101:910-915. [PMID: 28045877 DOI: 10.1097/tp.0000000000001623] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
433 Sinkus R, Lambert S, Abd-Elmoniem KZ, Morse C, Heller T, Guenthner C, Ghanem AM, Holm S, Gharib AM. Rheological determinants for simultaneous staging of hepatic fibrosis and inflammation in patients with chronic liver disease. NMR Biomed 2018;31:e3956. [PMID: 30059174 DOI: 10.1002/nbm.3956] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
434 Kim D, Kim B, Sim H, Lee TK, Tae HJ, Lee JC, Park JH, Cho JH, Won MH, Park Y, Ahn JH. Hypothermic treatment reduces matrix metalloproteinase-9 expression and damage in the liver following asphyxial cardiac arrest in rats. Lab Anim Res 2021;37:16. [PMID: 34261545 DOI: 10.1186/s42826-021-00095-z] [Reference Citation Analysis]
435 Fausther M, Sheung N, Saiman Y, Bansal MB, Dranoff JA. Activated hepatic stellate cells upregulate transcription of ecto-5'-nucleotidase/CD73 via specific SP1 and SMAD promoter elements. Am J Physiol Gastrointest Liver Physiol 2012;303:G904-14. [PMID: 22899823 DOI: 10.1152/ajpgi.00015.2012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
436 Huang W, Zheng Y, Feng H, Ni L, Ruan Y, Zou X, Ye M, Zou S. Total phenolic extract of Euscaphis konishii hayata Pericarp attenuates carbon tetrachloride (CCl4)-induced liver fibrosis in mice. Biomedicine & Pharmacotherapy 2020;125:109932. [DOI: 10.1016/j.biopha.2020.109932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
437 Michelotti GA, Xie G, Swiderska M, Choi SS, Karaca G, Krüger L, Premont R, Yang L, Syn WK, Metzger D, Diehl AM. Smoothened is a master regulator of adult liver repair. J Clin Invest 2013;123:2380-94. [PMID: 23563311 DOI: 10.1172/JCI66904] [Cited by in Crossref: 24] [Cited by in F6Publishing: 99] [Article Influence: 3.0] [Reference Citation Analysis]
438 Wang C, Wang B, Xue L, Kang Z, Hou S, Du J, Zhang C. Design, Synthesis, and Antifibrosis Activity in Liver of Nonsecosteroidal Vitamin D Receptor Agonists with Phenyl-pyrrolyl Pentane Skeleton. J Med Chem 2018;61:10573-87. [DOI: 10.1021/acs.jmedchem.8b01165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
439 Mercer PF, Chambers RC. Coagulation and coagulation signalling in fibrosis. Biochim Biophys Acta 2013;1832:1018-27. [PMID: 23298546 DOI: 10.1016/j.bbadis.2012.12.013] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 7.4] [Reference Citation Analysis]
440 Kim KH, Chen CC, Monzon RI, Lau LF. Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol Cell Biol 2013;33:2078-90. [PMID: 23508104 DOI: 10.1128/MCB.00049-13] [Cited by in Crossref: 167] [Cited by in F6Publishing: 100] [Article Influence: 20.9] [Reference Citation Analysis]
441 Liang C, Li J, Tian B, Tian L, Liu Y, Li J, Xin L, Wang J, Fu C, Shi Z, Xia J, Liang Y, Wang K. Foresight regarding drug candidates acting on the succinate-GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment. Biomed Pharmacother 2021;144:112298. [PMID: 34649219 DOI: 10.1016/j.biopha.2021.112298] [Reference Citation Analysis]
442 Wang YG, Xu L, Wang T, Wei J, Meng WY, Wang N, Shi M. Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation. World J Gastroenterol 2015; 21(27): 8326-8339 [PMID: 26217084 DOI: 10.3748/wjg.v21.i27.8326] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
443 Kumar S, Verma AK, Rani R, Sharma A, Wang J, Shah SA, Behari J, Salazar Gonzalez R, Kohli R, Gandhi CR. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis. Hepatology 2020;72:1586-604. [PMID: 32031683 DOI: 10.1002/hep.31167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
444 Li YK, Li YM, Li Y, Wei YR, Zhang J, Li B, You ZR, Chen Y, Huang BY, Miao Q, Wang QX, Peng YS, Gershwin ME, Tang RQ, Bian ZL, Ma X. CTHRC1 expression in primary biliary cholangitis. J Dig Dis 2019;20:371-6. [PMID: 31102333 DOI: 10.1111/1751-2980.12791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
445 Bowen T, Jenkins RH, Fraser DJ. MicroRNAs, transforming growth factor beta-1, and tissue fibrosis: MicroRNAs, TGF-β1, and tissue fibrosis. J Pathol 2013;229:274-85. [DOI: 10.1002/path.4119] [Cited by in Crossref: 121] [Cited by in F6Publishing: 109] [Article Influence: 13.4] [Reference Citation Analysis]
446 Jia Y, Zhong F, Jiang S, Guo Q, Jin H, Wang F, Li M, Wang L, Chen A, Zhang F, Shao J, Zheng S. Periostin in chronic liver diseases: Current research and future perspectives. Life Sci 2019;226:91-7. [PMID: 30978348 DOI: 10.1016/j.lfs.2019.04.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
447 Han X, Wu Y, Yang Q, Cao G. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis. Pharmacol Ther 2021;222:107791. [PMID: 33321113 DOI: 10.1016/j.pharmthera.2020.107791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
448 Matsumoto Y, Itami S, Kuroda M, Yoshizato K, Kawada N, Murakami Y. MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice. Mol Ther. 2016;24:1848-1859. [PMID: 27480597 DOI: 10.1038/mt.2016.127] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
449 Zhang W, Niu M, Yan K, Zhai X, Zhou Q, Zhang L, Zhou Y. Stat3 pathway correlates with the roles of leptin in mouse liver fibrosis and sterol regulatory element binding protein-1c expression of rat hepatic stellate cells. Int J Biochem Cell Biol. 2013;45:736-744. [PMID: 23295202 DOI: 10.1016/j.biocel.2012.12.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
450 Finkelmeier F, Kronenberger B, Zeuzem S, Piiper A, Waidmann O. Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis. PLoS One. 2015;10:e0132119. [PMID: 26121590 DOI: 10.1371/journal.pone.0132119] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
451 Wai PY, Kuo PC. Intersecting pathways in inflammation and cancer: Hepatocellular carcinoma as a paradigm. World J Clin Oncol 2012; 3(2): 15-23 [PMID: 22347691 DOI: 10.5306/wjco.v3.i2.15] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
452 Attallah AM, El-far M, Malak CAA, Omran MM, Farid K, Hussien MA, Albannan MS, Attallah AA, Elbendary MS, Elbesh DA, Elmenier NA, Abdallah MO. Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients. Annals of Hepatology 2015;14:225-33. [DOI: 10.1016/s1665-2681(19)30785-9] [Cited by in Crossref: 12] [Article Influence: 2.0] [Reference Citation Analysis]
453 Meng D, Li Z, Wang G, Ling L, Wu Y, Zhang C. Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells. Biomedicine & Pharmacotherapy 2018;108:1617-27. [DOI: 10.1016/j.biopha.2018.10.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
454 Xuan J, Chen Y, Zhu L, Guo Y, Deng L, Zheng Y, Wang Z, Wang Z, Ao M. Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model. Oncotarget 2017;8:108676-91. [PMID: 29312560 DOI: 10.18632/oncotarget.21358] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
455 Zeng C, Wang YL, Xie C, Sang Y, Li TJ, Zhang M, Wang R, Zhang Q, Zheng L, Zhuang SM. Identification of a novel TGF-β-miR-122-fibronectin 1/serum response factor signaling cascade and its implication in hepatic fibrogenesis. Oncotarget 2015;6:12224-33. [PMID: 25909171 DOI: 10.18632/oncotarget.3652] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 8.2] [Reference Citation Analysis]
456 Guan W, Cheng F, Wu H, Cao Q, Zhu X, Fan Y, Zhu H, Zhou Y. GATA binding protein 3 is correlated with leptin regulation of PPARγ1 in hepatic stellate cells. J Cell Mol Med 2017;21:568-78. [PMID: 27709831 DOI: 10.1111/jcmm.13002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
457 Huang Y, Fan X, Tao R, Song Q, Wang L, Zhang H, Kong H, Huang J. Effect of miR-182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway. J Cell Physiol 2018;233:6693-704. [PMID: 29323718 DOI: 10.1002/jcp.26469] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
458 Kobuch J, Cui H, Grünwald B, Saftig P, Knolle PA, Krüger A. TIMP-1 signaling via CD63 triggers granulopoiesis and neutrophilia in mice. Haematologica 2015;100:1005-13. [PMID: 26001794 DOI: 10.3324/haematol.2014.121590] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
459 Shajari S, Laliena A, Heegsma J, Tuñón MJ, Moshage H, Faber KN. Melatonin suppresses activation of hepatic stellate cells through RORα-mediated inhibition of 5-lipoxygenase. J Pineal Res 2015;59:391-401. [PMID: 26308880 DOI: 10.1111/jpi.12271] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
460 Leiting S, Seidl S, Martinez-Palacian A, Muhl L, Kanse SM. Transforming Growth Factor-β (TGF-β) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes. J Biol Chem 2016;291:21020-8. [PMID: 27462075 DOI: 10.1074/jbc.M116.744631] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
461 刘迎春, 顾小红. C/EBPα基因与PARs在肝星状细胞激活中的作用及关系. 世界华人消化杂志 2011; 19(36): 3656-3660 [DOI: 10.11569/wcjd.v19.i36.3656] [Reference Citation Analysis]
462 Yamane D, Mcgivern DR, Masaki T, Lemon SM. Liver Injury and Disease Pathogenesis in Chronic Hepatitis C. In: Bartenschlager R, editor. Hepatitis C Virus: From Molecular Virology to Antiviral Therapy. Berlin: Springer Berlin Heidelberg; 2013. pp. 263-88. [DOI: 10.1007/978-3-642-27340-7_11] [Cited by in Crossref: 12] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
463 Lim BJ, Lee WK, Lee HW, Lee KS, Kim JK, Chang HY, Lee JI. Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice. Cell Commun Signal 2018;16:93. [PMID: 30509307 DOI: 10.1186/s12964-018-0306-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
464 Chau BN, Xin C, Hartner J, Ren S, Castano AP, Linn G, Li J, Tran PT, Kaimal V, Huang X. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med. 2012;4:121ra18. [PMID: 22344686 DOI: 10.1126/scitranslmed.3003205] [Cited by in Crossref: 323] [Cited by in F6Publishing: 342] [Article Influence: 35.9] [Reference Citation Analysis]
465 Kang N, Shah VH, Urrutia R. Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis? Mol Cancer Res 2015;13:604-12. [PMID: 25548101 DOI: 10.1158/1541-7786.MCR-14-0542] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
466 Nowatzky J, Knorr A, Hirth-Dietrich C, Siegling A, Volk HD, Limmer A, Knolle P, Weber O. Inactivated Orf virus (Parapoxvirus ovis) elicits antifibrotic activity in models of liver fibrosis. Hepatol Res 2013;43:535-46. [PMID: 22971208 DOI: 10.1111/j.1872-034X.2012.01086.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
467 González-Ponce HA, Rincón-Sánchez AR, Jaramillo-Juárez F, Moshage H. Natural Dietary Pigments: Potential Mediators against Hepatic Damage Induced by Over-The-Counter Non-Steroidal Anti-Inflammatory and Analgesic Drugs. Nutrients 2018;10:E117. [PMID: 29364842 DOI: 10.3390/nu10020117] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
468 Chen X, Li XF, Chen Y, Zhu S, Li HD, Chen SY, Wang JN, Pan XY, Bu FT, Huang C, Li J. Hesperetin derivative attenuates CCl4-induced hepatic fibrosis and inflammation by Gli-1-dependent mechanisms. Int Immunopharmacol 2019;76:105838. [PMID: 31473406 DOI: 10.1016/j.intimp.2019.105838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
469 Lawrenczyk A, Kim S, Wen X, Xiong R, Yuan W. Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment. Pathogens. 2014;3:563-576. [PMID: 25438012 DOI: 10.3390/pathogens3030563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
470 Xing X, Chen S, Li L, Cao Y, Chen L, Wang X, Zhu Z. The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability - A Network Pharmacology and Transcriptomics Approach. Front Pharmacol 2018;9:525. [PMID: 29881350 DOI: 10.3389/fphar.2018.00525] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
471 Fu S, Wang F, Cao Y, Huang Q, Xiao J, Yang C, Popescu LM. Telocytes in human liver fibrosis. J Cell Mol Med 2015;19:676-83. [PMID: 25661250 DOI: 10.1111/jcmm.12542] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
472 Hoshikawa Y, Furukawa S, Irie K, Kimura M, Takeuchi K, Sugiyama A. Sequential histological changes in the liver of medaka exposed to methylazoxymethaol acetate. J Toxicol Pathol 2020;33:219-26. [PMID: 33239840 DOI: 10.1293/tox.2020-0033] [Reference Citation Analysis]
473 Zhang B, Lai L, Tan Y, Liang Q, Bai F, Mai W, Huang Q, Ye Y. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways. J Ethnopharmacol 2020;254:112714. [PMID: 32105750 DOI: 10.1016/j.jep.2020.112714] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
474 Giannitrapani L, Soresi M, Bondì ML, Montalto G, Cervello M. Nanotechnology applications for the therapy of liver fibrosis. World J Gastroenterol 2014; 20(23): 7242-7251 [PMID: 24966595 DOI: 10.3748/wjg.v20.i23.7242] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
475 Zheng S, Chen Y, Guo J, Qi D, Zheng S, Zhang S, Weng Z. Recombinant adeno-associated virus-mediated transfer of shRNA against Notch3 ameliorates hepatic fibrosis in rats. Exp Biol Med (Maywood) 2013;238:600-9. [DOI: 10.1177/1535370213480698] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
476 Yang Y, Bae M, Park YK, Lee Y, Pham TX, Rudraiah S, Manautou J, Koo SI, Lee JY. Histone deacetylase 9 plays a role in the antifibrogenic effect of astaxanthin in hepatic stellate cells. J Nutr Biochem 2017;40:172-7. [PMID: 27915160 DOI: 10.1016/j.jnutbio.2016.11.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
477 Liu M, Xu Y, Han X, Yin L, Xu L, Qi Y, Zhao Y, Liu K, Peng J. Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway. Sci Rep 2015;5:18038. [PMID: 26655640 DOI: 10.1038/srep18038] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 8.7] [Reference Citation Analysis]
478 Zmorzyński S, Styk W, Filip AA, Krasowska D. The Significance of NOTCH Pathway in the Development of Fibrosis in Systemic Sclerosis. Ann Dermatol 2019;31:365-71. [PMID: 33911613 DOI: 10.5021/ad.2019.31.4.365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
479 Makarev E, Izumchenko E, Aihara F, Wysocki PT, Zhu Q, Buzdin A, Sidransky D, Zhavoronkov A, Atala A. Common pathway signature in lung and liver fibrosis. Cell Cycle 2016;15:1667-73. [PMID: 27267766 DOI: 10.1080/15384101.2016.1152435] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
480 Yi HS, Jeong WI. Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend? J Gastroenterol Hepatol. 2013;28 Suppl 1:99-104. [PMID: 23855303 DOI: 10.1111/jgh.12017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
481 Wang L, Yang G, Yuan L, Yang Y, Zhao H, Ho C, Li S. Green Tea Catechins Effectively Altered Hepatic Fibrogenesis in Rats by Inhibiting ERK and Smad1/2 Phosphorylation. J Agric Food Chem 2019;67:5437-45. [DOI: 10.1021/acs.jafc.8b05179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
482 Zhao J, Zhang Z, Luan Y, Zou Z, Sun Y, Li Y, Jin L, Zhou C, Fu J, Gao B, Fu Y, Wang FS. Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment. Hepatology. 2014;59:1331-1342. [PMID: 24677193 DOI: 10.1002/hep.26916] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 16.1] [Reference Citation Analysis]
483 Wang H, Sit W, Tipoe GL, Liu Z, Wan JM. Comparative proteomic analysis of fibrotic liver of rats fed high fat diet contained lard versus corn oil. Clinical Nutrition 2017;36:198-208. [DOI: 10.1016/j.clnu.2015.10.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
484 Wei L, Chen Q, Guo A, Fan J, Wang R, Zhang H. Asiatic acid attenuates CCl 4 -induced liver fibrosis in rats by regulating the PI3K/AKT/mTOR and Bcl-2/Bax signaling pathways. International Immunopharmacology 2018;60:1-8. [DOI: 10.1016/j.intimp.2018.04.016] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 14.3] [Reference Citation Analysis]
485 Liu H, Pan X, Cao H, Shu X, Sun H, Lu J, Liang J, Zhang K, Zhu F, Li G, Zhang Q. IL-32γ promotes integrin αvβ6 expression through the activation of NF-κB in HSCs. Exp Ther Med 2017;14:3880-6. [PMID: 29042996 DOI: 10.3892/etm.2017.4956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
486 Wang Q, Dai X, Yang W, Wang H, Zhao H, Yang F, Yang Y, Li J, Lv X. Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP/PKA/CREB pathway in rat hepatic stellate cells. Int Immunopharmacol. 2015;25:340-352. [PMID: 25701503 DOI: 10.1016/j.intimp.2015.02.012] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
487 Verma VK, Li H, Wang R, Hirsova P, Mushref M, Liu Y, Cao S, Contreras PC, Malhi H, Kamath PS. Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J Hepatol. 2016;64:651-660. [PMID: 26632633 DOI: 10.1016/j.jhep.2015.11.020] [Cited by in Crossref: 115] [Cited by in F6Publishing: 109] [Article Influence: 19.2] [Reference Citation Analysis]
488 Tao XM, Li D, Zhang C, Wen GH, Wu C, Xu YY, Kan Y, Lu WP, Ding HY, Yang Y. Salvianolic acid B protects against acute and chronic liver injury by inhibiting Smad2C/L phosphorylation. Exp Ther Med 2021;21:341. [PMID: 33732314 DOI: 10.3892/etm.2021.9772] [Reference Citation Analysis]
489 Kaddai V, Negro F. Current understanding of insulin resistance in hepatitis C. Expert Review of Gastroenterology & Hepatology 2014;5:503-16. [DOI: 10.1586/egh.11.43] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
490 Osna NA, Ganesan M, Seth D, Wyatt TA, Kidambi S, Kharbanda KK. Second hits exacerbate alcohol-related organ damage: an update. Alcohol Alcohol 2021;56:8-16. [PMID: 32869059 DOI: 10.1093/alcalc/agaa085] [Reference Citation Analysis]
491 Harris TR, Bettaieb A, Kodani S, Dong H, Myers R, Chiamvimonvat N, Haj FG, Hammock BD. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice. Toxicol Appl Pharmacol 2015;286:102-11. [PMID: 25827057 DOI: 10.1016/j.taap.2015.03.022] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 8.8] [Reference Citation Analysis]
492 Yang Y, Bai T, Yao Y, Zhang D, Wu Y, Lian L, Nan J. Upregulation of SIRT1-AMPK by thymoquinone in hepatic stellate cells ameliorates liver injury. Toxicology Letters 2016;262:80-91. [DOI: 10.1016/j.toxlet.2016.09.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
493 Song Y, Zhan L, Yu M, Huang C, Meng X, Ma T, Zhang L, Li J. TRPV4 channel inhibits TGF-β1-induced proliferation of hepatic stellate cells. PLoS One. 2014;9:e101179. [PMID: 25013893 DOI: 10.1371/journal.pone.0101179] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
494 Aldaba-Muruato LR, Moreno MG, Shibayama M, Tsutsumi V, Muriel P. Allopurinol reverses liver damage induced by chronic carbon tetrachloride treatment by decreasing oxidative stress, TGF-β production and NF-κB nuclear translocation. Pharmacology 2013;92:138-49. [PMID: 24008378 DOI: 10.1159/000339078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
495 Wu T, Zhao F, Gao B, Tan C, Yagishita N, Nakajima T, Wong PK, Chapman E, Fang D, Zhang DD. Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis. Genes Dev 2014;28:708-22. [PMID: 24636985 DOI: 10.1101/gad.238246.114] [Cited by in F6Publishing: 170] [Reference Citation Analysis]
496 Ciceu A, Balta C, Herman H, Gharbia S, Ignat SR, Dinescu S, Váradi J, Fenyvesi F, Gyöngyösi S, Hermenean A, Costache M. Complexation with Random Methyl-β-Cyclodextrin and (2-Hidroxypropyl)-β-Cyclodextrin Enhances In Vivo Anti-Fibrotic and Anti-Inflammatory Effects of Chrysin via the Inhibition of NF-κB and TGF-β1/Smad Signaling Pathways and Modulation of Hepatic Pro/Anti-Fibrotic miRNA. Int J Mol Sci 2021;22:1869. [PMID: 33668543 DOI: 10.3390/ijms22041869] [Reference Citation Analysis]
497 You K, Li SY, Gong J, Fang JH, Zhang C, Zhang M, Yuan Y, Yang J, Zhuang SM. MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling. Mol Ther Nucleic Acids. 2018;12:57-66. [PMID: 30195793 DOI: 10.1016/j.omtn.2018.04.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
498 Shan L, Jiang T, Ci L, Liu Z, Lv X, Li J. Purine signaling regulating HSCs inflammatory cytokines secretion, activation, and proliferation plays a critical role in alcoholic liver disease. Mol Cell Biochem 2020;466:91-102. [PMID: 31989367 DOI: 10.1007/s11010-020-03691-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
499 Zhang F, Zhang Z, Chen L, Kong D, Zhang X, Lu C, Lu Y, Zheng S. Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. J Cell Mol Med 2014;18:1392-406. [PMID: 24779927 DOI: 10.1111/jcmm.12286] [Cited by in Crossref: 90] [Cited by in F6Publishing: 87] [Article Influence: 12.9] [Reference Citation Analysis]
500 Devhare PB, Sasaki R, Shrivastava S, Di Bisceglie AM, Ray R, Ray RB. Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells. J Virol. 2017;91. [PMID: 28077652 DOI: 10.1128/jvi.02225-16] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 13.5] [Reference Citation Analysis]
501 Koh EK, Kim JE, Song SH, Sung JE, Lee HA, Kim KS, Hong JT, Hwang DY. Ethanol extracts collected from the Styela clava tunic alleviate hepatic injury induced by carbon tetrachloride (CCl4) through inhibition of hepatic apoptosis, inflammation, and fibrosis. J Toxicol Pathol 2017;30:291-306. [PMID: 29097839 DOI: 10.1293/tox.2017-0021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
502 Bingül İ, Aydın AF, Başaran-Küçükgergin C, Doğan-Ekici I, Çoban J, Doğru-Abbasoğlu S, Uysal M. High-fat diet plus carbon tetrachloride-induced liver fibrosis is alleviated by betaine treatment in rats. Int Immunopharmacol 2016;39:199-207. [PMID: 27494683 DOI: 10.1016/j.intimp.2016.07.028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
503 Cui E, Long W, Wu J, Li Q, Ma C, Lei Y, Lin F. Predicting the stages of liver fibrosis with multiphase CT radiomics based on volumetric features. Abdom Radiol (NY) 2021;46:3866-76. [PMID: 33751193 DOI: 10.1007/s00261-021-03051-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
504 Ding Q, Xie XL, Wang MM, Yin J, Tian JM, Jiang XY, Zhang D, Han J, Bai Y, Cui ZJ, Jiang HQ. The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis. Exp Mol Med 2019;51:1-13. [PMID: 30635551 DOI: 10.1038/s12276-018-0199-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
505 Hsu DC, Sereti I. Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection. Drugs 2016;76:533-49. [PMID: 26915027 DOI: 10.1007/s40265-016-0546-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
506 Kimura K, Ikoma A, Shibakawa M, Shimoda S, Harada K, Saio M, Imamura J, Osawa Y, Kimura M, Nishikawa K, Okusaka T, Morita S, Inoue K, Kanto T, Todaka K, Nakanishi Y, Kohara M, Mizokami M. Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial. EBioMedicine 2017;23:79-87. [PMID: 28844410 DOI: 10.1016/j.ebiom.2017.08.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 9.8] [Reference Citation Analysis]
507 Ma T, Cai X, Wang Z, Huang L, Wang C, Jiang S, Hua Y, Liu Q. miR-200c Accelerates Hepatic Stellate Cell-Induced Liver Fibrosis via Targeting the FOG2/PI3K Pathway. Biomed Res Int. 2017;2017:2670658. [PMID: 28691020 DOI: 10.1155/2017/2670658] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
508 Cai X, Wang J, Wang J, Zhou Q, Yang B, He Q, Weng Q. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy. Pharmacol Res 2020;155:104720. [PMID: 32092405 DOI: 10.1016/j.phrs.2020.104720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 18.0] [Reference Citation Analysis]
509 Petrizzo A, Mauriello A, Tornesello ML, Buonaguro FM, Tagliamonte M, Buonaguro L. Cellular prognostic markers in hepatitis-related hepatocellular carcinoma. Infect Agent Cancer 2018;13:10. [PMID: 29599818 DOI: 10.1186/s13027-018-0183-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
510 Hazem SH, Shaker ME, Ashamallah SA, Ibrahim TM. The novel Janus kinase inhibitor ruxolitinib confers protection against carbon tetrachloride-induced hepatotoxicity via multiple mechanisms. Chem Biol Interact 2014;220:116-27. [PMID: 24973641 DOI: 10.1016/j.cbi.2014.06.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
511 Sun B, Zhang X, Cheng X, Zhang Y, Chen L, Shi L, Liu Z, Qian H, Wu M, Yin Z. Intratumoral hepatic stellate cells as a poor prognostic marker and a new treatment target for hepatocellular carcinoma. PLoS One 2013;8:e80212. [PMID: 24278260 DOI: 10.1371/journal.pone.0080212] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
512 Sferra R, Vetuschi A, Pompili S, Gaudio E, Speca S, Latella G. Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis. Pathol Res Pract 2017;213:58-65. [PMID: 27894619 DOI: 10.1016/j.prp.2016.11.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
513 Natarajan V, Moeun Y, Kidambi S. Exploring Interactions between Primary Hepatocytes and Non-Parenchymal Cells on Physiological and Pathological Liver Stiffness. Biology (Basel) 2021;10:408. [PMID: 34063016 DOI: 10.3390/biology10050408] [Reference Citation Analysis]
514 Li X, Wu XQ, Xu T, Li XF, Yang Y, Li WX, Huang C, Meng XM, Li J. Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis. Toxicol Appl Pharmacol 2016;306:58-68. [PMID: 27396813 DOI: 10.1016/j.taap.2016.07.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
515 Khalifa YH, Mourad GM, Stephanos WM, Omar SA, Mehanna RA. Bone Marrow-Derived Mesenchymal Stem Cell Potential Regression of Dysplasia Associating Experimental Liver Fibrosis in Albino Rats. Biomed Res Int 2019;2019:5376165. [PMID: 31781620 DOI: 10.1155/2019/5376165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
516 Zhang F, Hao M, Jin H, Yao Z, Lian N, Wu L, Shao J, Chen A, Zheng S. Canonical hedgehog signalling regulates hepatic stellate cell-mediated angiogenesis in liver fibrosis. Br J Pharmacol 2017;174:409-23. [PMID: 28052321 DOI: 10.1111/bph.13701] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
517 Yao J, Lin C, Jiang J, Zhang X, Li F, Liu T, Diao H. lncRNA-HEIM Facilitated Liver Fibrosis by Up-Regulating TGF-β Expression in Long-Term Outcome of Chronic Hepatitis B. Front Immunol 2021;12:666370. [PMID: 34168644 DOI: 10.3389/fimmu.2021.666370] [Reference Citation Analysis]
518 Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 2013;229:298-309. [PMID: 22996908 DOI: 10.1002/path.4104] [Cited by in Crossref: 352] [Cited by in F6Publishing: 333] [Article Influence: 44.0] [Reference Citation Analysis]
519 Paulsen D, Urban A, Knorr A, Hirth-Dietrich C, Siegling A, Volk HD, Mercer AA, Limmer A, Schumak B, Knolle P, Ruebsamen-Schaeff H, Weber O. Inactivated ORF virus shows antifibrotic activity and inhibits human hepatitis B virus (HBV) and hepatitis C virus (HCV) replication in preclinical models. PLoS One 2013;8:e74605. [PMID: 24066148 DOI: 10.1371/journal.pone.0074605] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
520 Shuai C, Xia GQ, Yuan F, Wang S, Lv XW. CD39-mediated ATP-adenosine signalling promotes hepatic stellate cell activation and alcoholic liver disease. Eur J Pharmacol 2021;905:174198. [PMID: 34033815 DOI: 10.1016/j.ejphar.2021.174198] [Reference Citation Analysis]
521 Cheng F, Su S, Zhu X, Jia X, Tian H, Zhai X, Guan W, Zhou Y. Leptin promotes methionine adenosyltransferase 2A expression in hepatic stellate cells by the downregulation of E2F-4 via the β-catenin pathway. FASEB J 2020;34:5578-89. [PMID: 32108965 DOI: 10.1096/fj.201903021RR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
522 Winkler I, Bitter C, Winkler S, Weichenhan D, Thavamani A, Hengstler JG, Borkham-Kamphorst E, Kohlbacher O, Plass C, Geffers R, Weiskirchen R, Nordheim A. Identification of Pparγ-modulated miRNA hubs that target the fibrotic tumor microenvironment. Proc Natl Acad Sci U S A 2020;117:454-63. [PMID: 31871210 DOI: 10.1073/pnas.1909145117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
523 Fang L, Huang C, Meng X, Wu B, Ma T, Liu X, Zhu Q, Zhan S, Li J. TGF-β1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-β1/Smad pathway. Toxicol Appl Pharmacol. 2014;280:335-344. [PMID: 25150141 DOI: 10.1016/j.taap.2014.08.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
524 Tibaldi E, Zonta F, Bordin L, Magrin E, Gringeri E, Cillo U, Idotta G, Pagano MA, Brunati AM. The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling. Biochim Biophys Acta 2014;1843:288-98. [PMID: 24140598 DOI: 10.1016/j.bbamcr.2013.10.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
525 Attallah AM, Albannan MS, Omran MM, Zayed R, Saif S, Farid A, Hassany M, Yosry A, Omran D. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis. Br J Biomed Sci 2019;76:105-10. [PMID: 30924403 DOI: 10.1080/09674845.2019.1600325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
526 Xue F, Lu J, Buchl SC, Sun L, Shah VH, Malhi H, Maiers JL. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice. Am J Physiol Gastrointest Liver Physiol 2021;320:G864-79. [PMID: 33728997 DOI: 10.1152/ajpgi.00453.2020] [Reference Citation Analysis]
527 Yang Y, Kim B, Park YK, Koo SI, Lee JY. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells. Biochim Biophys Acta. 2015;1850:178-185. [PMID: 25450180 DOI: 10.1016/j.bbagen.2014.10.014] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 7.4] [Reference Citation Analysis]
528 Lee J, Choi B, No da Y, Lee G, Lee SR, Oh H, Lee SH. A 3D alcoholic liver disease model on a chip. Integr Biol (Camb) 2016;8:302-8. [PMID: 26857817 DOI: 10.1039/c5ib00298b] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 5.6] [Reference Citation Analysis]
529 van den Berg PJ, Bansal R, Daoudi K, Steenbergen W, Prakash J. Preclinical detection of liver fibrosis using dual-modality photoacoustic/ultrasound system. Biomed Opt Express 2016;7:5081-91. [PMID: 28018726 DOI: 10.1364/BOE.7.005081] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
530 Yue ZM, Hong DM, Shengdi WM, Peili FM, Zheng LM, Wenjiao ZM, Wenping WM. Histological Reference for Shear Wave Elastography in Liver Fibrosis: Collagen Quantification and Scoring System. Advanced Ultrasound in Diagnosis and Therapy 2019;3:87. [DOI: 10.37015/audt.2019.190815] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
531 He S, Tang J, Diao N, Liao Y, Shi J, Xu X, Xie F, Bai L. Parathyroid hormone-related protein activates HSCs via hedgehog signalling during liver fibrosis development. Artificial Cells, Nanomedicine, and Biotechnology 2019;47:1984-94. [DOI: 10.1080/21691401.2019.1615931] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
532 黄小丽, 郭晓云, 姜海行, 覃山羽, 罗薇, 马诗家, 卢东红, 陈梅, 王家旭, 杨显文. Th17及Th1细胞在四氯化碳致肝纤维化小鼠模型中的表达及关系. 世界华人消化杂志 2014; 22(13): 1826-1833 [DOI: 10.11569/wcjd.v22.i13.1826] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
533 Feng J, Wang C, Liu T, Li J, Wu L, Yu Q, Li S, Zhou Y, Zhang J, Chen J, Ji J, Chen K, Mao Y, Wang F, Dai W, Fan X, Wu J, Guo C. Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis. J Cell Mol Med 2019;23:6479-93. [PMID: 31328391 DOI: 10.1111/jcmm.14543] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
534 Ni M, Wang L, Yu H, Wen X, Yang Y, Liu G, Hu Y, Li Z. Radiomics Approaches for Predicting Liver Fibrosis With Nonenhanced T1 -Weighted Imaging: Comparison of Different Radiomics Models. J Magn Reson Imaging 2021;53:1080-9. [PMID: 33043991 DOI: 10.1002/jmri.27391] [Reference Citation Analysis]
535 Fisher FM, Chui PC, Nasser IA, Popov Y, Cunniff JC, Lundasen T, Kharitonenkov A, Schuppan D, Flier JS, Maratos-Flier E. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. Gastroenterology 2014;147:1073-83.e6. [PMID: 25083607 DOI: 10.1053/j.gastro.2014.07.044] [Cited by in Crossref: 140] [Cited by in F6Publishing: 138] [Article Influence: 20.0] [Reference Citation Analysis]
536 Yu LM, Xu Y. Epigenetic regulation in cardiac fibrosis. World J Cardiol 2015; 7(11): 784-791 [PMID: 26635926 DOI: 10.4330/wjc.v7.i11.784] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
537 Wang Z, Cheng ZX, Abrams ST, Lin ZQ, Yates E, Yu Q, Yu WP, Chen PS, Toh CH, Wang GZ. Extracellular histones stimulate collagen expression in vitro and promote liver fibrogenesis in a mouse model via the TLR4-MyD88 signaling pathway. World J Gastroenterol 2020; 26(47): 7513-7527 [PMID: 33384551 DOI: 10.3748/wjg.v26.i47.7513] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
538 Gong J, Wang ZX, Liu ZY. miRNA‑1271 inhibits cell proliferation in neuroglioma by targeting fibronectin 1. Mol Med Rep 2017;16:143-50. [PMID: 28535003 DOI: 10.3892/mmr.2017.6610] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
539 Lu C, Xu W, Zheng S. Nrf2 activation is required for curcumin to induce lipocyte phenotype in hepatic stellate cells. Biomed Pharmacother 2017;95:1-10. [PMID: 28826090 DOI: 10.1016/j.biopha.2017.08.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
540 Meissner EG, McLaughlin M, Matthews L, Gharib AM, Wood BJ, Levy E, Sinkus R, Virtaneva K, Sturdevant D, Martens C, Porcella SF, Goodman ZD, Kanwar B, Myers RP, Subramanian M, Hadigan C, Masur H, Kleiner DE, Heller T, Kottilil S, Kovacs JA, Morse CG. Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial. Liver Int. 2016;36:1783-1792. [PMID: 27232579 DOI: 10.1111/liv.13177] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 10.4] [Reference Citation Analysis]
541 Chen Z, Yao L, Liu Y, Pan Z, Peng S, Wan G, Cheng J, Wang J, Cao W. Astragaloside IV regulates NF-κB-mediated cellular senescence and apoptosis of hepatic stellate cells to suppress PDGF-BB-induced activation. Exp Ther Med 2019;18:3741-50. [PMID: 31641375 DOI: 10.3892/etm.2019.8047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
542 Trépo E, Romeo S, Zucman-rossi J, Nahon P. PNPLA3 gene in liver diseases. Journal of Hepatology 2016;65:399-412. [DOI: 10.1016/j.jhep.2016.03.011] [Cited by in Crossref: 123] [Cited by in F6Publishing: 107] [Article Influence: 24.6] [Reference Citation Analysis]
543 Guimarães EL, Stradiot L, Mannaerts I, Schroyen B, van Grunsven LA. P311 modulates hepatic stellate cells migration. Liver Int 2015;35:1253-64. [DOI: 10.1111/liv.12691] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
544 Yang L, Han B, Zhang M, Wang YH, Tao K, Zhu MX, He K, Zhang ZG, Hou S. Activation of BK Channels Prevents Hepatic Stellate Cell Activation and Liver Fibrosis Through the Suppression of TGFβ1/SMAD3 and JAK/STAT3 Profibrotic Signaling Pathways. Front Pharmacol 2020;11:165. [PMID: 32210801 DOI: 10.3389/fphar.2020.00165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
545 Mohammadalipour A, Karimi J, Khodadadi I, Solgi G, Hashemnia M, Sheikh N, Bahabadi M. Dasatinib prevent hepatic fibrosis induced by carbon tetrachloride (CCl 4 ) via anti-inflammatory and antioxidant mechanism. Immunopharmacology and Immunotoxicology 2017;39:19-27. [DOI: 10.1080/08923973.2016.1263860] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
546 黄雯, 朱萱. PDGF及其受体与肝纤维化的相关性. 世界华人消化杂志 2013; 21(9): 773-778 [DOI: 10.11569/wcjd.v21.i9.773] [Reference Citation Analysis]
547 Lao Y, Li Y, Zhang P, Shao Q, Lin W, Qiu B, Lv Y, Tang L, Su S, Zhang H, Tian C, Sun A, Wei H, Zhang P, Wu Y, Jiang Y, He F. Targeting Endothelial Erk1/2-Akt Axis as a Regeneration Strategy to Bypass Fibrosis during Chronic Liver Injury in Mice. Mol Ther 2018;26:2779-97. [PMID: 30266653 DOI: 10.1016/j.ymthe.2018.08.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
548 Yu Y, Cai J, She Z, Li H. Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases. Adv Sci (Weinh). 2019;6:1801585. [PMID: 30828530 DOI: 10.1002/advs.201801585] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
549 Liu J, Kong D, Qiu J, Xie Y, Lu Z, Zhou C, Liu X, Zhang R, Wang Y. Praziquantel ameliorates CCl4 -induced liver fibrosis in mice by inhibiting TGF-β/Smad signalling via up-regulating Smad7 in hepatic stellate cells. Br J Pharmacol 2019;176:4666-80. [PMID: 31412137 DOI: 10.1111/bph.14831] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
550 Churin Y, Roderfeld M, Roeb E. Hepatitis B virus large surface protein: function and fame. Hepatobiliary Surg Nutr 2015;4:1-10. [PMID: 25713800 DOI: 10.3978/j.issn.2304-3881.2014.12.08] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
551 Pan TL, Wang PW. Explore the Molecular Mechanism of Apoptosis Induced by Tanshinone IIA on Activated Rat Hepatic Stellate Cells. Evid Based Complement Alternat Med 2012;2012:734987. [PMID: 23346212 DOI: 10.1155/2012/734987] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
552 Stokes CS, Volmer DA, Grünhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int 2013;33:338-52. [DOI: 10.1111/liv.12106] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 11.5] [Reference Citation Analysis]
553 Bradding P, Pejler G. The controversial role of mast cells in fibrosis. Immunol Rev 2018;282:198-231. [PMID: 29431218 DOI: 10.1111/imr.12626] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 25.5] [Reference Citation Analysis]
554 Lakshman MR, Reyes-Gordillo K, Varatharajalu R, Arellanes-Robledo J, Leckey LC, Garige M, Shah R. Novel modulators of hepatosteatosis, inflammation and fibrogenesis. Hepatol Int 2014;8 Suppl 2:413-20. [PMID: 26201319 DOI: 10.1007/s12072-014-9526-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
555 Elberry DA, Amin SN, Esmail RS, Rashed LA, Gamal MM. Effect of undifferentiated versus hepatogenic partially differentiated mesenchymal stem cells on hepatic and cognitive functions in liver cirrhosis. EXCLI J 2016;15:652-70. [PMID: 28337098 DOI: 10.17179/excli2016-645] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
556 Atanasova I, Sojoodi M, Leitão HS, Shuvaev S, Geraldes CFGC, Masia R, Guimaraes AS, Tanabe KK, Fuchs BC, Caravan P. Molecular Magnetic Resonance Imaging of Fibrin Deposition in the Liver as an Indicator of Tissue Injury and Inflammation. Invest Radiol 2020;55:209-16. [PMID: 31895219 DOI: 10.1097/RLI.0000000000000631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
557 Zhou Q, Guan W, Qiao H, Cheng Y, Li Z, Zhai X, Zhou Y. GATA binding protein 2 mediates leptin inhibition of PPARγ1 expression in hepatic stellate cells and contributes to hepatic stellate cell activation. Biochim Biophys Acta. 2014;1842:2367-2377. [PMID: 25305367 DOI: 10.1016/j.bbadis.2014.10.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
558 Li Y, Wang J, Song K, Liu S, Zhang H, Wang F, Ni C, Zhai W, Liang J, Qin Z, Zhang J. S100A4 promotes hepatocellular carcinogenesis by intensifying fibrosis-associated cancer cell stemness. Oncoimmunology 2020;9:1725355. [PMID: 32117590 DOI: 10.1080/2162402X.2020.1725355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
559 Lian N, Jiang Y, Zhang F, Jin H, Lu C, Wu X, Lu Y, Zheng S. Curcumin regulates cell fate and metabolism by inhibiting hedgehog signaling in hepatic stellate cells. Lab Invest. 2015;95:790-803. [PMID: 25938627 DOI: 10.1038/labinvest.2015.59] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
560 Lee SW, Jung DJ, Jeong GS. Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models. Tissue Eng Regen Med 2020;17:731-45. [PMID: 32207030 DOI: 10.1007/s13770-020-00245-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
561 Zhang F, Zhang Z, Kong D, Zhang X, Chen L, Zhu X, Lu Y, Zheng S. Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated PI3K/AKT and ERK pathways. Mol Cell Endocrinol. 2014;382:197-204. [PMID: 24071517 DOI: 10.1016/j.mce.2013.09.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
562 Liu Y, Li J, Liao L, Huang H, Fan S, Fu R, Huang J, Shi C, Yu L, Chen KX, Zhang YY, Luo C, Li GM. Cyclin-dependent kinase inhibitor roscovitine attenuates liver inflammation and fibrosis by influencing initiating steps of liver injury. Clin Sci (Lond) 2021;135:925-41. [PMID: 33786590 DOI: 10.1042/CS20201111] [Reference Citation Analysis]
563 Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3:1473-1492. [PMID: 24265236 DOI: 10.1002/cphy.c120035] [Cited by in Crossref: 347] [Cited by in F6Publishing: 346] [Article Influence: 49.6] [Reference Citation Analysis]
564 Li J, Hu R, Xu S, Li Y, Qin Y, Wu Q, Xiao Z. Xiaochaihutang attenuates liver fibrosis by activation of Nrf2 pathway in rats. Biomedicine & Pharmacotherapy 2017;96:847-53. [DOI: 10.1016/j.biopha.2017.10.065] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
565 He W, Shi F, Zhou ZW, Li B, Zhang K, Zhang X, Ouyang C, Zhou SF, Zhu X. A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver. Drug Des Devel Ther 2015;9:3989-4104. [PMID: 26347199 DOI: 10.2147/DDDT.S85426] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
566 Zhang X, Xin J, Shi Y, Xu W, Yu S, Yang Z, Liu C, Cao L, Guo Q. Assessing activation of hepatic stellate cells by (99m)Tc-3PRGD2 scintigraphy targeting integrin αvβ3: a feasibility study. Nucl Med Biol 2015;42:250-5. [PMID: 25530210 DOI: 10.1016/j.nucmedbio.2014.11.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
567 Zhan L, Yang Y, Ma TT, Huang C, Meng XM, Zhang L, Li J. Transient receptor potential vanilloid 4 inhibits rat HSC-T6 apoptosis through induction of autophagy. Mol Cell Biochem 2015;402:9-22. [PMID: 25600591 DOI: 10.1007/s11010-014-2298-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
568 Martin-Mateos R, De Assuncao TM, Arab JP, Jalan-Sakrikar N, Yaqoob U, Greuter T, Verma VK, Mathison AJ, Cao S, Lomberk G, Mathurin P, Urrutia R, Huebert RC, Shah VH. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis. Cell Mol Gastroenterol Hepatol 2019;7:197-209. [PMID: 30539787 DOI: 10.1016/j.jcmgh.2018.09.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
569 Yu F, Teng Y, Zhu Q, Zhang Q, Tang Y. Inhibitory effects of capsaicin on hepatic stellate cells and liver fibrosis. Biochem Cell Biol 2014;92:406-12. [DOI: 10.1139/bcb-2014-0036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
570 Ma L, Liu J, Xiao E, Ning H, Li K, Shang J, Kang Y. MiR-15b and miR-16 suppress TGF-β1-induced proliferation and fibrogenesis by regulating LOXL1 in hepatic stellate cells. Life Sci 2021;270:119144. [PMID: 33545201 DOI: 10.1016/j.lfs.2021.119144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
571 Jalan R, De Chiara F, Balasubramaniyan V, Andreola F, Khetan V, Malago M, Pinzani M, Mookerjee RP, Rombouts K. Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension. J Hepatol. 2016;64:823-833. [PMID: 26654994 DOI: 10.1016/j.jhep.2015.11.019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
572 Li X, Zhang H, Pan L, Zou H, Miao X, Cheng J, Wu Y. Puerarin alleviates liver fibrosis via inhibition of the ERK1/2 signaling pathway in thioacetamide-induced hepatic fibrosis in rats. Exp Ther Med 2019;18:133-8. [PMID: 31258646 DOI: 10.3892/etm.2019.7534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
573 Kandhare AD, Bodhankar SL, Mohan V, Thakurdesai PA. Glycosides Based Standardized Fenugreek Seed Extract Ameliorates Bleomycin-induced Liver Fibrosis in Rats Via Modulation of Endogenous Enzymes. J Pharm Bioallied Sci 2017;9:185-94. [PMID: 28979073 DOI: 10.4103/0975-7406.214688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
574 Guo L, Zhang P, Chen Z, Xia H, Li S, Zhang Y, Kobberup S, Zou W, Lin JD. Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression. J Clin Invest 2017;127:4449-61. [PMID: 29106384 DOI: 10.1172/JCI96324] [Cited by in Crossref: 63] [Cited by in F6Publishing: 37] [Article Influence: 15.8] [Reference Citation Analysis]
575 Pan XY, Yang Y, Meng HW, Li HD, Chen X, Huang HM, Bu FT, Yu HX, Wang Q, Huang C, Meng XM, Li J. DNA Methylation of PTGIS Enhances Hepatic Stellate Cells Activation and Liver Fibrogenesis. Front Pharmacol 2018;9:553. [PMID: 29892223 DOI: 10.3389/fphar.2018.00553] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
576 Damiris K, Tafesh ZH, Pyrsopoulos N. Efficacy and safety of anti-hepatic fibrosis drugs. World J Gastroenterol 2020; 26(41): 6304-6321 [PMID: 33244194 DOI: 10.3748/wjg.v26.i41.6304] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
577 Liu Y, Li L, Liu J, She WM, Shi JM, Li J, Wang JY, Jiang W. Activated hepatic stellate cells directly induce pathogenic Th17 cells in chronic hepatitis B virus infection. Exp Cell Res. 2017;359:129-137. [PMID: 28780305 DOI: 10.1016/j.yexcr.2017.08.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
578 Fan TT, Hu PF, Wang J, Wei J, Zhang Q, Ning BF, Yin C, Zhang X, Xie WF, Chen YX, Shi B. Regression effect of hepatocyte nuclear factor 4α on liver cirrhosis in rats. J Dig Dis 2013;14:318-27. [PMID: 23374293 DOI: 10.1111/1751-2980.12042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
579 Zhang C, An R, Bao Y, Meng X, Wang T, Sun H, Pan F, Zhang C. Inhibitory effects of octreotide on the progression of hepatic fibrosis via the regulation of Bcl-2/Bax and PI3K/AKT signaling pathways. International Immunopharmacology 2019;73:515-26. [DOI: 10.1016/j.intimp.2019.05.055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
580 You SP, Zhao J, Ma L, Tudimat M, Zhang SL, Liu T. Preventive effects of phenylethanol glycosides from Cistanche tubulosa on bovine serum albumin-induced hepatic fibrosis in rats. Daru 2015;23:52. [PMID: 26646297 DOI: 10.1186/s40199-015-0135-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
581 Crawford JM, Burt AD. Anatomy, pathophysiology and basic mechanisms of disease. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 1-77. [DOI: 10.1016/b978-0-7020-3398-8.00001-5] [Cited by in Crossref: 11] [Article Influence: 1.2] [Reference Citation Analysis]
582 Reza HM, Tabassum N, Sagor MA, Chowdhury MR, Rahman M, Jain P, Alam MA. Angiotensin-converting enzyme inhibitor prevents oxidative stress, inflammation, and fibrosis in carbon tetrachloride-treated rat liver. Toxicol Mech Methods 2016;26:46-53. [PMID: 26862777 DOI: 10.3109/15376516.2015.1124956] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
583 Hong L, Sun QF, Xu TY, Wu YH, Zhang H, Fu RQ, Cai FJ, Zhou QQ, Zhou K, Du QW, Zhang D, Xu S, Ding JG. New role and molecular mechanism of Gadd45a in hepatic fibrosis. World J Gastroenterol 2016; 22(9): 2779-2788 [PMID: 26973416 DOI: 10.3748/wjg.v22.i9.2779] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
584 Zhao P, Sun X, Chaggan C, Liao Z, In Wong K, He F, Singh S, Loomba R, Karin M, Witztum JL, Saltiel AR. An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis. Science 2020;367:652-60. [PMID: 32029622 DOI: 10.1126/science.aay0542] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 36.0] [Reference Citation Analysis]
585 Li Z, Ji L, Su S, Zhu X, Cheng F, Jia X, Zhou Q, Zhou Y. Leptin up-regulates microRNA-27a/b-3p level in hepatic stellate cells. Exp Cell Res 2018;366:63-70. [PMID: 29548749 DOI: 10.1016/j.yexcr.2018.03.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
586 Zhang W, Kong X, Wang ZJ, Luo S, Huang W, Zhang LJ. Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats. PLoS One 2015;10:e0129621. [PMID: 26076199 DOI: 10.1371/journal.pone.0129621] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
587 Chen YX, Weng ZH, Zhang SL. Notch3 regulates the activation of hepatic stellate cells. World J Gastroenterol 2012; 18(12): 1397-1403 [PMID: 22493555 DOI: 10.3748/wjg.v18.i12.1397] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
588 Choi YJ, Kim DH, Kim SJ, Kim J, Jeong S, Chung CH, Yu K, Kim S. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro. Life Sciences 2014;108:94-103. [DOI: 10.1016/j.lfs.2014.05.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
589 Tee JK, Yip LX, Tan ES, Santitewagun S, Prasath A, Ke PC, Ho HK, Leong DT. Nanoparticles' interactions with vasculature in diseases. Chem Soc Rev 2019;48:5381-407. [PMID: 31495856 DOI: 10.1039/c9cs00309f] [Cited by in Crossref: 108] [Cited by in F6Publishing: 27] [Article Influence: 54.0] [Reference Citation Analysis]
590 Nunez Lopez O, Bohanon FJ, Wang X, Ye N, Corsello T, Rojas-Khalil Y, Chen H, Chen H, Zhou J, Radhakrishnan RS. STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis. RSC Adv 2016;6:100652-63. [PMID: 28546859 DOI: 10.1039/C6RA17459K] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
591 Barghi M, Ashrafi M, Aminlari M, Namazi F, Nazifi S. The protective effect of Zataria multiflora Boiss essential oil on CCl4 induced liver fibrosis in rats. Drug Chem Toxicol 2021;44:229-37. [PMID: 30746963 DOI: 10.1080/01480545.2019.1571502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
592 Yu Q, Cheng P, Wu J, Guo C. PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis. J Cell Mol Med 2021;25:1645-60. [PMID: 33438347 DOI: 10.1111/jcmm.16267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
593 Saber S, Mahmoud AAA, Helal NS, El-Ahwany E, Abdelghany RH. Renin-angiotensin system inhibition ameliorates CCl4-induced liver fibrosis in mice through the inactivation of nuclear transcription factor kappa B. Can J Physiol Pharmacol. 2018;96:569-576. [PMID: 29425464 DOI: 10.1139/cjpp-2017-0728] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
594 Axley P, Mudumbi S, Sarker S, Kuo YF, Singal AK. Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS One 2018;13:e0197117. [PMID: 29746540 DOI: 10.1371/journal.pone.0197117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
595 Affo S, Yu LX, Schwabe RF. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer. Annu Rev Pathol 2017;12:153-86. [PMID: 27959632 DOI: 10.1146/annurev-pathol-052016-100322] [Cited by in Crossref: 183] [Cited by in F6Publishing: 189] [Article Influence: 36.6] [Reference Citation Analysis]
596 Zhu H, He C, Zhao H, Jiang W, Xu S, Li J, Ma T, Huang C. Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation. FASEB J 2020;34:14558-71. [PMID: 32946656 DOI: 10.1096/fj.202000494RR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
597 Toson el-SA, Shiha GE, El-Mezayen HA, El-Sharkawy AM. Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score. Eur J Gastroenterol Hepatol 2016;28:931-9. [PMID: 27159125 DOI: 10.1097/MEG.0000000000000656] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
598 Amer J, Grifat R, Doron S, Abu-Tair L, Mruwat R, El-Khatib A, Safadi R. The pro-fibrotic effects of pregnancy in a carbon-tetrachloride-induced liver injury in mouse model. Liver Int 2014;34:1232-40. [PMID: 24325428 DOI: 10.1111/liv.12371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
599 施凤, 朱萱. NOX介导的MAPK、PI3K/Akt信号通路与肝纤维化. 世界华人消化杂志 2012; 20(28): 2685-2690 [DOI: 10.11569/wcjd.v20.i28.2685] [Reference Citation Analysis]
600 Chen CH, Chang CL, Chen KH, Cheng BC, Chen HH, Chiang JY, Sung PH, Yip HK. Level and Value of T Cell-derived Circulating Microparticles in Liver Cirrhosis Patients. In Vivo 2019;33:2265-72. [PMID: 31662566 DOI: 10.21873/invivo.11732] [Reference Citation Analysis]
601 Kurtoğlu EL, Kayhan B, Gül M, Kayhan B, Akdoğan Kayhan M, Karaca ZM, Yeşilada E, Yılmaz S. A bioactive product lipoxin A4 attenuates liver fibrosis in an experimental model by regulating immune response and modulating the expression of regeneration genes. Turk J Gastroenterol 2019;30:745-57. [PMID: 31418419 DOI: 10.5152/tjg.2019.18276] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
602 Yang H, Ni HM, Ding WX. Emerging Players in Autophagy Deficiency-Induced Liver Injury and Tumorigenesis. Gene Expr 2019;19:229-34. [PMID: 30717822 DOI: 10.3727/105221619X15486875608177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
603 van Beuge MM, Poelstra K, Prakash J. Specific delivery of kinase inhibitors in nonmalignant and malignant diseases. Expert Opin Drug Deliv 2012;9:59-70. [PMID: 22111941 DOI: 10.1517/17425247.2012.638625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
604 Zhang F, Zhang M, Wang A, Xu M, Wang C, Xu G, Zhang B, Zou X, Zhuge Y. TWEAK increases SIRT1 expression and promotes p53 deacetylation affecting human hepatic stellate cell senescence. Cell Biol Int. 2017;41:147-154. [PMID: 27888541 DOI: 10.1002/cbin.10706] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
605 Howarth DL, Yin C, Yeh K, Sadler KC. Defining hepatic dysfunction parameters in two models of fatty liver disease in zebrafish larvae. Zebrafish 2013;10:199-210. [PMID: 23697887 DOI: 10.1089/zeb.2012.0821] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
606 Mukhopadhyay P, Rajesh M, Cao Z, Horváth B, Park O, Wang H, Erdelyi K, Holovac E, Wang Y, Liaudet L, Hamdaoui N, Lafdil F, Haskó G, Szabo C, Boulares AH, Gao B, Pacher P. Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis. Hepatology 2014;59:1998-2009. [PMID: 24089324 DOI: 10.1002/hep.26763] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 11.4] [Reference Citation Analysis]
607 Yang W, He H, Wang T, Su N, Zhang F, Jiang K, Zhu J, Zhang C, Niu K, Wang L, Yuan X, Liu N, Li L, Wei W, Hu J. Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice. Hepatology 2021. [PMID: 34089528 DOI: 10.1002/hep.31987] [Reference Citation Analysis]
608 Fioruci-Fontanelli BA, Chuffa LG, Mendes LO, Pinheiro PF, Delella FK, Kurokawa CS, Felisbino SL, Martinez FE. MMP-2 and MMP-9 activities and TIMP-1 and TIMP-2 expression in the prostatic tissue of two ethanol-preferring rat models. Anal Cell Pathol (Amst) 2015;2015:954548. [PMID: 26258010 DOI: 10.1155/2015/954548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
609 George J, Tsutsumi M, Tsuchishima M. Alteration of Trace Elements during Pathogenesis of N-Nitrosodimethylamine Induced Hepatic Fibrosis. Sci Rep 2019;9:708. [PMID: 30679730 DOI: 10.1038/s41598-018-37516-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
610 Bai T, Yao YL, Jin XJ, Lian LH, Li Q, Yang N, Jin Q, Wu YL, Nan JX. Acanthoic acid, a diterpene in Acanthopanax koreanum, ameliorates the development of liver fibrosis via LXRs signals. Chem Biol Interact. 2014;218:63-70. [PMID: 24802811 DOI: 10.1016/j.cbi.2014.04.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
611 Kim JH, Lee CH, Lee SW. Hepatitis C virus infection stimulates transforming growth factor-β1 expression through up-regulating miR-192. J Microbiol 2016;54:520-6. [PMID: 27350618 DOI: 10.1007/s12275-016-6240-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
612 Lee JH, Jang EJ, Seo HL, Ku SK, Lee JR, Shin SS, Park SD, Kim SC, Kim YW. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway. Chem Biol Interact. 2014;224:58-67. [PMID: 25451574 DOI: 10.1016/j.cbi.2014.10.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
613 Chen Y, Zheng S, Qi D, Zheng S, Guo J, Zhang S, Weng Z. Inhibition of Notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats. PLoS One. 2012;7:e46512. [PMID: 23056328 DOI: 10.1371/journal.pone.0046512] [Cited by in Crossref: 78] [Cited by in F6Publishing: 93] [Article Influence: 8.7] [Reference Citation Analysis]
614 Zhan J, Cao H, Hu T, Shen J, Wang W, Wu P, Yang G, Ho CT, Li S. Efficient Preparation of Black Tea Extract (BTE) with the High Content of Theaflavin Mono- and Digallates and the Protective Effects of BTE on CCl4-Induced Rat Liver and Renal Injury. J Agric Food Chem 2021;69:5938-47. [PMID: 34003645 DOI: 10.1021/acs.jafc.1c01851] [Reference Citation Analysis]
615 Negro F. Mechanisms of hepatitis C virus-related insulin resistance. Clin Res Hepatol Gastroenterol. 2011;35:358-363. [PMID: 21354385 DOI: 10.1016/j.clinre.2011.01.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
616 Teran-Hinojosa E, Sobral H, Sánchez-Pérez C, Pérez-García A, Alemán-García N, Hernández-Ruiz J. Differentiation of fibrotic liver tissue using laser-induced breakdown spectroscopy. Biomed Opt Express 2017;8:3816-27. [PMID: 28856052 DOI: 10.1364/BOE.8.003816] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
617 Chung SI, Moon H, Kim DY, Cho KJ, Ju HL, Kim DY, Ahn SH, Han KH, Ro SW. Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background. BMC Gastroenterol 2016;16:13. [PMID: 26821924 DOI: 10.1186/s12876-016-0423-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
618 Shi J, Zhao J, Zhang X, Cheng Y, Hu J, Li Y, Zhao X, Shang Q, Sun Y, Tu B, Shi L, Gao B, Wang FS, Zhang Z. Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients. Sci Rep 2017;7:44544. [PMID: 28291251 DOI: 10.1038/srep44544] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
619 Sun YM, Chen SY, You H. Regression of liver fibrosis: evidence and challenges. Chin Med J (Engl) 2020;133:1696-702. [PMID: 32568866 DOI: 10.1097/CM9.0000000000000835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
620 Xie H, Xie D, Zhang J, Jin W, Li Y, Yao J, Pan Z, Xie D. ROS/NF-κB Signaling Pathway-Mediated Transcriptional Activation of TRIM37 Promotes HBV-Associated Hepatic Fibrosis. Mol Ther Nucleic Acids 2020;22:114-23. [PMID: 32916597 DOI: 10.1016/j.omtn.2020.08.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
621 Fabregat I, Caballero-Díaz D. Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis. Front Oncol 2018;8:357. [PMID: 30250825 DOI: 10.3389/fonc.2018.00357] [Cited by in Crossref: 94] [Cited by in F6Publishing: 94] [Article Influence: 31.3] [Reference Citation Analysis]
622 Lutz HH, Sackett SD, Kroy DC, Gassler N, Trautwein C. Deletion of gp130 in myeloid cells modulates IL-6-release and is associated with more severe liver injury of Con A hepatitis. Eur J Cell Biol. 2012;91:576-581. [PMID: 22018663 DOI: 10.1016/j.ejcb.2011.09.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
623 Zhang Z, Gao Z, Hu W, Yin S, Wang C, Zang Y, Chen J, Zhang J, Dong L. 3,3’-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression. Br J Pharmacol. 2013;170:649-660. [PMID: 23902531 DOI: 10.1111/bph.12323] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
624 Mu M, Zuo S, Wu RM, Deng KS, Lu S, Zhu JJ, Zou GL, Yang J, Cheng ML, Zhao XK. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway. Drug Des Devel Ther 2018;12:4107-15. [PMID: 30584275 DOI: 10.2147/DDDT.S186726] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 8.7] [Reference Citation Analysis]
625 Read SA, Douglas MW. Virus induced inflammation and cancer development. Cancer Lett 2014;345:174-81. [PMID: 23941825 DOI: 10.1016/j.canlet.2013.07.030] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
626 Aghbash PS, Hemmat N, Nahand JS, Shamekh A, Memar MY, Babaei A, Baghi HB. The role of Th17 cells in viral infections. Int Immunopharmacol 2021;91:107331. [PMID: 33418239 DOI: 10.1016/j.intimp.2020.107331] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
627 Fabre T, Molina MF, Soucy G, Goulet J, Willems B, Villeneuve J, Bilodeau M, Shoukry NH. Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis. Sci Immunol 2018;3:eaar7754. [DOI: 10.1126/sciimmunol.aar7754] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 14.3] [Reference Citation Analysis]
628 Chan J, Sharkey FE, Kushwaha RS, VandeBerg JF, VandeBerg JL. Steatohepatitis in laboratory opossums exhibiting a high lipemic response to dietary cholesterol and fat. Am J Physiol Gastrointest Liver Physiol. 2012;303:G12-G19. [PMID: 22556142 DOI: 10.1152/ajpgi.00415.2011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
629 Ahrari A, Najafzadehvarzi H, Taravati A, Tohidi F. The inhibitory effect of PLGA-encapsulated berberine on hepatotoxicity and α-smooth muscle actin (α-SMA) gene expression. Life Sci 2021;284:119884. [PMID: 34389401 DOI: 10.1016/j.lfs.2021.119884] [Reference Citation Analysis]
630 Chen JY, Newcomb B, Zhou C, Pondick JV, Ghoshal S, York SR, Motola DL, Coant N, Yi JK, Mao C, Tanabe KK, Bronova I, Berdyshev EV, Fuchs BC, Hannun Y, Chung RT, Mullen AC. Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells. Sci Rep 2017;7:44867. [PMID: 28322247 DOI: 10.1038/srep44867] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
631 Cheng JC, Tseng CP, Liao MH, Peng CY, Yu JS, Chuang PH, Huang JT, Chen JJW. Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytes. Sci Rep 2017;7:4448. [PMID: 28667290 DOI: 10.1038/s41598-017-04259-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
632 Ballway JW, Song BJ. Translational Approaches with Antioxidant Phytochemicals against Alcohol-Mediated Oxidative Stress, Gut Dysbiosis, Intestinal Barrier Dysfunction, and Fatty Liver Disease. Antioxidants (Basel) 2021;10:384. [PMID: 33806556 DOI: 10.3390/antiox10030384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
633 Ramani K, Biswas PS. Interleukin-17: Friend or foe in organ fibrosis. Cytokine 2019;120:282-8. [PMID: 30772195 DOI: 10.1016/j.cyto.2018.11.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
634 Ma L, Li X, Bai Z, Lin X, Lin K. AdipoRs- a potential therapeutic target for fibrotic disorders. Expert Opin Ther Targets 2019;23:93-106. [PMID: 30569772 DOI: 10.1080/14728222.2019.1559823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
635 Churin Y, Roderfeld M, Stiefel J, Würger T, Schröder D, Matono T, Mollenkopf HJ, Montalbano R, Pompaiah M, Reifenberg K. Pathological impact of hepatitis B virus surface proteins on the liver is associated with the host genetic background. PLoS One. 2014;9:e90608. [PMID: 24594856 DOI: 10.1371/journal.pone.0090608] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
636 Alonso-Merino E, Martín Orozco R, Ruíz-Llorente L, Martínez-Iglesias OA, Velasco-Martín JP, Montero-Pedrazuela A, Fanjul-Rodríguez L, Contreras-Jurado C, Regadera J, Aranda A. Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses. Proc Natl Acad Sci U S A 2016;113:E3451-60. [PMID: 27247403 DOI: 10.1073/pnas.1506113113] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
637 Yang Y, Bae M, Kim B, Park YK, Koo SI, Lee JY. Astaxanthin prevents and reverses the activation of mouse primary hepatic stellate cells. J Nutr Biochem 2016;29:21-6. [PMID: 26895661 DOI: 10.1016/j.jnutbio.2015.11.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
638 Tong M, Zheng Q, Liu M, Chen L, Lin YH, Tang SG, Zhu YM. 5-methoxytryptophan alleviates liver fibrosis by modulating FOXO3a/miR-21/ATG5 signaling pathway mediated autophagy. Cell Cycle 2021;20:676-88. [PMID: 33734029 DOI: 10.1080/15384101.2021.1897241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
639 Sun X, Seidman JS, Zhao P, Troutman TD, Spann NJ, Que X, Zhou F, Liao Z, Pasillas M, Yang X, Magida JA, Kisseleva T, Brenner DA, Downes M, Evans RM, Saltiel AR, Tsimikas S, Glass CK, Witztum JL. Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis. Cell Metab 2020;31:189-206.e8. [PMID: 31761566 DOI: 10.1016/j.cmet.2019.10.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
640 Lin CY, Adhikary P, Cheng K. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Adv Drug Deliv Rev 2021;174:127-39. [PMID: 33857552 DOI: 10.1016/j.addr.2021.04.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
641 Xia P, He H, Kristine MS, Guan W, Gao J, Wang Z, Hu J, Han L, Li J, Han W, Yu Y. Therapeutic effects of recombinant human S100A6 and soluble receptor for advanced glycation end products(sRAGE) on CCl4-induced liver fibrosis in mice. Eur J Pharmacol 2018;833:86-93. [PMID: 29800549 DOI: 10.1016/j.ejphar.2018.05.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
642 Zhou Y, Chen Y, Zhang X, Xu Q, Wu Z, Cao X, Shao M, Shu Y, Lv T, Lu C, Xie M, Wen T, Yang J, Shi Y, Bu H. Brahma-Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion. Hepatology 2021;74:797-815. [PMID: 33650193 DOI: 10.1002/hep.31780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
643 Hou B, Zhao Y, Qiang G, Yang X, Xu C, Chen X, Liu C, Wang X, Zhang L, Du G. Puerarin Mitigates Diabetic Hepatic Steatosis and Fibrosis by Inhibiting TGF-β Signaling Pathway Activation in Type 2 Diabetic Rats. Oxid Med Cell Longev 2018;2018:4545321. [PMID: 30057680 DOI: 10.1155/2018/4545321] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
644 Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153:601-613. [PMID: 23622244 DOI: 10.1016/j.cell.2013.03.028] [Cited by in Crossref: 386] [Cited by in F6Publishing: 389] [Article Influence: 48.3] [Reference Citation Analysis]
645 Borkham-kamphorst E, Zimmermann HW, Gassler N, Bissels U, Bosio A, Tacke F, Weiskirchen R, Kanse SM. Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men. Journal of Hepatology 2013;58:104-11. [DOI: 10.1016/j.jhep.2012.09.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
646 Huang W, Ji R, Ge S, Zhou D, Liu Z, Sun Y, Huang W, Lu C. MicroRNA-92b-3p promotes the progression of liver fibrosis by targeting CREB3L2 through the JAK/STAT signaling pathway. Pathol Res Pract 2021;219:153367. [PMID: 33618248 DOI: 10.1016/j.prp.2021.153367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
647 Baglieri J, Brenner DA, Kisseleva T. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma. Int J Mol Sci 2019;20:E1723. [PMID: 30959975 DOI: 10.3390/ijms20071723] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 29.5] [Reference Citation Analysis]
648 Gil MN, Choi DR, Yu KS, Jeong JH, Bak DH, Kim DK, Lee NS, Lee JH, Jeong YG, Na CS, Na DS, Ryu KH, Han SY. Rhus verniciflua Stokes attenuates cholestatic liver cirrhosis-induced interstitial fibrosis via Smad3 down-regulation and Smad7 up-regulation. Anat Cell Biol 2016;49:189-98. [PMID: 27722012 DOI: 10.5115/acb.2016.49.3.189] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
649 Sun X, Nkennor B, Mastikhina O, Soon K, Nunes SS. Endothelium-mediated contributions to fibrosis. Semin Cell Dev Biol. 2020;101:78-86. [PMID: 31791693 DOI: 10.1016/j.semcdb.2019.10.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
650 Hintermann E, Christen U. The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis. Cells 2019;8:E1503. [PMID: 31771248 DOI: 10.3390/cells8121503] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
651 Wei S, Luo S, Wang J, Wang J, Li R, Zhang X, Guo Y, Chen C, Ma X, Chen Z, Liu H, Yang Z, Li J, Wang R, Zhang Y, Yang H, Xiao X, Zhao Y. San-Cao Granule (三草颗粒) Ameliorates Hepatic Fibrosis through High Mobility Group Box-1 Protein/Smad Signaling Pathway. Chin J Integr Med 2018;24:502-11. [DOI: 10.1007/s11655-015-2127-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
652 Ortiz C, Schierwagen R, Schaefer L, Klein S, Trepat X, Trebicka J. Extracellular Matrix Remodeling in Chronic Liver Disease. Curr Tissue Microenviron Rep 2021;:1-12. [PMID: 34337431 DOI: 10.1007/s43152-021-00030-3] [Reference Citation Analysis]
653 Simon TG, King LY, Zheng H, Chung RT. Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C. J Hepatol. 2015;62:18-23. [PMID: 25135867 DOI: 10.1016/j.jhep.2014.08.013] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 9.6] [Reference Citation Analysis]
654 Fabre T, Kared H, Friedman SL, Shoukry NH. IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-β receptor on hepatic stellate cells in a JNK-dependent manner. J Immunol 2014;193:3925-33. [PMID: 25210118 DOI: 10.4049/jimmunol.1400861] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 9.4] [Reference Citation Analysis]
655 Lotersztajn S, Mallat A. Hepatic Stellate Cells as Target for Reversal of Fibrosis/Cirrhosis. Stellate Cells in Health and Disease. Elsevier; 2015. pp. 175-84. [DOI: 10.1016/b978-0-12-800134-9.00011-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
656 Pan TL, Wang PW, Leu YL, Wu TH, Wu TS. Inhibitory effects of Scutellaria baicalensis extract on hepatic stellate cells through inducing G2/M cell cycle arrest and activating ERK-dependent apoptosis via Bax and caspase pathway. J Ethnopharmacol 2012;139:829-37. [PMID: 22210104 DOI: 10.1016/j.jep.2011.12.028] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
657 Huang Q, Wei L, Liang C, Nie J, Lu S, Lu C, Tan S, Lv S, Zhuo L, Lu Z, Lin X. Loss of Raf kinase inhibitor protein is associated with malignant progression in hepatic fibrosis. Biomed Pharmacother 2016;82:669-76. [PMID: 27470410 DOI: 10.1016/j.biopha.2016.06.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
658 Yan Z, Wang D, An C, Xu H, Zhao Q, Shi Y, Song N, Deng B, Guo X, Rao J, Cheng L, Zhang B, Mou L, Yang W, Jiang X, Xie J. The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis. Acta Pharm Sin B 2021;11:100-11. [PMID: 33532183 DOI: 10.1016/j.apsb.2020.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
659 Handayani DS, Ulfa M, Wikanendra GB, Arozal W. Effect of mangiferin on mRNA expression of transforming growth factor beta in rats with liver fibrosis induced by thioacetamide. J Phys : Conf Ser 2018;1073:032076. [DOI: 10.1088/1742-6596/1073/3/032076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
660 Han HS, Lee H, You D, Nguyen VQ, Song DG, Oh BH, Shin S, Choi JS, Kim JD, Pan CH, Jo DG, Cho YW, Choi KY, Park JH. Human adipose stem cell-derived extracellular nanovesicles for treatment of chronic liver fibrosis. J Control Release 2020;320:328-36. [PMID: 31981658 DOI: 10.1016/j.jconrel.2020.01.042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
661 Morisaka H, Motosugi U, Glaser KJ, Ichikawa S, Ehman RL, Sano K, Ichikawa T, Onishi H. Comparison of diagnostic accuracies of two- and three-dimensional MR elastography of the liver. J Magn Reson Imaging 2017;45:1163-70. [PMID: 27662640 DOI: 10.1002/jmri.25425] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
662 Cai S, Wu L, Yuan S, Liu G, Wang Y, Fang L, Xu D. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway. Eur J Pharmacol 2021;898:173982. [PMID: 33647257 DOI: 10.1016/j.ejphar.2021.173982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
663 Manka P, Coombes JD, Boosman R, Gauthier K, Papa S, Syn WK. Thyroid hormone in the regulation of hepatocellular carcinoma and its microenvironment. Cancer Lett 2018;419:175-86. [PMID: 29414304 DOI: 10.1016/j.canlet.2018.01.055] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
664 Wu L, Mao C, Ming X. Modulation of Bcl-x Alternative Splicing Induces Apoptosis of Human Hepatic Stellate Cells. Biomed Res Int. 2016;2016:7478650. [PMID: 27579319 DOI: 10.1155/2016/7478650] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
665 Lee JH, Kim YR, Lee GM, Ryu JH, Cho EY, Lee YH, Yoon KH. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B. Eur J Radiol 2018;102:95-101. [PMID: 29685552 DOI: 10.1016/j.ejrad.2018.02.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
666 Yu F, Geng W, Dong P, Huang Z, Zheng J. LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212. Cell Death Dis 2018;9:1014. [PMID: 30282972 DOI: 10.1038/s41419-018-1068-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 9.7] [Reference Citation Analysis]
667 Friedman SL. Extracellular matrix. In: Dufour J, Clavien P, editors. Signaling Pathways in Liver Diseases. Chichester: John Wiley & Sons, Ltd; 2015. pp. 85-96. [DOI: 10.1002/9781118663387.ch6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
668 Wu YJ, Xu MY, Lu LG. Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C. J Clin Transl Hepatol 2014;2:222-7. [PMID: 26357628 DOI: 10.14218/JCTH.2014.00029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
669 Özerkan D, Özsoy N, Akbulut KG, Güney Ş, Öztürk G. The protective effect of vitamin D against carbon tetrachloride damage to the rat liver. Biotech Histochem 2017;92:513-23. [PMID: 28910170 DOI: 10.1080/10520295.2017.1361549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
670 Fang L, Zhan S, Huang C, Cheng X, Lv X, Si H, Li J. TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways. Toxicol Appl Pharmacol 2013;272:713-25. [PMID: 23958495 DOI: 10.1016/j.taap.2013.08.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 6.5] [Reference Citation Analysis]
671 Shan C, Wang R, Wang S, Zhang Z, Xing C, Feng W, Zhao Z, Zhou S, Zhao AZ, Mu Y, Li F. Endogenous production of n-3 polyunsaturated fatty acids protects mice from carbon tetrachloride-induced liver fibrosis by regulating mTOR and Bcl-2/Bax signalling pathways. Exp Physiol 2021;106:983-93. [PMID: 33605486 DOI: 10.1113/EP089328] [Reference Citation Analysis]
672 Li Z, Sun J, Hu X, Huang N, Han G, Chen L, Zhou Y, Bai W, Yang X. Assessment of liver fibrosis by variable flip angle T1 mapping at 3.0T. J Magn Reson Imaging. 2016;43:698-703. [PMID: 26267123 DOI: 10.1002/jmri.25030] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
673 Park PH, Sanz-Garcia C, Nagy LE. Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver. Curr Pathobiol Rep 2015;3:243-52. [PMID: 26858914 DOI: 10.1007/s40139-015-0094-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
674 Lin XH, Liu HH, Hsu SJ, Zhang R, Chen J, Chen J, Gao DM, Cui JF, Ren ZG, Chen RX. Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop. J Exp Clin Cancer Res 2020;39:64. [PMID: 32293507 DOI: 10.1186/s13046-020-01568-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
675 Lu S, Bennett RG, Kharbanda KK, Harrison-Findik DD. Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. World J Hepatol 2016; 8(4): 211-225 [PMID: 26855692 DOI: 10.4254/wjh.v8.i4.211] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
676 Zhao Y, Ma X, Wang J, He X, Hu Y, Zhang P, Wang R, Li R, Gong M, Luo S, Xiao X. Curcumin protects against CCl4-induced liver fibrosis in rats by inhibiting HIF-1α through an ERK-dependent pathway. Molecules 2014;19:18767-80. [PMID: 25407718 DOI: 10.3390/molecules191118767] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
677 Cordie A, Salama A, El-Sharkawy M, El-Nahaas SM, Khairy M, Elsharkawy A, Hassany M, Esmat G. Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C. J Med Virol 2018;90:1106-11. [PMID: 29476628 DOI: 10.1002/jmv.25064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
678 Wuestefeld T, Pesic M, Rudalska R, Dauch D, Longerich T, Kang TW, Yevsa T, Heinzmann F, Hoenicke L, Hohmeyer A, Potapova A, Rittelmeier I, Jarek M, Geffers R, Scharfe M, Klawonn F, Schirmacher P, Malek NP, Ott M, Nordheim A, Vogel A, Manns MP, Zender L. A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration. Cell 2013;153:389-401. [PMID: 23582328 DOI: 10.1016/j.cell.2013.03.026] [Cited by in Crossref: 89] [Cited by in F6Publishing: 75] [Article Influence: 11.1] [Reference Citation Analysis]
679 Ji J, Yu Q, Dai W, Wu L, Feng J, Zheng Y, Li Y, Guo C. Apigenin Alleviates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Autophagy via TGF-β1/Smad3 and p38/PPARα Pathways. PPAR Res 2021;2021:6651839. [PMID: 33574836 DOI: 10.1155/2021/6651839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
680 Wang B, Sun MY, Long AH, Cao HY, Ren S, Bian YQ, Lu X, Gu HT, Liu CH, Liu P. Yin-Chen-Hao-Tang alleviates biliary obstructive cirrhosis in rats by inhibiting biliary epithelial cell proliferation and activation. Pharmacogn Mag 2015;11:417-25. [PMID: 25829784 DOI: 10.4103/0973-1296.153098] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
681 Moran-Salvador E, Garcia-Macia M, Sivaharan A, Sabater L, Zaki MYW, Oakley F, Knox A, Page A, Luli S, Mann J, Mann DA. Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells. Gastroenterology 2019;157:1398-1412.e9. [PMID: 31352003 DOI: 10.1053/j.gastro.2019.07.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
682 周娟娟, 朱萱. 熊果酸抗肝纤维化作用及其机制的研究进展. 世界华人消化杂志 2015; 23(21): 3390-3395 [DOI: 10.11569/wcjd.v23.i21.3390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
683 Friedman SL. Protect thee from the sins of thy fathers? Nat Med. 2012;18:1331-1332. [PMID: 22961157 DOI: 10.1038/nm.2936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]